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With Excimer Laser Coronary Angioplasty: The 
ELCA Registry Experience. 3S4A 
Two-Center Experience With the Palmaz-Schatz 
Biliary Stent for Treating Vein Graft and Native 
Coronary Stenoses. 336A 
Use of Prolonged Perfusion Balloon Inflations of 60 
Minutes as a "Temporary Stent" to Salvage 
Initially Unsuccessful Coronary Interventions: 
Acute and Long-Term Outcome. 58A 
Utility of the Framingham Risk Factor Profile in 
Predicting Lake Events After Coronary 
Angioplasty • 68A 
Vessel Remodeling After Angiopla~ty: Comparative 
Anatomic Studies. 138A 
What Are the Lessons Learned from Clinical Trials in 
PTCA? iii 
Angioscopy 
Accuracy of Angioscopy in Diagnosing Endoluminal 
Lesions. 407 A 
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Angioscopic Versus Angiographic Detection of 
Intimal Dissection and Intracoronary Thrombus 0 
407A 
Can Angioscopic Findings Predict the Early 
Outcome of !'TCA? 0 271A 
Coronary Angioscopy in Patients With Acute 
Myocardial Infarction Undergoing Direct 
Balloon Angioplasty 0 364A 
Coronary Angioscopy: Digital Recording of Real•
Time Moving Color Images: Techniques and 
Applications 0 33SA 
Coronary Lesion Morphology by Angioscopy Versus 
Angiography: The Ability of Angiography to 
Detect Thrombi 0 406A 
Differential Sensitivity of White and Red Coronary 
Thrombi to Thrombolytic Therapy 0 4S2A 
Intracoronary Angioscopy Impacts Clinical Decision 
Making in Patients With Acute Coronary 
Syndromes 0 170A 
Prevention of Thrombus Formation by Local 
Delivery of Antithrornbotic Agents o 374A 
Qualitative Comparison of Intravascular Ultrasound 
and Angioscopy With Angiographic Assessment 
of Palmaz-Schatz Coronary Stents 0 72A 
Size and Color of Intracoronary Thrombi in Unstable 
Coronary Syndromes: Relation of Angioscopic 
Findings to Clinical Presentation 0 408A 
The Mechanism of Reocclusion After Successful 
Coronary Thrombolysis as Validated by 
Percutaneous Angioscopy 0 13A 
Unstable Angina: A Comparison of Angioscopic 
Findings Between Diabetic and Nondiabetic 
Patients 0 17lA 
Angiotensin II 
Activation of the Cardiac Renin-Angiotensin System 
in Response to Sodium Restriction 0 llSA 
Angiotensin IT Regulates Expression of Insulin-Like 
Growth Factor Binding Proteins in Vascular 
Smooth Muscle Cells 0 294A 
Angiotensin IT Selectively Increases Cardiac 
Adrenergic Activity in Patients With Heart 
Failure 0 21SA 
Angiotensin II-Induced Collagen mRNA Expression 
in Cardiac Fibroblasts Depends on Amocrine 
Production of Transforming Growth Factor-Beta 
lo43A 
Angiotensin-IT Induces Differential Changes in the 
Innervated and Denervated Limbs of Patients 
With Unilateral Brachial Plexus Injury o 479A 
Free Cytosolic Calcium and Proliferative Activity of 
Human Vascular Smooth Muscle Cells Are 
Regulated by L-Type Calcium Channel 
Modulators 0 348A 
Intrarenal Angiotensin II Antagonism Restores the 
Natriuretic Response to Acute Volume 
Expansion in Cyclosporine Treated Dogs 0 141A 
Regression of Renal Fibrosis and Damage in 
Experimental Renovascular Hypertension Using 
an Angiotensin Type I Receptor Antagonist 0 
332A 
Antiarrhythmia agents 
A Comparison of Holter Suppression Criteria for 
Declaring Drug Efficacy in Patients with 
Sustained Ventricular Tachyarrhythmias in the 
ESVEM Trial 0 279A 
A Randomized Placebo-Controlled Trial of 
Propafenone in the Prophylaxis of Paroxysmal 
Supraventricular Tachyarrhythmias 0 2S1A 
Acute Amiodarone Terminates Ventricular 
Fibrillation by Improving Intracellular Calcium 
Homeostasis in Isolated Perfused Rat Hearts 0 
282A 
Adenosine Causes Contraction of Human Placental 
Arteries and Veins In Vitro 0 439A 
Bretylium Causes a Use-Dependent Increase in 
Refractoriness During Ventricular Fibrillation 0 
184A 
Catecholamines Facilitate the Reverse Use•
Dependence of D,L-Sotalol in Humans 0 91A 
Conversion of Atrial Fibrillation and Flutter by 
Intravenous Ibutilide: A Multicenter Dose 
Response Study 0 227 A 
Early Hospital Discharge After Initiation of 
Amiodarone Therapy: Mortality and Cost o 280A 
Effect of Sotalol on the Circadian Variation of Heart 
Rate and QTc Interval 0 323A 
Effects of Amiodarone and Quinidine on 
Depolarization, JT Interval and Dispersion in 
Patients With Intraventricular Conduction Delay 
o179A 
Efficacy of Almokalant on Termination and 
Induction of Paroxysmal Supraventricular 
Tachycardia 0 227 A 
Electrocardiographic Effects of Oral MK-499, 
A New Class III Antiarrhythmic in Patients With 
Coronary Disease 0 92A 
Electrophysiologic Effects of the New Class 
III Antiarrhythmic Almokalant in Postinfarction 
Porcine Model 0 183A 
Flecainide Versus Propafenone in the 
Prevention of Paroxysmal Atrial Fibrillation: A 
Long-Term Randomized Multicenter Study 0 
91A 
High Dose Oral Amiodarone Loading Exerts 
Important Hemodynamic Actions in Patients 
With Congestive Heart Failure 0 384A 
Interaction Between Erythromycin and 
Disopyramide on Ventricular Repolarization in 
Dogs With Chronic Atrioventricular Block 0 
326A 
Intravenous Propafenone in Paroxysmal Atrial 
Fibrillation: A Randomized Placebo Controlled 
Double Blind Multicenter Clinical Trial 0 368A 
Modulation of the Electrophysiologic Effects 
of Ambasilide Induced by Beta-Adrenergic 
Stimulation in Isolated Ventricular Myocytes 0 
444A 
Pharmacological Profile of Two Human 
Cardiac Potassium Channels 0 87 A 
Prophylactic Lidocaine Was Commonly Used 
in the GUSTO Trial o 31SA 
Rapid Determination of Apparent Quinidine 
Binding Rates in In Vivo Canine Myocardium 
Using Combined Analysis of Incremental and 
Declining Conduction Velocities 0 88A 
Selective Effect of the Class III Agent 
Dofetilide on Potassium Currents in Guinea Pig 
Cardiomyocytes • 283A 
Selectivity of Class III Antiarrhythmic Drug 
Block on Human Cardiac Potassium Channels. 
282A 
Termination and Suppression of Experimental 
Canine Atrial Flutter by Dofetilide: Effects on 
Dispersion of Repolarization and Conduction 
Velocity. 443A 
Torsade de Pointes With Sotalol: Relationship 
of Gender to Risk. 279 A 
Antibodies 
An Enzyme Linked Immunosorbent Assay of 
Autoantibodies to Oxidized Low Density 
Lipoprotein as a Predictor of Coronary Artery 
Disease. 216A 
Monoclonal Antibody to P-Selectin (PBl.3) 
Protects Against Loss of Coronary Flow Reserve 
and Myocardial Segmental Dysfunction 
Following Coronary Artery Occlusion and 
Reperfusion in Dogs 0 440A 
Anticoagulants 
A Prospective Study of the Value of 
Monitoring Heparin Treatment After 
Thrombolysis With the Activated Clotting Time 
• S7A 
ACT (Activated Clotting Time) Determination 
in Vascular Sheaths: Are ACT Values Different 
Arterial and Venous Samples After Heparin 
Flush or Heparin Bolus Administration? 0 376A 
Activated Clotting Time Predicts Abrupt 
Closure Risk During Angioplasty 0 470A 
Activated Clotting Time Predicts Bleeding 
Complications From Angioplasty 0 184A 
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Anticoagulation for Atrial Fibrillation. xviii 
Asymptomatic Stroke in Patients With Chronic 
Nonrheumatic Atrial Fibrillation o441A 
Brief Profound Inhibition of Thrombin Attenuates 
Stenosis Following Balloon-Induced Arterial 
Injury in Hyperlipidemic Miniswine • 20A 
Can Aspirin Potentiate the Antithrombotic Effect of 
Heparin at Sites of Deep Vessel Injury and Vessel 
Stenosis? • S7A 
Coronary Stenting Without Coumadin Phase II • 
33SA 
Differential Effects of Heparin and of a Direct 
Thrombin Inhibitor on the Plasma Levels of 
Plasminogen Activator Inhibitor and Tissue 
Plasminogen Activator in Unstable Angina. S6A 
Effect of Low Molecular Weight Derrnatan Sulfate 
on Blood Coagulation, Clot-Bound Thrombin 
and Platelet Deposition at Low and High Shear 
Rates .260A 
Heparin Administration via Nomogram Versus 
Standard Approach in Venous and Arterial 
Disorders. 381A 
Hirulog in the Treatment of Unstable Angina: Results 
of the TIMI 7 Trial 0 S6A 
Impact of Clinical Site on Ischemic Events and 
Bleeding Complications: Results From the EPIC 
Trial.404A 
Inhibition of the Progression of Thrombus Growth on 
Preexisting Mural Thrombus: Targeting Optimal 
Therapy 0 64A 
Initial Experience With Hirudin and Streptokinase in 
Acute Myocardial Infarction: Results of the TIMI 
6Trial o 344A 
Is a PTT the Appropriate Marker for Direct Thrombin 
Inhibitor Effect? A Comparison of Hirudin and 
Hirulog 0 376A 
Optimal Intensity of Oral Anticoagulant Therapy in 
3404 Postmyocardial Infarction Patients o 412A 
Plasma Fibrin D-Dimer Levels in Patients With 
Atrial Fibrillation and Left Ventricular 
Aneurysms: Effects of Introducing Warfarin 
Therapy on Thrombogenesis • 227 A 
Predictors of Blood Loss and Bleeding 
Complications After Angioplasty 0 69A 
Quantitative Coronary Angiography of the Culprit 
Coronary Artery Lesion Using a Direct Thrombin 
Inhibitor Versus Heparin as Adjunctive Therapy 
to Streptokinase in Acute Myocardial Infarction 
• 34SA 
Recombinant Hirudin for Unstable Angina: A Pilot 
Multicenter Randomized Angiographic Trial 0 
363A 
Should aPTT Assays Be Standardized in Multicenter 
Clinical Trials Designed to Investigate the 
Benefits of Heparin? S7A 
The Association Between Heparin Concentration and 
Measured Anticoagulant Effect by Four 
Commercially Available ACT Assays 0 18SA 
Three Year Clinical Follow-Up After Palmaz-Schatz 
Coronary Stent Implantation 0 134A 
Update on the Clinical Role of the New Anti•
Thrombin Agents: Hirudin, Hirulog, and Others. 
xxix 
Warfarin Monitoring Evaluation of the 
Reproducibility of Fingerstick INR 
Determinations and Comparison With Value 
Obtained With Recombinant Thromboplastins 0 
47SA 
Antihypertensive therapy 
Antihypertensive Medication Use by Hypertensives 
in the Women Take Heart Project. 332A 
Antioxidants 
Allopurinol Lowers Defibrillation Thresholds. 8SA 
Cardioprotective Effects of Platelets Against 
Ischemia and Reperfusion Injury in the Isolated 
Rat Heart Are Related to Platelet Glutathione 
Redox Cycle Antioxidants 0 330A 
Do Plasma Antioxidant Levels Correlate With 
Endothelial Dysfunction in Subjects With 
Normal Total Cholesterol? • 482A 
530A SUBJECf INDEX 
Effect of Vitamins A, C and E on Oxidative 
Modification of LDL From 
Hypercholesterolentic Subjects. 431A 
Estrogen Adntinistration Inhibits Oxidative 
Modification of LDL in Postmenopausal Women 
.481A 
Natural Antioxidant Vitantins Reduce Coronary 
Artery Lesion Progression as Assessed by 
Sequential Coronary Angiography. 481A 
The Effects of Iron, Free Radicals, and Antioxidants 
on the Development of Atherosclerosis • 41A 
Aorta 
Aneurysm of the Ascending Thoracic Aorta and 
Arch: Surgical Results in the Current Era. 73A 
Atheromatous Plaques in the Thoracic Aorta Are 
Associated With Decreased Aortic Distensibility 
Evaluated With Transesophageal 
Echocardiography and Automatic Boundaries 
Detection. 146A 
Frequency and Distribution of Atherosclerosis in the 
Thoracic Aorta in Patients With Coronary Artery 
Disease • 145A 
Intraaortic Spring Coil Loops: Late Results. 359A 
Measurement of Thoracic Aortic Wall Thickness by 
Transesophageal Echocardiography: An In Vitro 
Validation. 145A 
Reproducibility of Atherosclerotic Plaque Area 
Measurements in the Descending Aorta by 
Transesophageal Echocardiography • 14SA 
Aortic coarctation 
Balloon Angioplasty Versus Surgical Correction for 
Aortic Coarctation in Infants Three Months of 
Age • 357A 
Intravascular Stents in Coarctation of the Aorta: 
Early Results and Intermediate Follow-Up. 
358A 
Single-Stage Repair of Aortic Arch Obstruction and 
Associated Intracardiac Defects Using the 
Anterior Approach in Infants. 7 A 
Aortic diseases 
Distribution of Mobile Aortic Masses and Their 
Relationship to Aortic Atherosclerosis: A 
Transesophageal Echocardiographic Study of the 
Thoracic Aorta. 442A 
Evaluation of Aortic Dissection, Aneurysm, 
Coarctation and Atheroma by Volume and 
Surface-Rendered Three-Dimensional 
Echocardiographic Studies Using Omniplane 
Imaging Probe. lOA 
Identification of Elastin Gene Deletions in 
Supravalvular Aortic Stenosis. 43A 
Intermediate-Term Follow-Up of Balloon 
Valvotomy of Congenital Aortic Stenosis. 392A 
Linkage Analysis of the Elastin Gene Region in 
Fantilial Supravalvar Aortic Stenosis. 305A 
Prognostic Significance of Thrombooccluded Aortic 
Dissection Diagnosed by Transesophageal 
Echocardiography. 146A 
Surgery of the Aorta. xxvi 
Aortic regurgitation 
A New Quantitative Method for Valvular 
Regurgitation: A Control Volume Technique and 
Magnetic Resonance. 176A 
Aortic Valve Regurgitation at Long-Term Follow-Up 
in Pediatric Patients After Balloon Aortic 
Valvotomy. 358A 
Descending Aortic Flow Reversal Predicts 
Ascending Aortic Regurgitant Fraction in 
Chronic Aortic Regurgitation. 457 A 
Indications for Aortic Valve Replacement in 
Children With Severe Aortic Regurgitation. 7 A 
Medical and Surgical Management of Chronic Mitral 
and Aortic Regurgitation. xxii 
Mitral Inflow Affects Aortic Regurgitation Jet Area: 
An In Vitro Study. 221A 
New Noninvasive Methods to Assess Valve 
Regurgitation. xxix 
Nifedipine Reduces and/or Delays Need for Valve 
Replacement in Asymptomatic Patients With 
Severe Aortic Regurgitation. 321A 
Quantification of Valvular Regurgitation Using a 
Proximal Isovelocity Contours Method and 
Magnetic Resonance Data. 17 SA 
Relation of Phasic Coronary Blood Flow Velocity 
Profile to Clinical and Hemodynamic 
Characteristics of Patients With Aortic Valve 
Disease • 456A 
The Huge LV: Long-Term Outcome Following 
Valve Replacement for Severe Aortic 
Regurgitation.321A 
Vasodilator Therapy in Chronic Aortic 
Regurgitation: Enalapril Versus Hydralazine. 
367A 
What Is the Prognosis of Trace Aortic Regurgitation? 
• 192A 
Aortic valve 
Assessment of Aortic Valve and Ascending Aorta by 
Transesophageal Echocardiography: Incremental 
Information of Multiplane Over Biplane Imaging 
• 388A 
Dynantic Multidimensional Visualization of 
Acquired and Congenital Abnormalities of the 
Aortic Valve, Aortic Root, and Related 
Structures in Children and Adults: Direct 
Depiction of the Pathomorphology by 
Transthoracic and Transesophageal Three•
Dimensional Echocardiography • lOA 
Feasibility of Aortic Diameter Measurement Using 
Multiplane Transesophageal Echocardiography 
for Presurgical Selection and Preparation of 
Homograft Aortic Valves. 387A 
Prognosis of Aortic Valve Disease in Children. 
321A 
Pulmonary Autograft Replacement of the Aortic 
Valve and Root: Results in 30 Patients Assessed 
by Magnetic Resonance Imaging. 278A 
Aortic valve stenosis 
Aortic Stenosis With Severe Left Ventricular 
Dysfunction Determinants of Operative 
Mortality and Long-Term Survival. 457A 
Calculation of Pressure Overestimation Due to 
Subvalvular Acceleration and Pressure Recovery 
in Mild Aortic Stenosis: A Computer Simulation 
• 321A 
Dobutamine Stress Echocardiography in Patients 
With Severe Aortic Stenosis and Low 
Transvalvular Gradients. 142A 
Marked Diastolic Dysfunction Immediately After 
Aortic Valve Replacement for Aortic Stenosis. 
278A 
Relation of Phasic Coronary Blood Flow Velocity 
Profile to Clinical and Hemodynantic 
Characteristics of Patients With Aortic Valve 
Disease • 456A 
Surgical Treatment of Congenital Aortic Valve 
Disease. xxii 
The Use of the Internal Thoracle Artery in Patients 
With Aortic Stenosis and Hypertrophied Hearts. 
189A 
Threshold of Hemodynantic Benefit of Aortic Valve 
Replacement in Aortic Stenosis With Doppler 
Preoperative Mean Gradients Less Than 50 mm 
Hg.456A 
Aortocoronary bypass 
Acetylcholine Infusion Stimulates EDRF Release 
From Saphenous Vein Grafts. 273A 
Angiographic Correlates of Lesion Relevance and 
Suitability for PTCA and CABG in the Bypass 
Angioplasty Revascularization Investigation 
(BARI) • 460A 
Angioplasty Versus Coronary Artery Bypa~s in 
Octogenarians. 346A 
Changes in Wall Morphology and Stiffness of 
Saphenous Vein Graft One Year After 
Aortocoronary Bypass Surgery: Serial 
Intravascular Ultrasound Assessment In Vivo. 
24lA 
Does Coronary Bypass Surgery Have Long-Term 
Benefit in Women? Analysis of 1,242 Women 
Followed Up to 20 Years. 346A 
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Does Percutaneous Revascularization of Ostial 
Saphenous Vein Grafts Stenoses Carry an 
Adverse Outcome? Comparison With Proximal 
Shaft Disease. 351A 
Exercise Thallium-201 Single Photon Entission 
Computed Tomography: An Effective Tool to 
Detect Late Coronary Artery Bypass Graft 
Stenosis. 2S4A 
Functional Evaluation of the Internal Mammary 
Artery Bypass Graft in the Early and Late 
Postoperative Period. I08A 
Gender Determines Survival From Coronary Bypass 
Surgery. 347 A 
Gender Has No Effect on Course or Outcome of 
Patients Requiring Emergency Surgery for Failed 
PTCA • 189A 
Graft Angioplasty Versus Multiple Reoperative 
Aortocoronary Bypass. 189A 
Hibernating Myocardium Shows Different Degrees 
of Structural Adaptation and Its Functional 
Downregulation Is Not Sufficient to Prevent 
Structural Deterioration. 8lA 
Is CABG Superior to PTCA in Patients on Chronic 
Renal Dialysis? .346A 
Prediction of Ventricular Arrhythntias by Ventricular 
Late Potentials in the Short- and Long-Term 
Follow-Up After Coronary Artery Bypass 
Grafting. 461A 
Quality of Life in Octogenarians After Open Heart 
Surgery • 304A 
Small Diameter Dacron Grafts Seeded With Omental 
Endothelial Cells for Coronary Artery Bypass 
Grafting. 379A 
Smoking Cessation and the Risk of Acute 
Myocardial Infarction and After Venous 
Coronary Artery Bypass Grafting: 15 Year 
Follow-Up. 460A 
The Use of the Internal Thoracle Artery in Patients 
With Aortic Stenosis and Hypertrophied Hearts. 
189A 
Women Are at Higher Risk for Early Coronary 
Artery Bypass Graft Closure. 346A 
Apolipoproteins 
Can Apo A-IV Gene Polymorphism Explain the 
Differences Between the Effects of Diet in 
Oriental and Western Populations? • 99A 
Inhibition of Atherogenesis in Apolipoprotein(a) 
Mice by the Addition of Apolipoprotein AI 
Transgene • 216A 
Lp(a) in Ischemic Heart Disease: The Quebec 
Cardiovascular Study. 482A 
Modulation of Coronary Heart Disease Risk by 
Apolipoprotein E Genotype. 217A 
Recombinant Human Apolipoprotein AI-Milano 
Reduces Injury-Induced Neointimal 
Thickening in Hypercholesterolentic Rabbits 
• 233A 
Arrhythmias 
A Link Between Ventricular Arrhythntias and 
Autonontic Imbalance in Congestive Heart 
Failure. 392A 
Alphal-Adrenoceptor Influence on the Incidence of 
Arrhythntias During Coronary Occlusion and 
Reperfusion in Anesthetized Dogs. 183A 
An Animal Model of Propafenone-Induced 
Atrial Proarrhythntia • 206A 
Antiarrhythntic Effect of Ischentic 
Preconditioning in Patients With Variant Angina 
·80A 
Approach to the Patient With Ventricular 
Arrhythntias and a Prolonged QTc • xxvi 
Arrhythntias in Infants and Children After 
Fontan Operation. 191A 
Ascertainment of Arrhythmogenic Right 
Ventricular Dysplasia: Angiographic Markers • 
399A 
Clinical and Echocardiographic Predictors of 
Exercise-Induced Supraventricular Arrhythmias 
in Healthy Volunteers. lOlA 
Combination Therapy With Type 1 
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Antiarrhythmic Drugs: Electrophysiologic 
Predictors of Efficacy. 36A 
Double Potentials Recorded in the Superior Vena 
Cava During Sinus Rhythm: Physiological or 
Pathological? • 369A 
Ebstein's and Arrhythmias: The Outcome After 
Surgical Repair. 100A 
Effect of an Isthmus on Anisotropic Conduction of 
Atrial Myocardium: A Possible Model of Slow 
Conduction. 467A 
Emergent Treatment of Arrhythmias • xxvii 
Endocavitary Ablation for Arrhythmias. xvi 
Epicardial Mapping Demonstrates a Predictable 
Arrhythmia Following Unsuccessful 
Transvenous Defibrillation Near Threshold. 
421A 
Intracoronary Arterial Embolization and 
Electrothrombosis: A Novel Technique 
Potentially Useful for Ablation of Cardiac 
Arrhythmias • 88A 
Joint Symposium European Society of Cardiology! 
American College of Cardiology. xiv 
Mediation of Mechanoelectrical Feedback by Ca2+•
Activated Potassium Channels. 88A 
Optimalization of Criteria to Differentiate VT From 
SVT in Wide QRS Tachycardia Using Neural 
Network Techniques. 266A 
P Wave Morphology During Automatic Atrial 
Tachycardia in Man • 250A 
QT Dispersion in Normal Subjects and Patients With 
Myocardial Infarction. 36A 
Risk Factors for Atrial Tachydysrhythmias After 
Fontan Operation. 100A 
The Frequency-Dependent Effects of Beta•
Adrenergic Sympathetic Stimulation on 
Ventricular Repolarization and Conduction in 
Humans. 371A 
The Pattern of Block of Stimulated Premature 
Impulses Determines the QRS Morphology of the 
Initial Beats of Inducible Monomorphic 
Ventricular Tachycardia. 481A 
The Use of Computer-Assisted Instruction Programs 
to Enhance Physician Skills in the Interpretation 
of Routine ECGs and Arrhythmias. 169A 
Time-Course and Severity of Arrhythmias in 
Conscious Untethered Rats During the First 48 
Hours After Myocardial Infarction. 318A 
Vagal Modulation of Ventricular Repolarization and 
Fibrillation in Cats. 44SA 
Ventricular Tachycardia and Sudden Death 
Associated With Sleep in German Shepherd 
Dogs .445A 
VT Length Is a Better Predictor of Mortality Than 
Frequency of VT or VPD in Patients With 
Chronic Heart Failure. 391A 
Arrhythmias, treatment of 
"Curing" Arrhythmias With Radiofrequency 
Ablation. xv 
"Stored Electrograms" Accuracy in Arrhythmia 
Classification and Clinical Value in 
Cardioverter-Defibrillator Therapy. 420A 
Ablation of Atrial Fibrillation in a Dog Model. 
276A 
Approach to the Patient With Ventricular 
Arrhythmias and a Prolonged QTc • xxvi 
Assessment of Antiarrhythmic Drug Action on Local 
Atrial Refractoriness During Atrial Fibrillation in 
Humans. 458A 
Atrioventricular Activation Sequence at the Mitral 
Annulus in Left Free Wall Accessory Pathways. 
92A 
Catheter Ablation for Successful Management of 
Left Posterior Fascicular Tachycardia: An 
Approach Guided by Recording of Fascicular 
Potentials. 36A 
Catheter Ablation for Supraventricular Arrhythmias 
• viii 
Chronic Changes in Defibrillation Parameters With a 
Transvenous Lead System. 112A 
Classification of Shocks by History Versus 
Classification by Stored Electrograms in Patients 
With Implantable Defibrillators. 205A 
Clinical Outcome of Patients With Refractory 
Ventricular TachycardialFibrillation Treated 
With Implantable Cardioverter-Defibrillator and 
No Concomitant Antiarrhythmic Drug Therapy. 
204A 
Combination Therapy With Type I Antiarrhythmic 
Drugs: Electrophysiologic Predictors of Efficacy 
.36A 
Comparison of Monophasic and Biphasic Shocks in 
Cardioversion of Ventricular Tachycardia in the 
Canine Infarct Model • 208A 
Current Management of Atrial Fibrillation. xxiii 
Do Infants Have Medically Refractory 
Supraventricular Tachycardia? • 250A 
Does Microwave Heating in Saline Predict the 
Three-Dimensional Heating Pattern in 
Myocardium?3SA 
Effects of Amiodarone and Quinidine on 
Depolarization, JT Interval and Dispersion in 
Patients With Intraventricular Conduction Delay 
• 179A 
Efficacy of Almokalant on Termination and 
Induction of Paroxysmal Supraventricular 
Tachycardia. 227 A 
Efficacy of Amiodarone in Patients With Ventricular 
Tachycardia and Chronic Chagasic 
Cardiomyopathy. 322A 
Efficacy of Low Dose Amiodarone in Symptomatic 
Sustained Drug Refractory Atrial Fibrillation•
Flutter. 228A 
Electrograms Recorded From the Ablation Site 
During the Application of Radiofrequency 
Energy in Patients Undergoing Catheter Ablation 
.84A 
Electrophysiologic Effects of High Dose Oral 
Amiodarone Load in Heart Failure Patients. 
203A 
Endocardial Resection for Ventricular Tachycardia 
in 353 Patients. 480A 
Improving Cost-Effectiveness of the Transvenous 
Implantable Cardioverter-Defibrillator. 206A 
Inverse Relationship of Defibrillation Impedance and 
Delivered Energy. 87 A 
Long-Term Efficacy and Safety of 
Electrophysiologic Guided Sotalol Therapy for 
Life-Threatening Ventricular Arrhythmias. 
322A 
Management of Arrhythmias in Children. xi 
Predictive Value of Combined Holter Monitoring 
and Electrophysiologic Testing in the ESVEM 
Study.279A 
Quality of Life After Radiofrequency Catheter 
Ablation for Supraventricular Arrhythmias. 
225A 
Radiofrequency Ablation of Atrial Tissues: Power 
Requirements. 276A 
Results of the Maze Procedure in Patients 
Undergoing Mitral Valve Surgery. 190A 
Rise in Defibrillation Threshold Early After 
Implantation of Nonthoracotomy Defibrillation 
Lead Systems: Incidence and Predictors. 112A 
Risk and Benefit of Combined Maze Procedure for 
Atrial Fibrillation Associated With Valvular 
Heart Diseases. 459A 
Ryanodine Prevents Early Afterdepolarizations 
Dependent Torsade de Pointes Arrhythmias in 
the Intact Heart. 282A 
Selective Effect of the Class III Agent Dofetilide on 
Potassium Currents in Guinea Pig 
Cardiomyocytes • 283A 
Sinus Node Modification for Inappropriate Sinus 
Tachycardia. 155A 
Site-Dependent Variability of Electrode Temperature 
During Radiofrequency Catheter Ablation 
Procedures. 276A 
Stability: An ICD Detection Criteria Useful in 
Discriminating Atrial Fibrillation From 
Ventricular Tachycardia. 126A 
SUBJECT INDEX 531A 
The Effect of Tilt on Defibrillation Efficacy. 86A 
Which Ventricular Arrhythmias Require Treatment? 
• xvii 
Arteries 
A Windows Software Application to Assess Arterial 
Dynamic Behavior: A Useful Tool in Laboratory 
and Noninvasive Clinical Research. 4A 
Evaluation of Systemic Arterial Mechanical 
Properties During Septic Shock in the Absence of 
Volume Resuscitation. 165A 
False Aneurysm of Arterial Puncture Site After 
Coronary Angioplasty: Real Incidence and 
Therapy • 68A 
Mechanical Compression (FemostopTM) Alone 
Versus Combined Collagen Application 
(VasoseaITM) and FemostopTM for Arterial 
Puncture Site Closure After Coronary Stent 
Implantation: A Randomized Trial. 355A 
Radial Artery Mass Is Determined by the Level of 
Arterial Pressure and Correlated With Left 
Ventricular Mass. 114A 
Rapid Evaluation of Three-Dimensional Architecture 
of Normal and Atherosclerotic Rabbit Femoral 
Arteries Using Confocal Scanning Laser 
Microscopy. 378A 
Reduced Time for Femoral Venipuncture by Simple 
Bedside Application of Valsalva Maneuver: The 
Poor Cardiologist's Smart Needle. 381A 
Arteriosclerosis 
Characterization of Vascular Mechanical Properties 
With Three-Dimensional Intravascular 
Ultrasound and Finite Element Analysis. 378A 
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Expression In Acute Coronary Syndromes. 41A 
Monocyte Tissue Factor Expression: A Rapid and 
Sensitive Flow-Cytometric Method for 
Assessing Cellular Procoagulants • 40A 
Blood coagulation 
Activated Clotting Times and Whole Blood 
Activated Partial Thromboplastin Times During 
Coronary Intervention. 185A 
Influence of Lipids and Fibrinogen on Plasma and 
Blood Viscosity. 216A 
), a PTT the Appropriate Marker for Direct Thrombin 
Inhibitor Effect? A Comparison of Hirudin and 
Hirulog • 376A 
Monocyte Tissue Factor Expression: A Rapid and 
Sensitive Flow-Cytometric Method for 
Assessing Cellular Procoagulants • 40A 
Blood flow 
ATP-K Channel Blockade Improves Coronary 
Autoregulation. 379A 
Attenuated Response of Blood Flow Redistribution 
in Nonexercising Organs in Patients With Heart 
Failure. 400A 
Clinical and Angiographic Features of the No•
Reflow Phenomenon. 286A 
Colored 2-D Blood Flow Structure on B-Mode 
Echography Using Two-Dimensional Moving 
Target Indication. 410A 
Comparative Value of Myocardial Contrast 
Echocardiography, Dobutamine 
Echocardiography, and Sestamibi SPECf for 
Detecting Myocardial Viability in Patients With 
Resting Wall Motion Abnormalities. 468A 
Comparison of Normalized Uptake Index, 
Hyperemic Blood Flow, Flow Reserve, and 
Minimal Coronary Resistance for Predicting 
Stenosis Severity in Chronic Coronary Artery 
Disease Patients • 116A 
Coronary Revascularization Improves the Extent of 
Heterogeneity of Blood Flow in Dysfunctional 
Myocardium. 161A 
Effect of a Severe Stenosis on Fibrin(ogen) 
Deposition on Damaged Vessel Wall in Arterial 
Thrombosis.41A 
Effect of Estradiol-17beta on Forearm Blood Flow in 
Menopausal Women: A Double Blind 
Randomized Study. 273A 
Effects of Modified Pharmacologic Stress 
Approaches on Hyperemic Myocardial Blood 
Flow. 127A 
Myocardial Contrast Echocardiography: Correlation 
of Resting Perfusion Defects in Humans to 
Sestamibi SPECf • 450A 
Optimizing In Vivo Performance of Coronary 
Autoperfusion Balloons: A Doppler Flow Study 
.407A 
Quantification of the Absolute Volumetric Coronary 
Flow With Dual-Energy Digital Subtraction 
Angiography. 91A 
Quantitation of Coronary Collateral Flow Velocity 
by Anatomic Pathway in Patients. 415A 
Validation of a Noninvasive Method of Measuring 
Coronary Blood Flow Reserve: A Split Dose 
Thallium-20l Rest/Stress Imaging. 256A 
Blood pressure 
Higher Arterial Blood Pressure Is Associated With 
Lower Mortality but Higher Risk of Stroke: 
Results From the GUSTO Trial. 28A 
Overreliance on Diastolic Blood Pressure: 
Framingham Study. 114A 
Paradoxical Effect of Intravenous Diltiazem on 
Aortic Elastic Properties. 377 A 
KEY: Abstract or Session Title. page number (Abstracts = Arabic page numbers; Education Sessions = Roman numeral page numbers) 
JACC February 1994:523A-574A 
Blood pressure detennination 
Effects of Honnone Replacement Therapy on Blood 
Pressure in Hypertensive Women. 348A 
Body surface mapping 
Electrocardiographic Evidence of Nonunifonn 
Ventricular Recovery in Patients With Idiopathic 
Ventricular Fibrillation. 370A 
On-Une Computerized Body Surface Pace Mapping: 
Brain 
A Novel Method of Localizing the Origin of 
Ventricular Tachycardias. 51A 
Silent Cerebral Infarction in Patients With 
Asymptomatic and Symptomatic Paroxysmal 
Atrial Fibrillation. 249A 
Calcium 
Attenuation of Calcium Overload and Delay of Cell 
Death by Chlorpromazine and Trifluoperazine 
in Cardiomyocytes During Chemical Anoxia 
.31A 
Beat to Beat rCa 2+], Transients and Left Ventricular 
Function During Brief Bouts of Ischemia in Rats 
• 317A 
Cellular Cholesterol Modulation Affects the 
Intracellular Calcium Ion Concentration in 
Cardiomyocytes Independent of the Membrane 
Hnidity • 463A 
Coronary Calcium Predicts Coronary Heart Disease 
in High Risk Asymptomatic Adults. 180A 
Diastolic Dysfunction in Demand Ischemia: Relative 
Roles of Myocyte Ca++ Overload and High 
Energy Phosphate Depletion. 229A 
Do Changes in Calcium Transport During Changes in 
Contractility Affect Cardiac Energetics? • 94A 
Effects of Chronic Beta-Adrenergic Blockade on 
Excitation-Contraction Coupling in Noninfarcted 
Myocardium.32A 
Ethnic Differences in Coronary Calcium Prevalence 
.18OA 
Influence of Perfusate Calcium Concentration on 
Oxygen Free Radical Generation. 463A 
Intracellular Calcium Transients in Postextrasystolic 
Beats: Mechanical Altemans Associated With 
Intracellular Calcium Excess. 262A 
Is Left Ventricular Enlargement in Relatives of 
Patients With Dilated Cardiomyopathy Early 
Disease? • 341A 
New Ultrafast Computed Tomography Algorithm 
Can Accurately Predict Mass of Calcium in 
Diseased Coronary Arteries • 208A 
Probability of Multivessel Coronary Artery Disease 
in 531 Patients Based Upon Ultrafast CT (UFCT) 
Coronary Calcification: A Multicenter Study. 
179A 
Sarcoplasmic Reticulum Calcium Overload: A 
Mechanism for Contractile Dysfunction in Heart 
Failure • 263A 
The Quantity of Coronary Artery Calcium Predicts 
Maximum Stenosis Better Than Risk Factors. 
401A 
The Value of Receiver Operating Characteristic 
Curve Analysis to Detect Coronary Artery 
Disease Determined by Coronary Calcification 
on Ultrafast CT: A Multicenter Study. 208A 
Calcium channel blockers 
Amlodipine Prevents In Vivo LDL-Oxidation, 
Preserves Vitamin E, Inhibits Hyperinsulinemia, 
and Suppresses Plaque Growth. 437 A 
Amlodipine Reduces the Total Ischemic Burden of 
Patients With Coronary Disease: Double Blind 
Circadian Antiischemia Program in Europe 
(CAPE) Trial. 53A 
Assessment of Coronary Arterial Wall Elasticity 
Using Intravascular Ultrasound: Alteration 
Induced by Sublingual Nitadipina in Humans. 
242A 
Effect of Long Acting Oral Felodipine and 
Nifedipine on Left Ventricular Contractility in 
Patients With Systemic Hypertension: 
Differentiation Between Reflex Sympathetic and 
Direct Contractile Responses. 348A 
Effects of a New Calcium Channel Blocker in 
Patients With Stable Angina Pectoris. 416A 
Efficacy and Safety of Extended Release Nisoldipine 
as Monotherapy for Chronic Stable Angina 
Pectoris. 267 A 
Estimation of the Serum Digitalis Concentration 
Using Saliva. 92A 
Hunarizine as a Pharmacologic Probe to Identify 
Triggered Activity in Patients With Cardiac 
Arrhythmias. 228A 
Free Cytosolic Calcium and Proliferative Activity of 
Human Vascular Smooth Muscle Cells Are 
Regulated by L-Type Calcium Channel 
Modulators. 348A 
Mechanism of Ischemia Suppression by Amlodipine 
and Atenolol on Exercise Treadmill Testing and 
Ambulatory Monitoring. 53A 
Nisoldipine Therapy Improves Resting 
Abnormalities in Myocardial Perfusion in 
Patients With Severe Ischemic Left Ventricular 
Dysfunction. 383A 
Paradoxical Effect of Intravenous Diltiazem on 
Aortic Elastic Properties. 377 A 
Potent Antifibrillatory Effect of Combined Blockade 
of Calcium Channels and Serotonin 5-HT2 
Receptors With LU-49938 During Myocardial 
Ischemia and Reperfusion in Canines. 42A 
Prescription of Calcium Antagonists After 
Myocardial Infarction: The GISSI Experience • 
210A 
Prevention of Transplant Accelerated Coronary 
Vascular Disease With Diltiazem • 23lA 
Restoration of Endothelial Function in Monkeys 
With Atherogenic LDL Levels Through 
Prevention of In Vivo LDL Oxidation and 
Membrane Upid Bilayer Stabilization by 
Amlodipine • 162A 
Stress-Induced Hemodynamic and Hemostatic Acute 
Risk Factors in Patients With Hypertension: 
Effect of Verapamil • 333A 
The Calcium Channel Blocker Felodipine Protects 
Against Ischemia-Reperfusion Injury by a 
Mechanism Other Than Reducing O2 Demand. 
199A 
Cardiac arrest 
Cardiac Resuscitation: Role of N2 and O2 • 152A 
Cerebral Hypoperfusion Following Low How 
Cardiopulmonary Bypass and Hypothermic 
Circulatory Arrest. 236A 
Circumstances Surrounding Out-of-Hospital Cardiac 
Arrest in the Maastricht Area • 265A 
Evaluation of Active Compression-Decompression 
CPR in Victims of Out-of-Hospital 
Cardiopulmonary Arrest. 440A 
Syncope and Its Significance in Acute Myocardial 
Infarction. 312A 
Cardiac mapping 
Differential Effect of d-Sotalol on Nonnal and 
Infarcted Tissue in the Canine Infarct Model. 
398A 
Observations From Epicardial Maps on the 
Termination of Atrial Fibrillation in a Swine 
Model. 458A 
Percutaneous Computerized Electrical Activation 
Mapping of the Heart via Multipolar Electrode 
Catheters in the Coronary Arteries and Veins in 
Dogs.481A 
Termination of Circus Movement Atrial 
Hutter by the New 'JYpe-III-Agent Dofetilide: 
Differential Effects on the Components of the 
Reentrant Pathway. 206A 
Three-Dimensional Mapping of Cesium 
Chloride-Induced Ventricular Arrhythmias. 
467A 
Cardiac output 
A Computerized Method for Calculating 
Cardiac Output Based on Real-Time Color 
Doppler Images Using the Proximal How 
Convergence Technique: Experimental Studies 
in an Animal Model. 409A 
SUBJECT INDEX 
New Principle for Long-Tenn Cardiac Output 
Measurement. 182A 
535A 
Stroke Volume and Cardiac Output Assessment 
Using Fourier Velocity-Encoded Magnetic 
Resonance Imaging. 89A 
Cardiac pacing, artificial 
Comparison of Long-Tenn Chronic Epicardial and 
Endocardial Pacing Electrode Thresholds in 
Children. 305A 
Safety of Low Output (2.5/1.6 Volt) Pacing in 
Children From Time of Implant: Six Year 
Experience With Steroid-Eluting Electrodes. 
49A 
Cardiac tamponade 
Feasibility and Utility of Percutaneous Pericardial 
Biopsy as an Adjunct to Pericardiocentesis or 
Balloon Pericardiotomy for the Diagnosis and 
Treatment of Pericardial Disease • 27 SA 
Management of Cardiac Tamponade by 
Percutaneous Balloon Pericardiotomy. xv 
Percutaneous Balloon Pericardiotomy for the 
Treatment of Effusive Pericardial Disease: 104 
Patient Follow-Up. 274A 
Pericardial Effusion in Patients With Cancer: Natural 
History and Management Strategies. 275A 
Treatment of Rupture of Left Ventricular Free Wall 
With Fibrin-Glue: Experimental Study and 
Clinical Experience. 152A 
Cardiac volume 
Calibration of Conductance Catheter Ventricular 
Volume for Parallel Conductance by Dual•
Frequency Technique. 165A 
Collateral Developing After Myocardial Infarction 
Prevents Subsequent Dilatation of Left Ventricle 
• 269A 
Hemodynamic Changes During Exercise After 
Exposure to Low Level Carbon Monoxide in 
Patients With Ischemic Heart Disease. 67 A 
Improved Correlation Between Echo-Contrast 
Derived End Diastolic Volume and Left 
Ventriculography Using Intravenous Contrast 
Echo .468A 
Cardiomyopathies 
Abnormal Singal-Averaged Electrocardiogram in 
Patients With Nonischemic Dilated 
Cardiomyopathy: Correlation With Ventricular 
Tachyarrhythmias? • 254A 
Acute Evaluation of DOD Versus DOOR Mode 
Predicts Additional Benefit of Rate Adaptive 
Pacing in Hypertrophic Cardiomyopathy. lOA 
Acute Hemodynamic Assessment Fails to Identify 
Hypertrophic Cardiomyopathy Patients 
Responsive to DOD Pacing. 324A 
Acute Pacing Studies Are Not Valuable in Predicting 
Long-Tenn Benefits of DOD Pacing for LV 
Outflow Obstruction in Hypertrophic 
Cardiomyopathy. lOA 
Ascertainment of Arthythmogenic Right Ventricular 
Dysplasia: Angiographic Markers. 399A 
Assessment of Myocardial Perfusion and Oxidative 
Metabolism Using 15 0 and Positron Emission 
Tomography in Cardiomyopathy. 161A 
Atrioventricular Pacing Relieves Obstruction but 
Impairs Diastolic Function in Hypertrophic 
Cardiomyopathy. lOA 
Autonomic Dysfunction Evidenced by Heart Rate 
Variability Abnormalities in Latent or 
Indeterminate Phase of Chagas Disease. 15lA 
Chagas Disease Cardiopathy: Antigenic Mimicry 
Between Trypanosoma Cruzi and Heart Myosin 
With Clinico-Biological Relevance. 45A 
Changes in Sympatho-Vagal Balance Are Associated 
With Variability of Ventricular Arrhythmia 
Complexity in Idiopathic Dilated 
Cardiomyopathy. 371A 
Changes of Left Ventricular Systolic Function by 
Quantitative Echo-Doppler From a Prospective 
Long-Tenn Controlled Study of HIV-Infected 
Patients • 364A 
Characterization of a Heart-Specific and 
536A SUBJECT INDEX 
Developmentally Regulated Promoter in 
Transgenic Mice. 261A 
Chronic Opioid Receptor Blockade Improved 
Myocardial Mechanical Function and Beta•
Adrenergic Responsiveness in Congestive Heart 
Failure. 213A 
Comparison of the Echocardiographic and Clinical 
Findings in "HOCM-Like" and "Typical" 
Cardiac Amyloidosis. lllA 
Comparison of the Impact of Exercise on Left 
Ventricular Filling in Normal Subjects and With 
Dilated Cardiomyopathy. 419A 
Contractile Reserve in Patients With Peripartum 
Cardiomyopathy and Recovered Left Ventricular 
Function. 430A 
Contributions of Nitric Oxide to Basal Vasomotor 
Tone in Patients With Heart Failure. 272A 
Coronary Flow Reserve Measurement Allows 
Differentiation of Hypertrophic Cardiomyopathy 
From the Athlete's Heart. 160A 
Detection of a Regional Myopathic Process in 
Pacing-Induced Heart Failure Using Ultrasonic 
Integrated Backscatter. 243A 
Diastolic Transmitral Flow in Dilated 
Cardiomyopathy Following Long-Term Beta•
Blockade Treatroent • 340A 
Differences in Vasodilator Response by Race in 
Heart Failure: VHeFT • 382A 
Dilated Cardiomyopathy: Correlation Between 
Myocardial Catecholamine Hemodynamics and 
Long Time Survival. 148A 
Dobutarnine Echocardiography to Distinguish 
Ischemic From Nonischemic Dilated 
Cardiomyopathy. 149A 
Dose-Response Characteristics, Time-Course, and 
Hemodynamic Responses to QW3600, an 
Ultrasonic Contrast Agent Capable of 
Myocardial Opacification by Intravenous 
Injection. 393A 
Dual Chamber Pacing Is Effective Therapy for 
Hypertrophic Cardiomyopathy Patients With 
Provocable LV Outflow Tract Obstruction and 
Symptoms Refractory to Medical Therapy. llA 
Early Impairment of Coronary Microvascular 
Function Dilated Cardiomyopathy. 160A 
Echocardiography Abnormalities in Chronic Cocaine 
Users .lS0A 
Effect of Thermal Vasodilation on Coronary Blood 
Flow and Myocardial Metabolism. 2S8A 
Effects of Myocardial Muscarinic Stimulation on 
Dobutarnine Stimulated Inotropic Responses in 
the Normal and Failing Human Left Ventricle. 
454A 
Enhanced Sympathetic Activity Identified by Heart 
Rate Variability Analysis in Hypertrophic 
Cardiomyopathy. 47 A 
Enterovirus in Dilated Cardiomyopathic Hearts: 
Molecular Evidence Using PCR and Nucleotide 
Sequencing of the Amplified Product. 262A 
Epidermal Growth Factor Limits Left Ventricular 
Hypertrophy in Uremic Rats Independent of 
Blood Pressure Response. 97 A 
Exercise Training Improves Diastolic Filling at Rest 
and During Exercise in Patients With Dilated 
Cardiomyopathy. 399A 
Expression of an Inducible NO Synthase in Heart 
Tissue From Patients With Inflammatory Heart 
Disease. 263A 
Factors Predicting Long-Term Outcome in Patients 
With Acute Myocarditis. 364A 
Familial Dilated Cardiomyopathy Is Not Linked to 
the P-Myosin Heavy Chain Gene. 428A 
Hypertrophic Cardiomyopathy: New Advances. xxv 
Implantation of Nonthoracotomy Cardioverter•
Defibrillators in Patients With Hypertrophic 
Cardiomyopathy. ll2A 
Importance of the Collagen Matrix in Young Patients 
With Hypertrophic Cardiomyopathy and Sudden 
Death .llOA 
In Vivo Detection of Trypanosoma Cruzi in Hearts of 
Patients With Chronic Chagas Disease. ISlA 
Increased Frequency of Organ-Specific Cardiac 
Antibodies in Asymptomatic Relatives of 
Patients With Familial and Nonfamilial Dilated 
Cardiomyopathy. 341A 
Increased Left Ventricular Mass, Rather Than 
Atrophy, Is a Precursor of Cardiomyopathy in 
AIDS Patients Despite Significant Loss of Body 
Mass • 36SA 
Influence of Exercise and Sport Activity on 
Functional Symptoms and Ventricular 
Arrhythmias in Arrhythmogenic Right 
Ventricular Disease. 34A 
Initial Results of Combined Mitral Leaflet Extension 
and Myotomy-Myectomy in Patients With 
Hypertrophic Cardiomyopathy. lSOA 
Interstitial Fibrosis as a Substrate of Spontaneous 
Nonsustained Ventricular Tachycardia in 
Idiopathic Dilated Cardiomyopathy. 340A 
Is Hypertrophic Cardiomyopathy in the Elderly a 
Heterogenous Diagnosis? • 46SA 
Lack of Ejection Fraction Increase With Exercise 
Predicts the Progression to Left Ventricular 
Systolic Dysfunction in Hypertrophic 
Cardiomyopathy. llOA 
Late Cardiotoxicity Following Childhood 
Malignancy: The Effects of Gender and 
Doxorubicin Dose • 120A 
Left Ventricular Dilatation in HIV Infection: The 
Role of Clinical Disease Stage and Zidovudine 
Therapy. 36SA 
Length of Disease Correlates With Increased Left 
Ventricular Mass and Impaired Early Diastolic 
Function in Patients With Scleroderma. lS0A 
Levels of Soluble Interleukin-2 Receptor in Dilated 
Cardiomyopathy: Clinical and Histological 
Correlates • 214A 
Long-Term Prognosis of Arrhythmogenic Right 
Ventricular Disease: Follow-Up of74 Patients • 
203A 
Loss of Myofibrillar Components Predicts Left 
Ventricular Remodeling in Idiopathic Dilated 
Cardiomyopathy. 340A 
Lyme Disease Is Not a Common Cause of Idiopathic 
Dilated Cardiomyopathy. 428A 
Magnetic Resonance Imaging Determines the Extent 
of Fibrosis in Patients With Endomyocardial 
Fibrosis. 149A 
Management and Prognosis of Hypertrophic 
Cardiomyopathies • xxvi 
Management of Hypertrophic Cardiomyopathy in 
Children. xii 
Mechanism of Relief in Hypertrophic 
Cardiomyopathy: Characterization of Dual 
Chamber Pacing-Induced and Septal Ablation•
Induced Left Ventricular Dyssynchrony Using 
Fourier Phase Analysis. 349A 
Mitral Regurgitation by Echocardiography Predicts 
18 Months Survival in Dilated Cardiomyopathy. 
21A 
Morphologic Expression of Hypertrophic 
Cardiomyopathy Differs in North American and 
European Patients. llOA 
Myocardial Contrast Echocardiography: Assessment 
of Myocardial Perfusion of Dilated 
Cardiomyopathy Patients With Comparison to 
Thallium Uptake by SPEeT • 394A 
Neural Network Performance in Recognizing 
Echocardiographic Pixel Luminance Patterns. 
182A 
New Approach With Gd-DTPA Enhanced Magnetic 
Resonance Imaging to Evaluate Myocardial 
Tissue Characterization With Cardiac Histology 
.44SA 
Obstructive Hypertrophic Cardiomyopathy Treated 
By DDD Pacing: The Major Importance of AV 
Synchrony • llA 
Potential Diagnostic Role of Circumferential 
Thallium Washout Analysis in Patients With 
Hypertrophic Cardiomyopathy. IlIA 
JACC February 1994:523A-574A 
Predictors of Outcome in Dilated Cardiomyopathy • 
399A 
Prognostic Implications of Pulmonary Venous Flow 
Pattern Assessed by Transesophageal 
Echocardiography in Dilated Cardiomyopathy • 
361A 
Prognostic Stratification of Patients With Idiopathic 
Dilated Cardiomyopathy by Doppler 
Echocardiography of Left Ventricular Filling. 
340A 
Risk Stratification of Asymptomatic Patients With 
Hypertrophic Cardiomyopathy. llOA 
Safety of Defibrillator Implantation in Patients With 
Hypertrophic Cardiomyopathy. lIA 
Systolic and Diastolic Dysfunction Among Patients 
With the Clinical Diagnosis of Dilated 
Cardiomyopathy. 469A 
The Standard ECG: A Screening Test for 
Hypertrophic Cardiomyopathy? • 149A 
Cardiomyoplasty 
Cardiomyoplasty: Effect of Latissimus Dorsi Muscle 
Contraction on Exercise Capacity. 471A 
Cardiomyoplasty: Hemodynamic Effect of 
Latissimus Dorsi Muscle Contraction After Six 
Months. 430A 
Doppler Echocardiographic Demonstration of 
Improved Systolic Function After Dynamic 
Cardiomyoplasty • 74A 
Factors Associated With Acute Hospital Mortality 
Following a Latissimus Dorsi Cardiomyoplasty • 
74A 
Cardioplegia 
Altered p-Adrenergic and Cyclic AMP-Mediated 
Coronary Microvascular Responses After 
Crystalloid Cardioplegia. 303A 
Comparison of Left Ventricular Performance 
Immediately After Aortic Valve Replacement 
Using Crystalloid or Blood Cardioplegia. 304A 
Increased Systemic Lactate Production During 
Normothermic Bypass: The Cause of Elevated 
Coronary Sinus Lactate During Continuous 
Cardioplegia. 303A 
Multidose Cardioplegia Is Safe and Effective in 
Newborn Hearts. 237A 
Retrograde Cardioplegia Does Not Perfuse the Right 
Ventricle. 302A 
Warm Continuous Retrograde Cardioplegia: The 
Importance of High Flow Rates for Myocardial 
ProtectionlPatient Outcome. 303A 
Cardiopulmonary development 
Differentiation of Cells With Conduction System 
Phenotype From Fetal Ventricular Myocytes • 
330A 
Cardiopulmonary resuscitation 
A Randomized Prospective Trial of Active 
Compression-Decompression Cardiopulmonary 
Resuscitation During Asystole or 
Electromechanical Dissociation • 44IA 
Aminophylline Does Not Improve the Outcome of 
Resuscitation From Prolonged Ventricular 
Fibrillation in Dogs. IS2A 
Bystander Initiated CPR Maintains Ventricular 
Fibrillation and Triples Survival After Witnessed 
out of Hospital Cardiac Arrest. lS3A 
Cardiac Resuscitation: Role of N2 and 02 • lS2A 
Cardiopulmonary Resuscitation: New Techniques, 
Results, and Ethical Dilemmas • xxi 
Emergency Revascularization for Refractory 
Ventricular Fibrillation. 440A 
Evaluation of Active Compression-Decompression 
CPR in Victims of Out-of-Hospital 
Cardiopulmonary Arrest. 440A 
Incidence but Not Duration of Silent Myocardial 
Ischemia Correlates With Severity of Coronary 
Artery Disease. 132A 
The Profile of Basic Life Support Course Trainees: 
Should Course Design Be Restructured? • ISlA 
Treatroent of Rupture of Left Ventricular Free Wall 
With Fibrin-Glue: Experimental Study and 
Clinical Experience. lS2A 
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Cardiovascular disease 
A Database for Multimedia Computer Assisted 
Instruction. 168A 
Impairment of Cardiac and Endothelial Function Is 
Independent From Blood Pressure Increase in 
Transgenic Rats Expressing the Renin-2 Gene. 
347A 
Regional and Ethnic Comparison of Total and 
Specific Cardiovascular Disease Mortality Rates 
in New York City, 1990. SOA 
Sources and Characteristics of Patients Suitable for 
Randomized Coronary Artery Disease Trials: An 
ACIP Database Study. 24M 
Women Are at Higher Risk for Early Coronary 
Artery Bypass Graft Closure. 346A 
Cardiovascular disease prevention 
Evaluation of Syncope. ix 
Hormone Replacement After Menopause: 
Importance of Heart Disease in Women's 
Decision Making. SIA 
Predictors of Future Coronary Events in 
Asymptomatic Siblings of People With 
Premature Coronary Artery Disease. 264A 
Serum Cholesterol Levels After Coronary 
Angioplasty in Men and Women. 299A 
Carotid arteries 
Aging Causes Parallel Remodeling of Descending 
Thoracic Aorta and Carotid Artery. lOlA 
Percutaneous Transluminal Carotid Angioplasty: 
Early Experience. 474A 
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AutocrinelParacrine Trophic Function of Acidic 
Fibroblast Growth Factor for Cardiac Myocytes • 
98A 
Cells 
Asymmetric Injury at the Ends of Ventricular Cells 
Induced by Strong Electric Field Stimulation. 
293A 
Impaired Flow-Mediated Vasodilation of the 
Brachial Artery Is a Reliable Indicator of 
Obstructive Coronary Artery Disease. 20lA 
Central nervous system 
Impaired Perceptive Function of High Level 
Central Nervous System as a Cause of Silent 
Myocardial Ischemia. 247 A 
Matrix XCMD on HyperCard Is Useful for 
Calculating Cosinor-Rhythmometry • 333A 
Cerebrovascular circulation 
Changes in Cerebral Perfusion During 
Implantable Cardioverter-Defibrillator Testing. 
42lA 
Cholesterol 
Atherosclerotic Burden Detected by 
Intravascular Ultrasound in Familial 
Hyperlipidemia Relates Inversely to High 
Density Lipoproteins. 290A 
Cellular Cholesterol Modulation Affects the 
Intracellular Calcium Ion Concentration in 
Cardiomyocytes Independent of the Membrane 
Fluidity. 463A 
Cholesterol: Is It Always True That Lower Is 
Better? xx 
Do Plasma Antioxidant Levels Correlate With 
Endothelial Dysfunction in Subjects With 
Normal Total Cholesterol? • 482A 
The Familial Hypercholesterolemia 
Regression Study (FHRS) • 13lA 
Cholesterol screening 
Lack of Patient Awareness and Physician 
Treatment of Hypercholesterolemia in Patients 
Undergoing Coronary Angioplasty • SOA 
Cholesterol-lowering drugs 
Abnormal Regulation of the LDL-Receptor 
Gene in Subjects With the "French Canadian" 
Mutation of the LDL-R Gene Who Fail To 
Respond To HMG CoA Reductase Inhibitors • 
482A 
Cholesterol: Is It Always True That Lower Is 
Better? xx 
Effect on Monotherapy With an HMG CoA 
Reductase Inhibitor Upon the Progression of 
Coronary Atherosclerosis in Women: A CCAIT 
Substudy • 4SSA 
Influence of Cholesterol Lowering on Plasma 
Membrane Lipids and Cationic Transport 
Systems. 432A 
Pravachol Decreases Platelet Thrombus Formation in 
Hypercholesterolemic Coronary Patients in 
Conjunction With Improvements in Serum 
Lipids. 13lA 
Pravastatin Limitation of Atherosclerosis in the 
Coronary Arteries (PLAC I) • 13lA 
Prevention of Severe Cardiac Allograft Rejection 
With Pravastatin: A Randomized Trial. 483A 
Remodeling of Coronary Artery Lesions: Regression 
to the Mean or Effect of Cholesterol-Lowering 
Therapy? • 132A 
The Importance of Criteria Selected to Define Pro•
and Regression in Angiographic Intervention 
Trials·414A 
Treatment of Severe Hypercholesterolemia and 
Coronary Heart Disease by Simvastatin and LDL 
Apheresis (HELP): Effects on Coronary Lesions 
.132A 
Circadian rhythm 
Absence of a Morning Peak of Ambulatory Ischemia 
in Diabetic Patients Is Related to Autonomic 
Dysfunction.319A 
Absence of Morning Increase in Transient Ischemia 
in Survivors of Acute Myocardial Infarction. 
147A 
Beta Blockade Blunts Diurnal Variations in 
Ventricular Refractoriness. 398A 
Circadian and Circannual Rhythm of Pulmonary 
Embolism in a Hospitalized Population. 38lA 
Circadian Pattern of Heart Rate Variability in Heart 
Failure Is Progressively Disturbed With 
Increasing Neurohumoral Activation. 392A 
Circadian Pattern of Ventricular Tachyarrhythmias in 
Patients With Implantable Cardioverter•
Defibrillators. 204A 
Circadian Variation of Ischemic Threshold in 
Syndrome X • 371A 
Dynamic Behavior of QTc Measured in Holter Tapes 
in Different Groups of Postmyocardial Infarction 
Patients: Evidence of Circadian Variation of QTc 
Lengthening. 37 A 
Effect of Sotalol on the Circadian Variation of Heart 
Rate and QTc Interval. 323A 
Standalone C-Language-Based Program for Single 
and Mean Cosinor Analysis of Time Series. 
334A 
Clinical laboratory information systems 
A Cardiology Database Integrated With the VAMC 
Decentralized Hospital Computer Program With 
Image Capture and Display. 218A 
Clinical trials 
A Reliable and Reproducible Echocardiographic 
Method for Selecting High Risk Patients With 
Left Ventricular Dysfunction Shortly After Acute 
Myocardial Infarction in Multicenter Studies. 
40lA 
Advantages of Patient-Specific Predictions Over 
Subgroup Analysis in Defining Differential 
Treatment Effects of t-PA and Streptokinase 
From the GUSTO Trial. 27A 
Changing Patterns of Pharmacological Treatment 
After Myocardial Infarction: The GISSI 
Experience. 210A 
Clinical Trials in Myocardial Ischemia. xvi 
Controlled Clinical Trials in Cardiology: Costs, 
Ethics, and Proven Impact on Clinical Practice. 
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Diabetics With Coronary Disease Have Less Severe 
Ambulatory Ischemia and a Similar Prevalence 
of Asymptomatic Ischemia Compared With 
Nondiabetic Patients: An ACIP Database Study. 
318A 
Early Patency and Reocclusion in Acute Myocardial 
Infarction: A Comparison Between the 
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of Cocaine • 427 A 
Contribution of Nitric Oxide Release to Metabolic 
Vasodilation in the Human Heart. 274A 
Coronary and Limb Vascular Vasoconstriction After 
Successful Single Angioplasty of the Left 
Anterior Descending Coronary Artery. l08A 
Coronary Flow Response to Dipyridamole Using 
Transesophageal Echo Correlates With 
Myocardial Blood Flow Measured by Positron 
Emission Tomography. 360A 
Coronary Vasodilation Response to Captopril Is 
Mediated by Endothelium-Derived Relaxing 
Factor. 427 A 
Coronary Vasomotion and Serum Cholesterol in 
Angiographically Normal Vessels of Patients 
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With and Without Coronary Artery Disease. 
209A 
Determination of Regional Myocardial Perfusion by 
3-D Reconstruction of Biplane Coronary 
Angiograrns • 107 A 
Different Flow Reserve of Coronary Artery Bypass 
Grafts Assessed by a Doppler Guidewire: 
Comparison Between Internal Mammary Artery 
Grafts and Saphenous Vein Grafts. 410A 
Dissociation of Coronary Vascular Tolerance and 
Neurohormonal Adjustments During Long-Term 
Nitroglycerin Infusion in Patients With Coronary 
Artery Disease • 211A 
Dobutarnine Alters Flow and Functional Reserve in a 
Region Remote to a Critical Coronary Stenosis: 
Implications for Dobutarnine Stress Imaging • 
127A 
ECG Changes and Coronary Flow Reserve During 
Stress Testing in Hypertensive Patients. 47A 
EDRF-Mediated Control of Coronary Vascular Tone 
Is Associated With Local Platelet cGMP 
Accumulation. 273A 
Effect of Inhibition of Nitric Oxide Synthesis in the 
Human Coronary Circulation. 427 A 
Effect of Long-Term Calcium Channel Blocker 
Antihypertensive Therapy on Coronary 
Physiology. 115A 
Effects of Dobutarnine Stimulation on Myocardial 
Blood Flow, Glucose Metabolism, and Wall 
Motion in PET Mismatch Regions. 117A 
Effects of Dynamic Exercise and Calcium Channel 
Blocker on Alteration of Plasma Endothelin-I in 
Coronary Vasculature. 257 A 
Endothelin-l Induces Coronary Vasoconstriction via 
the ET -A Receptors. 339A 
Influence of In Situ Intrinsic Cardiac Neuronal 
Activation With Bradykinin on the Determinants 
of Coronary Blood Flow in Anesthetized Dogs. 
94A 
Inhibition of Coronary Nitric Oxide Release 
Decreases Left Ventricular Contractility in Dogs 
• 123A 
Mechanism of Subendocardial Ischemia Associated 
With Decreased Aortic Compliance. 81A 
Monoclonal Antibody to P-Selectin (PB 1.3) Protects 
Against Loss of Coronary Flow Reserve and 
Myocardial Segmental Dysfunction Following 
Coronary Artery Occlusion and Reperfusion in 
Dogs .440A 
Progressive Deterioration of Coronary Reserve After 
Heart Transplant: A Time-Dependent 
Observation. 230A 
Pronounced Neurohumoral Activation Following 
Acute Beta-Blockade Affects Coronary Reserve 
and Limits the Antiischemic Efficacy of This 
Intervention in Patients With Cardiac 
Dysfunction. 81A 
Reduced Coronary Flow Reserve During Exercise 
After Heart Transplantation. 425A 
Relationship of Postprocedural Distal Coronary Flow 
Dynamics With Restenosis After Coronary 
Angioplasty: Results of a Multicenter Pilot Study 
• 137A 
Relationship of Regional Myocardial Function to 
Intracoronary Doppler Guidewire Derived 
Diastolic to Systolic Flow Velocity Ratio. 93A 
Role of Calcium Channel and a-Adrenoceptor 
Antagonism in Estrogen-Induced Vasodilation in 
Coronary Conductance and Resistance Arteries. 
211A 
Coronary heart disease 
3-D Shape Based Tracking of Left Ventricular Wall 
Motion: Experimental Validation. 181A 
Benefit of Steroid Weaning Late After Cardiac 
Transplant: Relationship to Transplant Coronary 
Artery Disease • 230A 
Can Intravascular Ultrasound Yield Accurate 
Measures of Vascular Anatomy? Documentation 
of the Critical Importance of Uniform Rotational 
Velocity. 173A 
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Can Quantitative Wall Motion Analysis (Centerline 
Method) Improve the Sensitivity and Specificity 
of Exercise Echocardiography for the Detection 
of Coronary Artery Disease? • 240A 
Coronary Arterial Acetylcholine-Induced 
Vasoconstriction Is Reversed by Intracoronary 
Administration of Estradiol-17B in Menopausal 
Women With Coronary Artery Disease. 7A 
Coronary Calcium Predicts Coronary Heart Disease 
in High Risk Asymptomatic Adults. l80A 
Diagnostic Value and Safety of Early Adenosine Tl 
201 SPECT to Predict Severity of Coronary 
Atherosclerosis in Patients With Unstable 
Angina. 363A 
Differentiation of False Positive Scintigraphy by 
Intracoronary Ultrasound and Doppler. 257 A 
Do Racial Differences Affect Outcome After New 
Device Angioplasty? • 30lA 
Dobutamine Echocardiography Predicts Recovery of 
Hypoperfused Dysfunctional Myocardium in 
Patients With Coronary Artery Disease. SSA 
Does Ischemic Preconditioning Alter Risk Area 
Size? A Study Using Myocardial Contrast 
Echocardiography • 22lA 
Effect of Nitroglycerin on Sestamibi Uptake in 
Coronary Artery Disease and Left Ventricular 
Dysfunction and Assessment of Myocardial 
Viability. 343A 
Effects of Nitric Oxide on Coronary Artery Stenoses 
in Patients With Stable Angina. 200A 
Endocardial Phase Mapping Improves Detection of 
Regional Wall Motion Abnormalities. 3l0A 
Estrogen Replacement in Post-Menopausal Women 
for Primary and Secondary Prevention of 
Coronary Artery Disease Sequelae • xii 
Ethnic Differences in Coronary Calcium Prevalence 
.18OA 
Identification of Viable Myocardium With Contrast 
Echo in Patients With Myocardial Infarction and 
Poor Left Ventricular Function. 4S0A 
Increasing Myocardial Oxygen Demand Adding 
Atropine to Dipyridamole Improves Diagnostic 
Accuracy of Dipyridamole Echo-Stress Test. 
l6A 
Is Coronary Artery Disease the Leading Cause of 
Death Among Black Americans? • 338A 
Long-Term Clinical Results and Safety of Epidural 
Spinal Stimulation for Angina. 389A 
Modulation of Coronary Heart Disease Risk by 
Apolipoprotein E Genotype. 217 A 
Prognostic Significance of Effort-Induced Silent 
Myocardial Ischemia in Patients With Coronary 
Artery Disease. l33A 
Racial Differences in Myocardial Ischemia and 
Coronary Flow Reserve in Hypertension. 4lSA 
Rest-Redistribution 201 Thallium Tomography 
Identifies Viable Dysfunctional Myocardium in 
Patients With Coronary Artery Disease. 423A 
Surgery Versus Angioplasty for Proximal Left 
Anterior Descending Coronary Artery Stenosis 
(SALAD): A Prospective Randomized Trial. 
268A 
Tagged Cine Magnetic Resonance Imaging During 
Low Dose Dobutamine Infusion to Identify 
Viable Myocardium. 297A 
Tc-99m-Sestamibi SPECT Under Nitrate Infusion for 
Detecting Viable Hibernating Myocardium in 
Asynergic Territories. 343A 
The Tl-201-Tc-99m Difference Bullseye: An 
Objective Method to Identify Perfusion 
Abnormalities and Attenuation Artifacts in Dual 
Tl-201 Rest Tc-99m Stress Perfusions Scans. 
lS9A 
Timing of Detection and Prognosis After Appearance 
of Coronary Artery Disease in Heart Transplant 
Recipients. 230A 
Coronary microcirculation 
Altered j3-Adrenergic and Cyclic AMP-Mediated 
Coronary Microvascular Responses After 
Crystalloid Cardioplegia. 303A 
Aminophylline Attenuates Dipyridamole but Not 
Adenosine-Induced Coronary Hyperemia: 
Challenging Clinically Accepted Drug-Receptor 
Mechanisms. 107 A 
Association of Decreased Endothelium-Dependent 
Relaxation With Preserved Coronary Flow 
Reserve Causes Exercise-Induced Ischemia in 
Patients With Chest Pain, Angiographically 
Normal Coronary Arteries. 200A 
Circadian Variation of Ischemic Threshold in 
Syndrome X • 371A 
Coronary Microvascular Response to Intracoronary 
Administration of Nicorandil in Humans: 
Comparison With Intracoronary Papaverine. 
2l2A 
Coronary Pressure-Flow Diagrams During Maximal 
Vasodilation as Assessed by Transesophageal 
Doppler of Left Coronary Artery: A New Tool 
for Evaluation of Absolute Coronary Flow 
Reserve • 11SA 
Detection of Enteroviral RNA by Polymerase Chain 
Reaction in Patients With Myocarditis and 
Dilated Cardiomyopathy. l49A 
Differential Effect of Acetylcholine on Atrial and 
Ventricular Resistance Vessels Isolated From 
Human Hearts. 427A 
Distal Coronary Flow Velocity and Physiology 
During Direct Angioplasty for Acute Myocardial 
Infarction in Patients. 243A 
Early Impairment of Coronary Microvascular 
Function Dilated Cardiomyopathy. t60A 
Effects of Escherichia Coli Endotoxemia on 
Coronary Microvascular Responses to Serotonin 
and ADP • 339A 
Effects of Gender on Coronary Microvascular 
Responses to Endothelin • 163A 
Estimation of Myocardial Blood Volume by Contrast 
Echocardiography Can Provide an Assessment of 
Myocardial Blood Flow. 4S0A 
Functional Evaluation of the Internal Mammary 
Artery Bypass Graft in the Early and Late 
Postoperative Period. t08A 
High Dose Dipyridamole Compared With Standard 
Infusion Fails to Further Augment Coronary 
Hyperemia in Patients. l27A 
Is Impaired Exercise-Induced Coronary Vasomotion 
in Hypercholesterolemic Patients Due to 
Microvascular Dysfunction? .209A 
Myocardial Blood Flow Response to Increasing 
Oxygen Consumption and to Pharmacologic 
Vasodilation Is Globally Impaired in Patients 
With Single Vessel Coronary Artery Disease. 
116A 
Neither Coronary nor Forearm Flow Reserve Predict 
Exercise ST Depression or Symptoms in Patients 
With Chest Pain and Normal Coronary Arteries. 
20lA 
Quantitation of Myocardial Perfusion in Normal 
Subjects and Patients Using Subsecond Magnetic 
Resonance Imaging. 90A 
The Dissociation of Microvascular and Myocardial 
Stunning After Acute Myocardial Infarction. 
363A 
The Effect of Intravenously Administrated L•
Arginine on Myocardial Perfusion Abnormality 
in Patients With Microvascular Angina. 20lA 
Thrombus Contains Soluble Factors Which Decrease 
Blood Flow in Swine Coronary Arteries Through 
a Nitrous Oxide-Dependent Pathway. 64A 
Coronary vasospasm 
Acute Myocardial Infarction and Normal Coronary 
Artery: A Study of Percutaneous Angioscopy • 
l71A 
Chest Pain With Normal Coronary Arteries: Do 
Atherogenic Risk Factors Cause Syndrome X? • 
67A 
Endothelium-Dependent Contraction of Canine 
Coronary Artery Is Enhanced by Cardiac 
Preservation Solution. 2lA 
Intracoronary Injection of Thromboxane A2 
SUBJECT INDEX 541A 
Synthetase Inhibitor Is Effective To Relieve 
Coronary Spasm Induced by Acetylcholine. 
212A 
The Improved Myocardial Perfusion by L-Arginine 
in Patients With Vasospastic Angina. 20lA 
Coronary vessels 
C-Tree: A Graphic Editor for Delineating and 
Annotating the Anatomy of Coronary Arteries. 
334A 
Can Angioscopic Findings Predict the Early 
Outcome of PTCA? • 271A 
Dynamic Expansion of Coronary Arteries: 
Implications for Intravascular Ultrasound 
Measurements. 242A 
Incidence But Not Duration of Silent Myocardial 
Ischemia Correlates With Severity of Coronary 
Artery Disease. l32A 
Magnetic Resonance Angiography of Coronary 
Arteries: A Two-Dimensional Versus Three•
Dimensional Approach. 298A 
Multi-Slice Magnetic Resonance Coronary 
Angiography. 89A 
Persistence of Luciferase Gene Expression 
Following Adenovirus-Mediated In Vivo Direct 
Gene Transfer Into Porcine Coronary Arteries. 
39SA 
Thrombus Contains Soluble Factors Which Decrea~e 
Blood Flow in Swine Coronary Arteries Through 
a Nitrous Oxide-Dependent Pathway. 64A 
Variability of Remodeling in Early Coronary 
Atherosclerosis: An Intravascular Ultrasound 
Study.17SA 
Creatine kinase 
Myoglobin and Creatine Kinase MB2 Release After 
Elective Percutaneous Transluminal Coronary 
Angioplasty • 69A 
Death, sudden 
Bystander Initiated CPR Maintains Ventricular 
Fibrillation and Triples Survival After Witnessed 
Out-of-Hospital Cardiac Artest • lS3A 
Circumstances Surrounding Out-of-Hospital Cardiac 
Arrest in the Maastricht Area. 26SA 
Clinical Outcome of Patients With Refractory 
Ventricular TachycardialFibrillation Treated 
With Implantable Cardioverter-Defibrillator and 
No Concomitant Antiarrhythmic Drug Therapy. 
204A 
Coronary Artery Morphology in Sudden Death 
Due to Atherosclerosis. l72A 
Dispersion of Ventricular Repolarization and 
Sudden Cardiac Death in Ischemic Heart Disease 
.148A 
Exacerbation of Heart Failure Precedes 
Sudden Death in Patients With and Without 
Implantable Defibrillators. 393A 
Factors Associated With Sudden Cardiac 
Death in Patients Evaluated for Orthotopic 
Cardiac Transplantation. 3S6A 
Implantable Cardioverter-Defibrillators: 
Should Patients Be Allowed to Drive? 206A 
Induction of Ventricular Fibrillation but Not of 
Sustained Monomorphic Ventricular 
Tachycardia Predicts Sudden Death in Patients 
on Arniodarone Because of Ventricular 
Tachyarrhythmias After Myocardial Infarction. 
280A 
Intravascular Guide Wire Current Shunting 
During Nonthoracotomy Defibrillator 
Implantation. 86A 
Is Antitachycardia Pacing Really an 
Advantage in Patients With Cardioverter•
Defibrillators? • 20SA 
Joint Symposium European Society of 
Cardiology/American College of Cardiology. 
xiv 
Mechanism of Termination of Circus Reentry 
in Ventricular Fibrillation. 207 A 
National Survey of Sudden Adult Death • 
264A 
Prevention of Sudden Cardiac Death. xvii 
542A SUBJECT INDEX 
QT Dispersion: A Predictor of Sudden Unexplained 
Death in Congestive Cardiac Failure. 392A 
Right Ventricular Dysplasia: A Need for Precise 
Pathological Definition for Interpretation of 
Sudden Death. 34A 
The Causes of Death in Grown-Up Congenital Heart 
Patients: Avoidable and Unavoidable. 119A 
Ventricular Fibrillation and Polymorphic Ventricular 
Tachycardia With Critical Coronary Stenosis: Is 
Bypass Surgery Enough? • 421A 
Decision making, computer-assisted 
A Cardiology Database Integrated With the VAMC 
Decentralized Hospital Computer Program With 
Image Capture and Display. 218A 
Overestimation of the Risk of Mortality Following 
Coronary Artery Bypass Surgery May Result in 
Inappropriate Denial of Revascularization in 
Patients Older Than 70 • 190A 
Use of an Interactive Database To Compare Different 
Scoring Systems of Revascularization 
Appropriateness. 218A 
Validation of 3-D Surface Area Measurement 
Algorithms: Necessity of Standardized Test 
Objects. SlA 
Defibrillation 
"Stored Electrograms" Accuracy in Arrhythmia 
Classification and Clinical Value in 
Cardioverter-Defibrillator Therapy. 420A 
A Prospective Randomized Comparison in Humans 
of 60 uF Versus 120 uF 65% Tilt Biphasic Pulse 
Defibrillation Using a Unipolar Pectoral 
Transvenous Defibrillation System. 13A 
A Second Subcutaneous Patch Will Increase 
Implantation Rates for Nonthoracotomy 
Defibrillators • 12A 
Allopurinol Lowers Defibrillation Thresholds. 8SA 
Array Electrode Improves Defibrillation Efficacy of 
an Endocardial-Based Lead System Compared to 
Standard Subcutaneous Patch. 84A 
Asymmetric Injury at the Ends of Ventricular Cells 
Induced by Strong Electric Field Stimulation. 
293A 
Cardiac Blood Volume and Geometry Influence 
Upper Limit of Vulnerability and Its Relationship 
to Defibrillation Threshold. 32SA 
Changes in Cerebral Perfusion During Implantable 
Cardioverter-Defibrillator Testing. 421A 
Chronic Changes in Defibrillation Parameters With a 
Transvenous Lead System. 1I2A 
Clinical Efficacy and Safety of Atrial Defibrillation 
Using Current Nonthoracotomy Endocardial 
Lead Configurations: A Prospective Randomized 
Study. 12SA 
Comparison of Three Commercially Available 
Waveforms Using the ENDOTAK 
Nonthoracotomy Lead System in Pigs. 13A 
Complications Following Implantation of 
Nonthoracotomy Lead System Cardioverter•
Defibrillators. lIlA 
Determination of Positive Sensitivity of a New 
Subcutaneous Electrode for Implantable 
Defibrillator in Pigs. 12A 
Double-Pulse Defibrillation Reduces Defibrillation 
Energy for Longer Duration Shocks. 86A 
Effect of Capacitor Size on Defibrillation Threshold 
in Humans. 86A 
Effects of Biphasic Shocks on Electrogram 
Amplitudes Using a New Integrated Bipolar 
Transvenous Dual Chamber Defibrillator 
Electrode System. 420A 
Effects of Defibrillation Shock on Ventricular 
Excitability in Man: Is High Output 
Postdefibrillation Bradycardia Pacing Clinically 
Necessary? • 420A 
Epicardial Mapping Demonstrates a Predictable 
Arrhythmia Following Unsuccessful 
Transvenous Defibrillation Near Threshold. 
421A 
How to Program and Troubleshoot the Third 
Generation Cardioverter-Defibrillator • xxix 
Implantation of Nonthoracotomy Cardioverter•
Defibrillators in Patients With Hypertrophic 
Cardiomyopathy. 112A 
Improving Cost-Effectiveness of the Transvenous 
Implantable Cardioverter-Defibrillator. 206A 
Influence of a Right Ventricular Foamed Electrode 
on Defibrillation Efficacy. 8SA 
Initial Experience With 71 Patients Undergoing 
Nonthoracotomy Defibrillator System 
Implantation Using the New Subcutaneous Array 
.204A 
Initial Experience With a Transvenous Implantable 
Cardioverter-Defibrillator System Using a 
Biphasic Shock. 112A 
InnovationslNew Technologies in Implantable 
Defibrillators • xii 
Intravascular Guide Wire Current Shunting During 
Nonthoracotomy Defibrillator Implantation. 
86A 
Inverse Relationship of Defibrillation Impedance and 
Delivered Energy. 87 A 
Mechanisms of Lidocaine-Induced Elevation in 
Defibrillation Threshold. 2S9A 
Membrane Time Constant of Myocardial Cells 
During a Shock. 294A 
Occurrence of Spontaneous Shocks in Patients With 
Implantable Cardioverter-Defibrillator Without 
any Shocks Before Generator Replacement for 
Battery Depletion. 20SA 
Rapid Pacing Moves the Upper Limit of 
Vulnerability Higher on the Defibrillation 
Probability of Success Curve. 293A 
Refractory Period Extension for Monophasic Versus 
Biphasic Shocks • 422A 
Relationship of Upper Limit of Vulnerability to 
Defibrillation Threshold for Monophasic and 
Biphasic Waveform Human Nonthoracotomy 
Defibrillation.293A 
Right Atri?! r strode Location for Transvenous 
Atrial Defibrillation. 12SA 
Rise in Defibrillation Thr~shold Early After 
Implantation of Nonthoracotomy Defibrillation 
Lead Systems: Incidence and Predictors. 112A 
Safety and Efficacy of Implantation of Cardioverter•
Defibrillators With Nonthoracotomy Lead 
Systems by Electrophysiologists • 20SA 
Safety of Defibrillator Implantatiol' "/ Patients With 
Hypertrophic Cardiomyopathy. llA 
Spatially Distributed Noncardiac Electrode Reduces 
Endocardial-Based Defibrillation Energy 
Requirements Compared to Unipolar 
Configuration. 8SA 
Specificity of Algorithms Used by Implantable 
Devices for the Detection of Ventricular 
Tachycardia. 420A 
Successful Atrial Defibrillation Using Temporary 
Pericardial Electrodes. 12SA 
The Clinical Utility and Limitations of Stored 
Electrograrns in Determining the 
Appropriateness of Implantable Cardioverter•
Defibrillator Therapy. 419A 
The Effect of Polarity on Defibrillation Threshold 
Using a Nonthoracotomy Lead System. 12A 
The Effect of Tilt on Defibrillation Efficacy. 86A 
The Effects of Lidocaine on the Vulnerable Period 
During Ventricular Fibrillation. 292A 
The SQ Array: A New Nonthoracotomy Implantable 
Cardioverter-Defibrillator Lead That Reduces 
,the Defibrillation Threshold. 111A 
Transvenous Atrial Defibrillation in Two Canine 
Models of Atrial Fibrillation. 12SA 
Upper Limit of Vulnerability Tested on or Before the 
Peak ofT Wave Predicts Defibrillation Threshold 
in Dogs. 293A 
Diabetes mellitus 
Absence of a Morning Peak of Ambulatory Ischemia 
in Diabetic Patients Is Related to Autonomic 
Dysfunction.319A 
Acute Carnitine Administration Improves Left 
Ventricular Ejection Fraction in Type I Diabetic 
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Without Cardiac Ischemic Disease. 212A 
Association Between Glycosylated Hemoglobin and 
Levels of Fibrinogen in Patients With Type I 
Diabetes Mellitus. 163A 
Augmentation of Synthesis of Plasminogen Activator 
Inhibitor Type-I in Arterial Endothelial Cells by 
High Concentrations of Glucose and Its Clinical 
Implications. 176A 
Diabetics With Coronary Disease Have Less Severe 
Ambulatory Ischemia and a Similar Prevalence 
of Asymptomatic Ischemia Compared With 
Nondiabetic Patients: An ACIP Database Study. 
318A 
Endothelium-Dependent Dilation Is Impaired in the 
Large Arteries of Heahhy Young Adult Type I 
Diabetics and Is Related to the Presence of 
Microalbuminuria • 426A 
Mechanisms of Silent Myocardial Ischemia in 
Diabetic Patients. 319A 
Silent Myocardial Ischemia in Coronary Artery 
Disease: Comparison Between Patients With and 
Without Diabetes Mellitus. 319A 
Unstable Angina: A Comparison of Angioscopic 
Findings Between Diabetic and Nondiabetic 
Patients • 171A 
Diagnosis, computer-assisted 
A Physiology-Based Program To Assist in 
Diagnosing Heart Disease. 181A 
Computer-Based Classification From Left 
Ventricular Early Filling Patterns in Color M•
Mode Doppler Images of Normals and Coronary 
Artery Disease. 266A 
The Value of Receiver Operating Characteristic 
Curve Analysis to Detect Coronary Artery 
Disease Determined by Coronary Calcification 
on Ultrafast CT: A Multicenter Study. 208A 
Diagnostic techniques 
A Comprehensive Approach for Image 
Segmentation, Cutting Planes, and Display 
Projections in Three-Dimensional 
Echocardiography: Suggested Guidelines for 
Clinically Useful Projections Based on 
Multicenter Experience in 300 Adult and 
Pediatric Patients • 9 A 
A Prospective Randomized Study to Compare Multi•
plane With Biplane Transesophageal Echo•
cardiography in Anatomic Visualization and 
Doppler Assessment of Cardiac Structures. 387 A 
Accuracy of Dobutarnine Stress Electrocardiography 
in the Diagnosis of Suspected Coronary Artery 
Disease. lSA 
Assessment of Left Ventricular Volumes, Ejection 
Fraction and Cardiac Output by Quantitative 
Three-Dimensional Echocardiography From 
Multiplane Transesophageal Echocardiographic 
Studies: Validation and Clinical Application in 
Various Patient Care Scenari • 388A 
Automated Regional Endocardial Motion Analysis 
Using Contour Definition and Tracking Based on 
Shape Characteristics Using Gated Magnetic 
Resonance Imaging. 90A 
Development and Characterization of an Improved 
Rapid Enzyme Immuno Assay Specific for 
Cardiac Troponin T • 77 A 
Diagnostic Methods in Peripheral Artery Disease. 
xxvii 
Dobutamine Alters Flow and Functional Reserve in a 
Region Remote to a Critical Coronary Stenosis: 
Implications for Dobutarnine Stress Imaging. 
127A 
Effects of Modified Pharmacologic Stress 
Approaches on Hyperemic Myocardial Blood 
Flow. 127A 
Fractal Analysis of Surface Areas of 3-D Objects in 
Echocardiography.436A 
Hyperacute Visualization of Myocardial Ischemic 
Injury: Comparison of Tc-99m-glucarate, 
Thallium-20l, and Indium-Ill-antimyosin • 
317A 
Image Quality and Safety Following Intravenous BY 
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963, a New Transpulmonary Echo Contrast 
Medium in Humans. 24A 
Intracardiographic Echocardiography With a 
Steerable Linear Array Device Permits High 
Resolution Imaging of Cardiac Chambers and 
Valves With an Extended Depth of Field and 
Thus Left Heart Imaging From the Right Side • 
462A 
Myoglobin Detects Acute Myocardial Infarction 
More Rapidly Than Creatine Kinase-MB or 
Troponin-T Irrespective of Day I 
Electrocardiogram Diagnosis • 78A 
Noninvasive Assessment of Patients Following 
Myocardial Infarction and Thrombolytic Therapy 
• xviii 
Pulmonary Artery Pressure Estimated From a Right 
Ventricular Sensor. 430A 
Quantitative Echocardiography/Doppler. xi 
Similar Sensitivities of Cardiac Troponin I and MB 
Creatine Kinase for Detection of Acute 
Myocardial Infarction. 78A 
The Clinical Utility and Umitations of Stored 
Electrograrns in Determining the 
Appropriateness of Implantable Cardioverter•
Defibrillator Therapy. 419A 
Three-Dimensional Echocardiography • xiv 
Three-Dimensional Echocardiography Using an 
Omniplane Transesophageal Echocardiographic 
Probe: Automated Data Collection and 
Combined Volume and Surface Rendering Allow 
Qualitative and Quantitative Assessment of 
Cardiac Structures and Abnormalities. 309A 
Trajectory Technique in Three-Dimensional 
Echocardiography: A Method to Aid in Three•
Dimensional Localization of Cardiac Lesions and 
Direct an Approach With Potential Implications 
in Planning Interventional and Surgical 
Procedures for Cardiac Lesions. 309A 
Ultrasound Holography of the Heart and Great 
Vessels and True Three-Dimensional Delineation 
of Cardiac Structures: Validation of the 
Technique in Identifying Pathology in In Vitro 
Hearts and Clinical Application in Displaying 
Cardiac Abnormalities in Patients. 9A 
Diastole 
Abnormal Left Ventricular Diastolic Function in 
Symptomatic and Asymptomatic Human 
Immunodeficiency Virus Carriers: 
Documentation by Echo-Doppler and Digitalized 
M-Mode Measures. 364A 
Altered Effects of Load on Rate of Pressure Fall in 
the Stunned Left Ventricle: Impaired Relaxation 
or Decreased Contractility. 229A 
Atrioventricular Pacing Relieves Obstruction but 
Impairs Diastolic Function in Hypertrophic 
Cardiomyopathy. lOA 
Comparison of the Impact of Exercise on Left 
Ventricular Filling in Normal Subjects and With 
Dilated Cardiomyopathy. 419A 
Congestive Heart Failure and Left Ventricular 
Ejection Fraction: The Gender Paradox. 6A 
Diastolic Dysfunction in Demand Ischemia: Relative 
Roles of Myocyte C.++ Overload and High 
Energy Phosphate Depletion. 229A 
Effect of Varying AV Delay on Isovolumic 
Relaxation Time, Mitral Flow Pattern, and 
Diastolic Filling Period in Subjects With Dual 
Chamber Pacemakers. 349A 
Effects of Dobutamine on the Afterload Mismatch of 
Left Atrial Booster Pump Function. 361A 
Endogenous Nitric Oxide Selectively Enhances Left 
Ventricular Relaxation. 228A 
Exercise Training Improves Diastolic Filling at Rest 
and During Exercise in Patients With Dilated 
Cardiomyopathy. 399A 
Hemodynamic Correlates of Left Ventricular 
Relaxation and Filling in Patients Early After 
Acute Myocardial Infarction. 270A 
How to Detect and Manage Diastolic Dysfunction in 
Patients With Heart Failure. xiv 
Instantaneous Left Ventricular Filling Gradients 
Through Nonstenotic Mitral Valves Can Be 
Derived From Color Doppler M-Mode 
Velocities: Intraoperative Clinical Validation. 
463A 
Left Ventricular Diastolic Dysfunction in 
Asymptomatic Patients With ST Segment-T 
Wave Abnormalities in the Resting ECG • 2S2A 
Moderate Potassium Depletion Impairs Diastolic 
Function. 228A 
Prognostic Implications of Diastolic Filling Patterns 
Following Acute Myocardial Infarction. 312A 
Right and Left Ventricular Diastolic Function at Rest 
and Exercise in Pulmonary Hypertension. 418A 
Systolic and Diastolic Dysfunction Among Patients 
With the Clinical Diagnosis of Dilated 
Cardiomyopathy. 469A 
Time Constants of Isovolumic Pressure Fall: 
Determinants on Left Ventricular Pressure•
Volume Relation In-Situ Heart. 16SA 
Digitalis-glycosides 
Digitalis Augments Cardiopulmonary Baroreflex 
Control of Muscle Sympathetic Nerve Activity in 
Heart Failure. 21SA 
Digitalization Increases Cardiac Potassium 
Exposure During Physical Activity. 2S8A 
Estimation of the Serum Digitalis 
Concentration Using Saliva. 92A 
Reduction of Na,K-ATPase in the Failing 
Myocardium Is Umited to the a3 Isoform • 98A 
There Is an Increased Morbidity and Mortality 
Incidence With Digoxin Use in the Elderly: 
Results of the Bronx Longitudinal Aging Study. 
100A 
Doppler ultrasound 
A New Method for Determining Pulsatile 
Volume Flow Rate by Surface Integration of 
Velocity Vectors from Biplane Doppler 
Echocardiograms • 239A 
Accuracy of Doppler Ultrasound Assessment 
of Transvalvular Pressure Gradients Across 
Normal St. Jude Valve Prostheses In Vitro. 
462A 
Automated Doppler Analysis Allows On-Line 
Quantification of Velocities, Velocity Time 
Integrals, Pressure Gradients, and Acceleration 
Times: An Advance in Quantitative 
Echocardiography. l09A 
Colored 2-D Blood Flow Structure on B-Mode 
Echography Using Two-Dimensional Moving 
Target Indication. 410A 
Comparison of Intralesional Doppler Flow 
Velocity and Quantitative Angiography for 
Determination of Translesional Pressure 
Gradients in Patients. 174A 
Continuous Wave Doppler Overestimates 
Maximal Regurgitant Velocity Through 
Mechanical Valve Prostheses. 193A 
Contrast Enhanced Color Doppler Technique 
for Measuring Left Ventricular Ejection Fraction 
.468A 
Determinants of Functional Tricuspid 
Regurgitation in Incomplete Tricuspid Valve 
Closure: Doppler Color Flow Study of 110 
Patients. 221A 
Different Flow Reserve of Coronary Artery 
Bypass Grafts Assessed by a Doppler Guidewire: 
Comparison Between Internal Mammary Artery 
Grafts and Saphenous Vein Grafts. 410A 
Doppler in Hydrops Fetalis • 308A 
Doppler Pressure Half-Time in Mitral 
Stenosis: Inaccurate in the Elderly? • 194A 
Effect of Enalapril on Mitral Flow Profile 
After Myocardial Infarction. 269A 
Efficacy of Coronary Collateral Circulation 
Detected by a Doppler Guidewire During 
Balloon Angioplasty • 410A 
First Trimester Normal Human Cardiac 
Doppler. 26A 
High Wall Filter Imaging Stabilizes Color 
SUBJECT INDEX 543A 
Doppler Jet Area and Reduces Chamber Size 
Dependence: Computer Model Studies. 217A 
Impact of Ventricular Septal Defect on Outflow Tract 
Fluid Dynamics: Finite Difference Solution of 
Navier-Stokes Equations. 23A 
In Vitro Experiments for Visualization and 
Measurement of Flow Convergences Using a 
New Calibrated Two-Dimensional Soap Film 
Tunnel. 108A 
Instantaneous Left Ventricular Filling Gradients 
Through Nonstenotic Mitral Valves Can Be 
Derived From Color Doppler M-Mode Velocities: 
Intraoperative Clinical Validation. 463A 
Is the Bernoulli Pressure-Velocity Relationship 
Correct for St. Jude Valves? • 193A 
Left Ventricular Outflow Obstruction and 
Hypotensive Response During Dobutamine 
Stress Echocardiography: Is There a 
Relationship? • 143A 
Loading and Cardiac Mechanical Determinants of 
Left Atrial Appendage Doppler Flow Velocities. 
280A 
Mechanism of Intravascular Hemolysis After Mitral 
Valve Repair: Assessment by TransesophageaJ 
Echocardiography • 248A 
Mitral Inflow Affects Aortic Regurgitation Jet Area: 
An In Vitro Study. 221A 
New Concepts in the Noninvasive Assessment of 
Valvular Heart Disease. xxv 
Noninvasive Ultrasound Demonstration of 
Atherosclerosis Progression and Its Suppression 
by the Antioxidant Calcium Channel Blocker 
Amlodipine • 373A 
Noninvasive Estimation of Pulmonary Wedge 
Pressure With Doppler Transmitral Inflow in 
Patients With Heart Disease. 240A 
Progressive Deterioration of Coronary Reserve After 
Heart Transplant: A Time-Dependent 
Observation. 230A 
Quantitative Echocardiography/Doppler • xi 
Reduced Time for Femoral Venipuncture by Simple 
Bedside Application of Valsalva Maneuver: The 
Poor Cardiologist's Smart Needle. 381A 
Regurgitant Orifice Area in Tricuspid Incompetence: 
Clinical Follow-Up Study. 222A 
Relationship of Regional Myocardial Function to 
Intracoronary Doppler Guidewire Derived 
Diastolic to Systolic Flow Velocity Ratio. 93A 
Responses of Internal Mammary Artery Graft Flow 
to Nitroprusside: A Duplex Doppler Study in 
Hypertensive Hearts. 331A 
The Doppler Pulmonary Venous Flow Pattern Has 
Clinical Relevance in Constructive Pericarditis. 
281A 
Tricuspid Regurgitation Jet Area: Physical Factors 
Influencing Its Display in the Clinical 
Environment. 222A 
Value of Contrast Transcranial Duplex Sonography 
(cTCD) as a Routine Test Additional to 
Transthoracic Echocardiography (cTTE) in 
Patients With Suspected Patent Foramen Ovale 
(PFO).24A 
Dose-response relationship, drug 
Coronary Microvascular Response to Intracoronary 
Administration of Nicorandil in Humans: 
Comparison With Intracoronary Papaverine. 
212A 
High Dose Dipyridamole Compared With Standard 
Infusion Fails to Further Augment Coronary 
Hyperemia in Patients. 127 A 
Optimal Duration of the Stages in Dobutamine Stress 
Echocardiography • 121A 
Predicting the Effects of Therapy in Cardiovascular 
Disease. 266A 
Relative Sensitivity of the Cardiac Adenosine A I and 
A2 Receptors to Nonspecific Adenosine 
Blockade in Humans. 329A 
Drug administration 
Cardiac Toxicity of Interleukin-2 Plus Alfa-2 
Interferon. 80A 
544A SUBJECT INDEX 
Effect of Local Delivery of Urokinase on Platelet 
Deposition During In Vivo Balloon Angioplasty 
Using Hydrogel-Coated Balloons. SA 
Effect of Placebo and Naloxone on Exercise 
Perfonnance • 2S8A 
Feasibility of Local Drug Application With a New 
Catheter. lS8A 
How Should Heart Failure Be Treated in 1994? • xix 
How to Get the Most From Antianginal Drugs. xix 
Intramural Delivery of H-Heparin With a New 
Site-Specific Drug Delivery System: The D3 
Catheter. l86A 
Intramural Delivery of Marker Agent in Ex Vivo and 
In Vivo Models Using a Novel Drug Delivery 
Sleeve. 187 A 
Is Diagnostic Accuracy of Exercise 
Ecbocardiography Affected by Antianginal 
Agents? • 308A 
Local Delivery of r-Hirudin by a Double Balloon 
Perfusion Catheter Inhibits Platelet Deposition 
Postangioplasty • lSA 
Locally Delivered Microspheres in Atherosclerotic 
Arteries via a New Channeled Balloon PTCA 
Catheter Are Retained Intramurally for at Least 
24 Hours. 19A 
Somatostatin Analogue Octreotide Reversibly 
Decreases Arterial Insulin-Like Growth Factor-I 
Gene Expression. 44A 
Drug interactions 
Proarrhythmia of a Class Ie Antiarrhythmic Drug 
Suppressed by Combination With a Potassium 
Channel Blocking Drug in the Dog Late After 
Infarction. 324A 
Echocardiography 
A Comprehensive Approach for Image 
Segmentation, Cutting Planes, and Display 
Projections in Three-Dimensional 
Echocardiography: Suggested Guidelines for 
Clinically Useful Projections Based on 
Multicenter Experience in 300 Adult and 
Pediatric Patients. 9A 
A Computerized Method for Calculating Cardiac 
Output Based on Real-Time Color Doppler 
Images Using the Proximal Flow Convergence 
Technique: Experimental Studies in an Animal 
Model.409A 
A New 3(+1)-Dimensional Interactive Computer•
Based Model for Reconstruction and 
Interpretation of Cardiac Ultrasound 
Investigations Using the Concepts of Virtual 
Reality (CoCard) • ISlA 
A New Low Cost, Versatile Intravascular Imaging 
System Provides High Quality Studies With 
Substantially Reduced Cost of Catheters for the 
Patient. 24IA 
A New Phase Shift Echo Contrast Agent: EchoGen 
(Sonus Pharmaceuticals) Becomes a Gas in 
Blood to Produce Left Heart and Quantifiable 
Myocardial Contrast After Venous Injection: 
Studies in Sheep and Monkeys • 4S0A 
A Prospective Randomized Study to Compare 
Multiplane With Biplane Transesophageal 
Echocardiography in Anatomic Visualization 
and Doppler Assessment of Cardiac Structures. 
387A 
A Real-Time Satellite-Based Telecommunications 
System Providing Live Video Conferencing and 
Instantaneous Transmission of Echo Doppler 
Images. 409A 
A Reliable and Reproducible Echocardiographic 
Method for Selecting High Risk Patients With 
Left Ventricular Dysfunction Shortly After Acute 
Myocardial Infarction in Multicenter Studies. 
40lA 
Accuracy of Three-Dimensional Echocardiographic 
Reconstruction by Electromagnetic Positional 
Location: A Further Step Toward Practical 
Implementation of the Technique. 9A 
Aortic Arch Atheromas as a Risk Factor for 
Cryptogenic Stroke. l4SA 
Aortic Valve Resistance in Surgical Aortic Stenosis: 
A Doppler Echocardiographic Study of 422 
Patients • 193A 
Assessment of Aortic Valve and Ascending Aorta by 
Transesophageal Echocardiography: Incremental 
Information of Multiplane Over Biplane Imaging 
• 388A 
Assessment of Left Ventricular Volumes, Ejection 
Fraction and Cardiac Output by Quantitative 
Three-Dimensional Echocardiography From 
Multiplane Transesophageal Echocardiographic 
Studies: Validation and Clinical Application in 
Various Patient Care Scenari • 388A 
Assessment of Mitral Regurgitation by Color Flow 
Imaging of the Vena Contracta: Superiority of 
Multiplane Over Monoplane Transesophageal 
Echocardiography • 387 A 
Assessment of Right Ventricular Volume and 
Function With Intracardiac Ultrasonography: In 
Vivo Validation. 4lIA 
Atherosclerotic Disease of the Aortic Arch and the 
Risk of Ischemic Stroke: Preliminary Results of a 
Case Control Study, French Study of Aortic 
Plaques in Stroke (FAPS) • 144A 
Attenuation Deforms Time-Intensity Curves During 
Contrast Echocardiography: Practical 
Implications. 24A 
Automated Computer Algorithms Measuring Length 
and Area Parameters for Echo Images Are 
Unaffected by 25:1 JPEG Compression. lOlA 
Automatic Detection of Arterial Lumen and 
Medioadventitial Boundaries in Intravascular 
Ultrasound Images Using Textural Operators and 
Mathematical Morphology. 3A 
Biologic Color Encoding in Surface Modeling of 
Three-Dimensional Echocardiograms Enhances 
Appraisal of Cardiac Anatomy and Spatial 
Relations of Cardiac Structures by Simulating 
Natural Gross Anatomy. 3l0A 
Brockenbrough Transseptal Puncture With Guidance 
of Intracardiac Echocardiography • 3lIA 
Calculation of Left Ventricular Volume From Its 
Three-Dimensional Reconstruction Is 
Independent of Its Geometry. 309A 
Calculation of Pressure Overestimation Due to 
Subvalvular Acceleration and Pressure Recovery 
in Mild Aortic Stenosis: A Computer Simulation 
• 32lA 
Calculation of Regurgitant Volumes From the 
Proximal Orifice Flowfield Using a New 
Nondimensionalized Technique. 463A 
Can Transthoracic or Transesophageal 
Echocardiography Predict Successful Inoue 
Balloon Mitral Commissurotomy? • 194A 
Changes of Left Ventricle Volume During Head-Up 
Tilt in Patients With Vasovagal Syncope: An 
Echocardiographic Study. 329A 
Clinical and Echocardiographic Findings in Patients 
With Dynamic Left Ventricular Mid-Cavity 
Obstruction • 193A 
Clinical Application of Echocardiographic 
Automatic Myocardial Contour Detection. 
218A 
Clinical Outcome in Prosthetic Valve Endocarditis as 
Compared With Native Valve Endocarditis in the 
Era of Transesophageal Echocardiography • 
366A 
Color Visualization of Propagating Contraction 
From the Focus of Ventricular Premature 
Contraction by High Speed Digital Subtraction 
Echography • 4l0A 
Comparison Between Automatic Border Detection 
and Planimetry of Right Ventricular Size and 
Function Following Surgical Treatment of 
Thromboembolic Pulmonary Hypertension. 
239A 
Comparison of Dobutamine Stress Echocardiography 
to Dobutamine SPECT Isonitrile Perfusion 
Imaging for Detection of Coronary Artery 
Disease • SSA 
JACC February 1994:523A-574A 
Comparison of the Echocardiographic and Clinical 
Findings in "HOCM-Like" and "Typical" 
Cardiac Amyloidosis. IlIA 
Compression of Two-Dimensional 
Echocardiographic Images: How Far Can We 
Go? .I02A 
Computer-Based Classification From Left 
Ventricular Early Filling Patterns in Color M•
Mode Doppler Images of Normals and Coronary 
Artery Disease. 266A 
Concentration and Pressure Dependence of 
Ultrasonic Integrated Backscatter of a New Echo 
Contrast Agent. 394A 
Conservation Medical Treatment Can Be 
Appropriate in the Management of Peri valvular 
Abscess: Diagnosis and Follow-Up by 
Transesophageal Echocardiography • 322A 
Cost-Effectiveness of Transesophageal 
Echocardiography-Guided Cardioversion With 
Anticoagulation Compared to Conventional 
Therapy in Patients With Atrial Fibrillation. 
12SA 
Defining the Normal Heart in Elite Basketball 
Players. 40lA 
Delineation of Congenital Malfonnations of Mitral 
Valve Apparatus by Dynamic Three•
Dimensional Echocardiography and Unique 
Image Segmentation Using a Tomographic 
Transthoracic Approach. 169A 
Detection of a Regional Myopathic Process in 
Pacing-Induced Heart Failure Using Ultrasonic 
Integrated Backscatter. 243A 
Diagnosis of Patent Foramen Ovale by Contrast 
Versus Color Doppler Using Transesophageal 
Echocardiography: Relationship to Left Atrial 
Size.7SA 
Diagnostic Yield of Echocardiography in Patients 
With Syncope: Is Current Use Justified? 307A 
Differentiation of Hemopericardium and Serous 
Pericardial Effusion by Acoustic Densitometry • 
307A 
Direct Validation of the "Stasis Hypothesis" of 
Cardioembolism During Atrial Fibrillation or 
Flutter.76A 
DistributioJl of Mobile Aortic Masses and Their 
Relationship to Aortic Atherosclerosis: A 
Transesophageal Echocardiographic Study of the 
Thoracic Aorta. 442A 
Dobutamine Stress Echocardiography Correlates 
With Positron Emission Tomography in 
Predicting Tissue Viability in Patients With 
Chronic Left Ventricular but Does Not Predict 
Recovery of Function Within Six Weeks 
Postrevascularization • S6A 
Dobutamine Stress Echocardiography for Risk 
Stratification Following Acute Myocardial 
Infarction. 297 A 
Dobutamine Stress Echocardiography in Orthotopic 
Heart Transplant Recipients. 22A 
Dobutamine Stress Echocardiography in the 
Presence of Left Bundle Branch Block: Clinical 
Utility.143A 
Does Echocardiography Accurately Reflect the 
Severity of Hemodynamics in Cardiac 
Tamponade? 27SA 
Does Ischemic Preconditioning Alter Risk Area 
Size? A Study Using Myocardial Contrast 
Echocardiography • 22lA 
Doppler Echocardiographic Demonstration of 
Improved Systolic Function After Dynamic 
Cardiomyoplasty • 74A 
Dose-Response Characteristics, Time-Course, and 
Hemodynamic Responses to QW3600, an 
Ultrasonic Contrast Agent Capable of 
Myocardial Opacification by Intravenous 
Injection. 393A 
Dynamic Multidimensional Visualization of 
Acquired and Congenital Abnormalities of the 
Aortic Valve, Aortic Root, and Related 
Structures in Children and Adults: Direct 
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Depiction of the Pathomorphology by 
Transthoracic and Transesophageal Three•
Dimensional. lOA 
Dynamic Three-Dimensional Imaging of Mitral 
Valve Pathologies Using Echo-CT. 175A 
Echo Phase Analysis of the Sequence of Annular 
Descent and Its Value in Localizing Accessory 
Pathways • 411A 
Echocardiographic Correlates of Only Temporary 
Improvement After Mitral Balloon 
Commissurotomy. 194A 
Echocardiographic Fourier Phase and Amplitude 
Imaging for Objective Quantification of Ischemic 
Regional Wall Asynergy: An Experimental 
Study in Dogs. 22lA 
Echocardiographic Identification of Spontaneously 
Occurring Feline Hypertrophic Cardiomyopathy: 
A Potential Animal Model of Human Disease. 
26A 
Echocardiography Has a Low Diagnostic Yield in the 
Evaluation of Syncope of Unclear Etiology. 
435A 
Echocardiography in the Assessment of Patients 
With Coronary Artery Disease. ix 
Effect of Pulsatile Pressure on Echocardiographic 
Contrast Persistence: Is It Due to Peak or 
Duration of Pressure? .25A 
Efficacy of Dobutamine Stimulation in an Animal 
Model of Hibernating Myocardium. 144A 
Estimation of Mean Pulmonary Wedge Pressure 
From Transesophageal Echocardiography • 
36lA 
Estimation of Mitral Valve Area by Transthoracic 
and Transesophageal Echocardiography Using 
Different Techniques. 360A 
Estimation of Myocardial Blood Volume by Contrast 
Echocardiography Can Provide an Assessment of 
Myocardial Blood Flow. 4SOA 
Evaluation of Aortic Dissection, Aneurysm, 
Coarctation and Atheroma by Volume and 
Surface-Rendered Three-Dimensional 
Echocardiographic Studies Using Omniplane 
Imaging Probe. lOA 
Evaluation of Intraoperative Transesophageal 
Echocardiography During Congenital Heart 
Surgery. 23A 
Evaluation of Mammary Artery Graft Perfusion 
Using Contrast Echocardiography • 393A 
Feasibility of Aortic Diameter Measurement Using 
Multiplane Transesophageal Echocardiography 
for Presurgical Selection and Preparation of 
Homograft Aortic Valves. 387 A 
Feasibility of Applying Karhunen-Loeve Procedure 
to Transesophageal Echocardiographic Images. 
217A 
Fetal Echocardiography • xvii 
Fractal Analysis of Surface Areas of 3-D Objects in 
Echocardiography • 436A 
Frequency-Dependent Ultrasound Transducer 
Observations With Microbubbles: A Better 
Method to Enhance Signals? • 26A 
Gender Differences in Postinfarction Left 
Ventricular Remodeling and Function. 130A 
Highly-Compressed Digital Archival of 
Echocardiograms Can Replace Analog 
Videotape and Improve Objective Image Quality 
• 409A 
How to Perform and Interpret Stress 
Echocardiography • xxi 
Identification of Viable Myocardium With Contrast 
Echo in Patients With Myocardial Infarction and 
Poor Left Ventricular Function. 450A 
Impact of the Shape of the Proximal Flow 
Convergence Region on the Accuracy of Flow 
Rate Calculation. I08A 
Importance of Imaging the Pulmonary Veins After 
Lung Transplantation: A Prospective 
Transesophageal Echocardiographic Study. 
3S7A 
Improved Correlation Between Echo-Contrast 
Derived End Diastolic Volume and Left 
Ventriculography Using Intravenous Contrast 
Echo .468A 
Improved Risk Stratification of Heart Failure 
Patients Using Exercise V02 and 
Echocardiographic Indexed Left Ventricular 
Mass .400A 
Incidence and Baseline Predictors of Left Ventricular 
Enlargement Postmyocardial Infarction: Survival 
and Ventricular Enlargement (SAVE) Trial. 
129A 
Influence of Ultrasonic Contrast Enhancement on the 
Size and Shape of the Flow Convergence Area 
By Color Doppler: An In Vitro Study. 45lA 
Influence of Variable Loading Conditions on Pulsed 
Doppler Indices of Left Ventricular Ejection 
Dynamics. 240A 
Initial In Vivo Studies Using a New Forward•
Viewing Intravascular Ultrasound Catheter. 
29lA 
Intracardiac Echocardiography: Observations in 
Normal and Diseased Hearts Using lO-MHz 
Catheter Transducer. 411A 
Intracardiac Ultrasound Measurement of Left 
Ventricular Wall Thickening: In Vivo Validation 
With Sonomicrometers • 462A 
Intracardiac Ultrasound Provides More Accurate 
Assessment of Left Ventricular Volume as 
Compared With Biplane Angiography: An In 
Vitro Study. 462A 
Intracardiographic Echocardiography With a 
Steerable Linear Array Device Permits High 
Resolution Imaging of Cardiac Chambers and 
Valves With an Extended Depth of Field and 
Thus Left Heart Imaging From the Right Side. 
462A 
Intracoronary Ultrasound: Lessons Learned. xxvii 
Intravascular Echo Assists Determination of the 
Anatomy and Position of Obstructions in Right 
Ventricular to Pulmonary Artery Conduits. 22A 
Intravascular Ultrasound Imaging. xxvi 
Is Left Ventricular Concentric Remodeling a 
Predictor of Left Ventricular Hypertrophy in 
Cardiac Transplant Recipients? • 2lA 
Is Left Ventricular Enlargement in Relatives of 
Patients With Dilated Cardiomyopathy Early 
Disease? • 34IA 
Is Mitral Regurgitation After Myocardial Infarction 
Primarily Caused by Papillary Muscle 
Dysfunction or Left VentricularlMitral Annular 
Remodeling? • 195A 
Is Spontaneous Echocardiographic Contrast in the 
Aorta a Marker for Embolic Events? • 128A 
Lack of Ventricular Remodeling in Non-Q Wave 
Myocardial Infarction. 269A 
Left Atrial Appendage Function in Atrial Fibrillation 
and Flutter as a Predictor of Outcome Following 
Cardioversion: A Transesophageal 
Echocardiography Doppler Study With One Year 
Follow-Up.28IA 
Left Atrial Appendage Function in Atrial 
Fibrillation: Assessment With Transesophageal 
Echocardiographic On-Line Automated Border 
Detection System. 282A 
Left Atrial Function Estimated by Biplane 
Transesophageal Echocardiography: When Is 
Big Too Big? • 28lA 
Left Atrial Spontaneous Contrast in DC•
Cardioversion for Nonrheumatic Atrial 
Fibrillation Without Anticoagulation. 128A 
Left Ventricular Ejection Fraction: Three•
Dimensional Echocardiography Versus Two•
Dimensional Echocardiographic Visual 
Estimation With Comparison to Multigated 
Acquisition Radionuclide Angiography. lOA 
Left Ventricular Fibromuscular Band Is the Substrate 
for Idiopathic Left Ventricular Tachycardia. 
398A 
Left Ventricular Mass Measurement by 
Echocardiographic Area-Length Method: Should 
SUBJECT INDEX 545A 
Papillary Muscles Be Included or Not? • 239A 
Long-Term Effects of Single Lung Transplantation 
on Right Ventricular Remodeling. 190A 
Long-Term Estrogen Deprivation Alters 
Cardiovascular Structure and Function in Adult 
Female Rats • 469A 
Low Dose Dobutamine Echocardiography 
Accurately Identifies Hibernating Myocardium 
in Patients With Severe Chronic Ischemic Left 
Ventricular Dysfunction. 429A 
Measurement of Thoracic Aortic Wall Thickness by 
Transesophageal Echocardiography: An In Vitro 
Validation. 145A 
Measuring Intraluminal Area: Significant Machine 
Dependent Intravascular Ultrasound Imaging 
Differences. 406A 
Mechanism of Hemolysis With Mitral Prosthetic 
Regurgitation: A Study Using Transesophageal 
Echo and Fluid Dynamic Simulation. 359A 
Mechanism of Regressed Aneurysm in Kawasaki 
Disease: Significance of Intimal Thickening at 
Diseased Sites. 120A 
Mechanism of Stress-Induced ST Elevation 
Determined by Dobutamine Echocardiography • 
443A 
Mitral Valvular Resistance to Inertiance Ratio 
Determination by Doppler Echocardiography • 
192A 
Morphologic Expression of Hypertrophic 
Cardiomyopathy Differs in North American and 
European Patients • 11 OA 
Morphological Characteristics of Atrial Septal 
Aneurysms: A French Multicenter Study Using 
Transesophageal Echocardiography in 259 
Patients • 74A 
Myocardial Contrast Echocardiography: Assessment 
of Myocardial Perfusion of Dilated 
Cardiomyopathy Patients With Comparison to 
Thallium Uptake by SPECT • 394A 
Myocardial Perfusion Using New Intravenous 
Ultrasound Contrast Agents: Comparison 
Between Video and Integrated Backscatter 
Images With a Prototype Program. 393A 
Myocardial Viability Assessed by Dobutamine 
Echocardiography Soon After Myocardial 
Infarction: Influence of Myocardial Echo 
Contrast Opacification of Infarcted Area and 
TIMI Grading of Infarcted Related Artery. 360A 
Neural Network Performance in Recognizing 
Echocardiographic Pixel Luminance Pattems • 
182A 
New and Evolving Echocardiography Techniques! 
Advances in Echo. xxiii 
New Color Doppler Techniques for Demonstrating 
Free Vortices and Radial Vortex Shedding: An In 
Vitro Study. 309A 
New Information on the Morphology of Subvalvar 
Left Ventricular Outflow Tract Obstruction by 
Real-Time Three-Dimensional 
Echocardiography • I09A 
On-Line Left Ventricular Pressure-Volume Relations 
During Alterations in Preload: Comparison of 
Transesophageal Echocardiographic Automated 
Border Detection With Conductance Catheter 
Techniques.311A 
Pediatric Biplane Transesophageal 
Echocardiography: Preliminary Experience • 
170A 
Pediatric Echocardiography • xxii 
Pericardial Heart Disease. xxv 
Positive Echo-Contrast Does Not Correlate With 
Physiologic Shunt Studies in Patients With 
Severe Liver Disease. 25A 
Prognostic Implications of Pulmonary Venous Flow 
Pattern Assessed by Transesophageal 
Echocardiography in Dilated Cardiomyopathy. 
36lA 
Prognostic Significance of Thrombooccluded Aortic 
Dissection Diagnosed by Transesophageal 
Echocardiography. 146A 
546A SUBJECf INDEX 
Progressive Changes in Regional and Global Left 
Ventricular Dilation During Remodeling 
Postmyocardial Infarction 0 269A 
Proximal Isovelocity Surface Area Measurement of 
the Effective Regurgitant Orifice of Mitral 
Regurgitation: Clinical Accuracy and 
Limitations 0 194A 
Quantification of Flow Rate Through Restrictive 
Orifices Using the Proximal Flow Convergence 
Region: Development of a New Algorithm Using 
Hemispherical Isovelocity Surfaces Guided by a 
Centerline VelocitylDistance Function in an In 
Vitro Study 0 239A 
Quantification of Left Atrial Spontaneous Echo 
Contrast Using a New Approach of Integrated 
Backscatter 0 76A 
Quantification of Mitral Regurgitation by Doppler 
Backscatter Power 0 446A 
Quantitation of Left-to-Right Shunts in Secundum 
Atrial Septal Defect: A Clinical Application of 
Two-Dimensional Contrast Echocardiography 
With Use of Sonicated Albumin 0 468A 
Quantitative and Qualitative Three-Dimensional 
Echocardiographic Evaluation of Ventricular 
Size, Shape and Function in Patients With 
Singular Ventricular Morphology: In Vitro 
Validation and Clinical Application 0 I09A 
Rare Occurrence of Fibrin Strands Attached to 
Mechanical Valve Prostheses After the Initial 
Postoperative Period: A Transesophageal 
Echocardiographic Study With 320 Prostheses 0 
129A 
Real-Time Three-Echocardiography and Innovative 
Image Segmentation Provide Views Unavailable 
From 2-D Echo and Permit Transthoracic In Vivo 
Assessment of the Dynamic Surgical Anatomy of 
Ventricular Septal Defects 0 I09A 
Red Cells and Plasma Proteins Are Required for 
Echocardiographic Contrast Formation in 
Human Blood 0 128A 
Redundant Loops of Chordae Tendineae: A New 
Potential Cardiac Source of Embolism Detected 
by Transesophageal Echocardiography 0 7SA 
Reported Loss of Contrast Intensity in the LV Cavity 
During Systole: Is It an Artifact of Microbubble 
Velocity? 0 2SA 
Response of Left Ventricular Regional Wall 
Thickening to Dobutamine Infusion Is Critically 
Dependent on the Balance Between Regional 
Coronary Flow and Oxygen Consumption 0 
121A 
Reverse Shunting Across the Ductus Arteriosus or 
Atrial Septum In Utero Signifies Severe 
Congenital Heart Disease 0 238A 
Role of Transesophageal Echo in Suspected 
Cardiogenic Stroke 0 xvii 
Safety and Efficacy of High Dose (55 ug) 
Dobutamine/Atropine Stress Echo o238A 
Simultaneous Biplane Transesophageal 
Echocardiography and Concomitant 
Transesophageal Atrial Pacing of the Right 
Ventricle Substantiates Right Ventricular Wall 
Motion Abnormalities 0 311A 
Superiority of Rotational Scan Reconstruction 
Strategies for Transthoracic Three-Dimensional 
Real-Time Echocardiographic Studies in 
Pediatric Patients With Congenital Heart Disease 
o 169A 
Systolic Anterior Motion of the Mitral Valve During 
Dobutamine Stress Echocardiography in Normal 
Subjects Versus Patients 0 144A 
Tamponade in the Cardiac Surgery Patient: A 
Clinical-Echo Diagnosis o 276A 
The Anatomically Unfavorable Rheumatic Mitral 
Valve: Improved Results of Balloon Mitral 
Commissurotomy Using the Inoue Balloon 
Technique 0 292A 
The Changing Shape of the Flow Convergence 
Region as a Function of Orifice Size: Color 
Doppler, Laser-Induced Fluorescent Particles 
and Soap-Film Observations in an In Vitro Model 
o240A 
The Concentration, Ratio and Bolus of Sonicated 
Dextrose Albumin Required to Produce Maximal 
Left Ventricular Opacification Following 
Intravenous Injection in Humans 0 26A 
The Effect of Internal Mammary Artery Grafting on 
Basal Blood Flow in the Left Anterior 
Descending Coronary Artery 0 189A 
The Potential Value of Echocardiographic Fourier 
Phase Imaging of Left Ventricular Contraction 
Sequence in Patients With Coronary Artery 
Disease 0 361A 
The Role of Transthoracic Echocardiography in the 
Diagnosis of Infectious Endocarditis in Children 
o307A 
The Severity of Mitral Regurgitation and the 
Prognosis in Mitral Valve Prolapse 0 291A 
Three-Dimensional Echocardiography 0 xiv, 
xxvii 
Three-Dimensional Echocardiography Using an 
Omniplane Transesophageal Echocardiographic 
Probe: Automated Data Collection and 
Combined Volume and Surface Rendering Allow 
Qualitative and Quantitative Assessment of 
Cardiac Structures and Abnormalities 0 309A 
Three-Dimensional Echocardiography: A Method for 
Right Ventricular Volume and Endocardial 
Surface Area Computation In Vivo by Polyhedral 
Surface Reconstruction 0 333A 
Three-Dimensional Echocardiography: In Vitro 
Validation of Left Ventricular Volumes 0 
310A 
Threshold of Hemodynamic Benefit of Aortic Valve 
Replacement in Aortic Stenosis With Doppler 
Preoperati ve Mean Gradients Less Than 50mm 
Hgo 4S6A 
Trajectory Technique in Three-Dimensional 
Echocardiography: A Method To Aid in Three•
Dimensional Localization of Cardiac Lesions and 
Direct an Approach With Potential Implications 
in Planning Interventional and Surgical 
Procedures for Cardiac Lesions 0 309A 
Transesophageal Echo for Predicting Results for 
Repair of Tetralogy of Fallot: Using New High 
Resolution Biplane 5-7.5 MHz Probes With CW 
Doppler Capability 0 22A 
Transesophageal Echocardiographic Diagnosis of 
Sinus Venosus Atrial Septal Defects. 7SA 
Transesophageal Echocardiography: Current and 
Future Applications 0 xxii 
Transesophageal Multiplane 3-D Volume 
Calculation in Patients With Normal and 
Aneurysmatic Left Ventricular Geometry: 
Comparison to Angiography 0 388A 
Transpulmonary Passage of Acrosomes: A 
Pressure Stable Lipid-Based Echocardiographic 
Contrast Agent: Studies in Pigs 0 2SA 
Transverse Versus Apical Assessment of 
Systolic and Diastolic Function in Children 
Using Automatic Border Detection 0 23A 
Two-Dimensional Doppler Echocardiography 
as the Initial Diagnostic Tool for Acute 
Pulmonary Embolism 0 9SA 
Ultrasound Holography of the Heart and Great 
Vessels and True Three-Dimensional Delineation 
of Cardiac Structures: Validation of the 
Technique in Identifying Pathology in In Vitro 
Hearts and Clinical Application in Displaying 
Cardiac Abnormalities in Patients 0 9A 
Validation of 3-D Surface Area Measurement 
Algorithms: Necessity of Standardized Test 
Objects 0 SIA 
Value of Combined Transesophageal 
Echocardiography and Acoustic Quantification 
for the Early Detection of Abnormal Elastic 
Properties of the Aorta in Patients With Mild 
Marfan Syndrome 0 146A 
Value of Contrast Transcranial Duplex 
Sonography (cTCD) as a Routine Test Additional 
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to Transthoracic Echocardiography (cTTE) in 
Patients With Suspected Patent Foramen Ovale 
(PFO)o24A 
Value of Transesophageal Echocardiography in the 
Evaluation of Persistent Hypoxemia in an ICU 
Setting o7SA 
Volume Estimation of Single Ventricles Using 
Multiplane Transesophageal Echocardiography 
and Three-Dimensional Reconstruction: 
Validation in Human Pathological Specimens 0 
170A 
What Is the Prognosis of Trace Aortic Regurgitation? 
o 192A 
When Is Transesophageal Echo Really Necessary? 0 
xix 
Ejection fraction 
Acute Carnitine Administration Improves Left 
Ventricular Ejection Fraction in Type I Diabetic 
Without Cardiac Ischemic Disease 0 212A 
Inclusion of Patients Only With Low Ejection 
Fraction in Heart Failure Trial Bia<;es the 
Population Against Women and the Elderly 0 
428A 
Left Ventricular Ejection Fraction Response to 
Amrinone Bolus: A Challenge in Order To 
Identify Patients With Ischemic Cardiomyopathy 
and Reversible Chronic Left Ventricular 
Dysfunction 0 343A 
Mitral Valve Repair Preserves LV Function and 
Lowers LV Mass More Than Valve Replacement 
for Mitral Regurgitation 0 447 A 
Monitored Titration of Medical Therapy Improves 
Prognostic Indicators in Patients Referred for 
Cardiac Transplantation 0 3S6A 
Technetium-99m Sestamibi Distinguishes Stunned 
From Infarcted Myocardium and Predicts Six 
Week Left Ventricular Ejection Fraction After 
Acute Myocardial Infarction 0 476A 
Electric countershock 
Array Electrode Improves Defibrillation Efficacy of 
an Endocardial-Based Lead System Compared to 
Standard Subcutaneous Patch 0 84A 
Atrial Fibrillation in the Elderly: Is the Same 
Therapeutic Strategy Feasible? o 368A 
Determination of Positive Sensitivity of a New 
Subcutaneous Electrode for Implantable 
Defibrillator in Pigs 0 12A 
Double-Pulse Defibrillation Reduces Defibrillation 
Energy for Longer Duration Shocks. 86A 
Electrocardiographic Predictors of High 
Defibrillation Thresholds With Nonthoracotomy 
Cardioverter-Defibrillator Lead Systems o38A 
Refractory Period Extension for Monophasic Versus 
Biphasic Shocks 0 422A 
Spatially Distributed Noncardiac Electrode Reduces 
Endocardial-Based Defibrillation Energy 
Requirements Compared to Unipolar 
Configuration 0 8SA 
Transvenous Low-Energy Cardioversion of Short•
Duration Atrial Fibrillation in Humans 0 126A 
Electrocardiography 
Adjustment of the Signal-Averaged 
Electrocardiogram for Differences in Baseline 
QRS Duration 0 460A 
Can New ECG Diagnostic Algorithms Detect Atrial 
Fibrillation During VVI Pacing? 0 167 A 
Coarseness of Nonrheumatic Atrial Fibrillation: An 
Analysis of 464 Patients Followed for 1.3 Years 
o2S3A 
Criteria for Delayed Repolarization in Patients With 
Wide QRS Complex o37A 
Dispersion of Ventricular Repolarization and Sudden 
Cardiac Death in Ischemic Heart Disease 0 148A 
Dobutamine-Provoked Myocardial Ischemia 
Increases Beat-to-Beat QRS Amplitude 
Variability in Patients With Coronary Artery 
Disease 0 37 A 
Does Addition of Dobutamine to Dipyridamole 
Electrocardiographic Negative Tests Improve 
Diagnostic Accuracy of Pharmacological 
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Stresses to Match That Achieved by Routine 
Exercise Test? • ISA 
Electrocardiographic Identification of Left 
Ventricular Hypertrophy: Relationship of Test 
Perfonnance to QRS Duration and Validation of 
the Voltage-Duration Product. 370A 
Electrocardiographic Predictors of High 
Defibrillation Thresholds With Nonthoracotomy 
Cardioverter-Defibrillator Lead Systems. 38A 
Electrocardiography Discriminates Anomalous Left 
Coronary Artery From Myocarditis and 
Cardiomyopathy in Infants • 30SA 
Gender Differences in QRS Duration and Voltage: 
Relationship to the Electrocardiographic 
Identification of Left Ventricular Hypertrophy. 
369A 
Left Ventricular Diastolic Dysfunction in 
Asymptomatic Patients With ST Segment-T 
Wave Abnormalities in the Resting ECG • 2S2A 
Mechanism of Surface ECG Polymorphism of 
Monomorphic Ventricular Tachycardia: Insights 
From Simultaneous Endocardial and Epicardial 
Activation Sequence Mapping in a Canine Infarct 
Model.32M 
Myocardial Infarction Q Waves Are Related to Slow 
Conduction. 442A 
Natural History of Early Repolarization on EKG: A 
Prospective Study' 264A 
Noninvasive Prediction of Reperfusion and Coronary 
Patency by Continuous ST-Segment Monitoring 
in the GUSTO Trial. 14A 
Normal Subjects ECG-and-Respiration Reference 
Databases on CD-ROM. 168A 
Optimalization of Criteria To Differentiate VT From 
SVT in Wide QRS Tachycardia Using Neural 
Network Techniques. 266A 
QT Dispersion in Normal Subjects and Patients With 
Myocardial Infarction. 36A 
QTc Prolongation in Hypothyroidism' 36A 
Reduction in Precordial QT Interval Dispersion 
Following Coronary Angioplasty • 179A 
Short- and Long~Term Reproducibility of QT, QTc 
and QT Dispersion Measurement in Healthy 
Subjects • 178A 
Sympathetic Modulation Affects Repolarization 
Disparity in LQTS and Normals: QTp/QTe 
Changes During Exercise and ~-Blockade .37A 
The ECG as a Predictor of Outcome in Acute 
Coronary Syndromes: Results of the TIMI III 
Registry ECG Ancillary Study. 19M 
The Predictive Value of QT Versus IT Dispersion 
After Thrombolysis for Acute Myocardial 
Infarction. 178A 
The ST Interval in Children With Long QT 
Syndrome. 179A 
The Standard ECG a Screening Test for Hypertrophic 
Cardiomyopathy? • 149A 
Total QRS Voltage: Echocardiographic Evaluation 
of Its Accuracy in Diagnosing Left Ventricular 
Hypertrophy. 370A 
Use of P Wave Morphology To Predict Site of Origin 
of Retrograde Atrial Activation: Validation With 
Atrial Pacing at the AV Annulus 0 2S3A 
Value of Exercise-Induced QTc Dispersion in the 
Interpretation of Stress Electrocardiogram. 
178A 
Electropharmacology 
Bretylium Tosylate Is Ineffective for Ventricular 
Tachycardia. 3SA 
Class III Antiarrhythmic Effects of LY-I90l47 on 
Defibrillation Threshold. 8SA 
Electrophysiologic Effects of the New Class III 
Antiarrhythmic Almokalant in Postinfarction 
Porcine Model. 183A 
Endpoints of Drug Therapy: Is Tachycardia Slowing 
Enough? • 280A 
Interaction Between Erythromycin and 
Disopyramide on Ventricular Repolarization in 
Dogs With Chronic Atrioventricular Block. 
32M 
Ryanodine Prevents Early Afterdepolarizations 
Dependent Torsade de Pointes Arrhythmias in 
the Intact Heart. 282A 
UL-FS 49, a Rather Selective Blocker of the 
Pacemaker Current I Has No Effect on Automatic 
Ventricular Arrhythmias Occurring 24 Hours 
After Infarction. 183A 
Electrophysiology 
"Curing" Arrhythmias With Radiofrequency 
Ablation' xv 
A Prospective Randomized Comparison of 
Amiodarone and Sotalol for the Treatment of 
Ventricular Tachycardia. 398A 
Action Potential Altemans and Slow Conduction 
Provoked by Overdrive Pacing in the 
"Substrate" Area in Atrial Flutter. 4S8A 
An Animal Model for StUdying Class III-Induced 
Proarrhythmias in the Halothane-Anesthetized 
Dog • 32M 
Automatic Accurate Analysis of Monophasic Action 
Potential Recordings. 4A 
Cardiac Blood Volume and Geometry Influence 
Upper Limit of Vulnerability and Its Relationship 
to Defibrillation Threshold. 32SA 
Complications of Radiofrequency Catheter 
Modifications of the Atrioventricular Node: 
Results of the Multicenter European 
Radiofrequency Survey. 22SA 
Computer Simulation Using Nonlinear Dynamics 
Accurately Predicts Action Potential Altemans 
Following Sudden Rate Changes and Iscl1emia • 
334A 
Differential Effect of d-Sotalol on Normal and 
Infarcted Tissue in the Canine Infarct Model. 
398A 
Double Potentials Recorded in the Superior Vena 
Cava During Sinus Rhythm: Physiological or 
Pathological? • 369A 
Effect of an Isthmus on Anisotropic Conduction of 
Atrial Myocardium: A Possible Model of Slow 
Conduction.467A 
Effect of Informed Consent on Patient Anxiety 
Levels • 167 A 
Effect of Sustained Load on Electrophysiologic 
Parameters During Steady-State Pacing and 
Premature Extrastimulation in the Isolated Intact 
Rabbit Heart. 327 A 
Electrophysiologic Effects of High Dose Oral 
Amiodarone Load in Heart Failure Patients • 
203A 
Evidence Against the Existence of Adenosine•
Induced Activation of ATP-Sensitive K+ 
Channels in Guinea Pig Cardiac Myocytes • 
467A 
How Useful Is Electrophysiologic Testing in Patients 
Resuscitated From Ventricular Fibrillation? • 
202A 
Increased Electrophysiological Responsiveness of 
Cardiac Myocytes to Isoproterenol After Their 
Exposure to Acetylcholine. 87 A 
Mediation of Mechanoelectrical Feedback by Ca2+_ 
Activated Potassium Channels. 88A 
Membrane Time Constant of Myocardial Cells 
During a Shock. 294A 
Radiofrequency Energy Delivery Results in 
Nonuniform Heating Patterns. 480A 
Rapid Determination of Apparent Quinidine Binding 
Rates in In Vivo Canine Myocardium Using 
Combined Analysis of Incremental and 
Declining Conduction Velocities. 88A 
Rapid Pacing Moves the Upper Limit of 
Vulnerability Higher on the Defibrillation 
Probability of Success Curve. 293A 
Short- and Long-Term Reproducibility of QT, QTc 
and QT Dispersion Measurement in Healthy 
Subjects. 178A 
Short-Term Predictability of Epicardial Potential 
Fields in VF • IS2A 
Sinus Node Dysfunction After Cardiac 
Transplantation. 22A 
SUBJECT INDEX 547A 
The Diastolic Slope as a Parameter to Demonstrate 
Delayed Afterdepolarizations and Triggered 
Arrhythmias In Vivo: Validation With Lidocaine 
• 426A 
The Response to Atrial Pacing as an Aid to the 
Diagnosis of Arypical Atrioventricular Nodal 
Reentrant Tachycardia. 444A 
UL-FS 49, a Rather Selective Blocker of the 
Pacemaker Current I Has No Effect on Automatic 
Ventricular Arrhythmias Occurring 24 Hours 
After Infarction. 183A 
Use of Natural Magnetic Electrode Catheters for 
Catheter Mapping and Ablation. 277A 
Utility of Electrophysiologic Evaluation for Syncope 
in Women. 202A 
Emergency care 
A Randomized Prospective Trial of Active 
Compression-Decompression Cardiopulmonary 
Resuscitation During Asystole or 
Electromechanical Dissociation • 441A 
Clinical Efficacy and Cost-Effectiveness of Rapid 
Emergency Department Rule Out Myocardial 
Infarction and Noninvasive Cardiac Evaluation 
in Patients With Acute Chest Pain. 284A 
Emergent Treatment of Arrhythmias • xxvii 
Estimation of Mean Pulmonary Wedge Pressure 
From Transesophageal Echocardiography • 
361A 
Impact of Hospital Protocols on Time to Treatment 
With Thrombolytic Therapy (Door to Drug 
Time)·14A 
Prehospital Thrombolysis in Rural Emergency Room 
and Subsequent Transport to a Coronary Care 
Unit • 362A 
Endocarditis 
Clinical Outcome in Prosthetic Valve Endocarditis a~ 
Compared With Native Valve Endocarditis in the 
Era of Transesophageal Echocardiography • 
366A 
Conservation Medical Treatment Can Be 
Appropriate in the Management of Peri valvular 
Abscess: Diagnosis and Follow-Up by 
Transesophageal Echocardiography • 322A 
Predictors of Early Mortality in Patients Treated 
Surgically for Infective Endocarditis. 2S2A 
The Role of Transthoracic Echocardiography in the 
Diagnosis of Infectious Endocarditis in Children 
.307A 
Endothelin 
Acute Hypoxia and Endogenous Renal Endothelin in 
the Dog. 339A 
Changes in Plasma Levels of Endothelin Reflect the 
Long-Term Clinicliland Hemodynamic Effects 
of Beta-Blockade in Patients With Chronic Heart 
Failure. 172A 
Coronary Endothelin During Acetylcholine-Induced 
Coronary Vasoconstriction in Humans. 29SA 
Effects of Dynamic Exercise and Calcium Channel 
Blocker on Alteration of Plasma Endothelin-l in 
Coronary Vasculature. 257 A 
Effects of Gender on Coronary Microvascular 
Responses to Endothelin • 163A 
Elevated Endogenous Endothelin Mediates Systemic 
Vasoconstriction in Experimental Chronic 
Congestive Failure. 172A 
Endothelin, 1994 • xxiii 
Endothelin-l as a Predictor of Response to Head-Up 
Tilt Study in Children With Syncope. 30M 
Endothelin-I Does Not Selectively Impair Blood 
Flow to Collateral-Dependent Myocardium. 
372A 
Endothelin-l Induces Coronary Vasoconstriction via 
the ET-A Receptors. 339A 
Endothelins Protect the Ischemic Myocardium' 
30AA 
Insulin Increases Endothelin-I Release From Human 
Endothelial CeJls • 4ZA 
Is Impaired Exercise-Induced Coronary Vasomotion 
in Hypercholesterolemic Patients Due to 
Microvascular Dysfunction? • 209A 
548A SUBJECT INDEX 
Local Release of Endothelin in Human Coronary 
Arteries in Response to Balloon Angioplasty • 
124A 
The Endothelin System in Thoracic Inferior Vena 
Caval Constriction. 4S3A 
The Role of Endothelin Receptors in the Regulation 
of Cardiovascular Function. 425A 
Transcoronary and Pulmonary Vascular Kinetics of 
Endothelin-l in Cardiac Transplant Recipients. 
141A 
Endothelium 
Abnormal EndotheliallErythrocyte Adherence in 
Acute Ischemic Syndromes. 162A 
Augmentation of Synthesis of Plasminogen Activator 
Inhibitor 'JYpe-1 in Arterial Endothelial Cells by 
High Concentrations of Glucose and Its Clinical 
Implications. 176A 
Chronic Cocaine Use Impairs Endothelium•
Dependent Vasorelaxation • 274A 
Coronary Flow-Mediated Dilation Is Preserved in 
Hypertensive Patients. 107 A 
Do Coronary Vascular Smooth Muscle Cells Become 
Dysfunctional as Lesion Severity Increases? • 
379A 
Effect of Insulin Infusion on Endothelium-Derived 
Vasoactive Mediators. 372A 
Effects of Escherichia Coli Endotoxemia on 
Coronary Microvascular Responses to Serotonin 
and ADP • 339A 
Effects of Nitric Oxide on Coronary Artery 
Stenoses in Patients With Stable Angina. 200A 
Endothelium-Dependent Contraction of 
Canine Coronary Artery Is Enhanced by Cardiac 
Preservation Solution. 21A 
Endothelium-Dependent Dilation Is Impaired 
in the Large Arteries of Healthy Young Adult 
Type I Diabetics and Is Related to the Presence of 
Microalbuminuria • 426A 
Endothelium-Dependent Dilation in the 
Arteries of Asymptomatic Subjects Relates to 
Coronary Risk Factors and Their Interaction. 
426A 
Endothelium-Dependent Vasodilation of 
Small Arteries Is Impaired in Rats With Chronic 
Heart Failure: Effect of Angiotensin Converting 
Enzyme Inhibition. 272A 
Endothelium-Derived Relaxing Factor 
Maintains Low Pulmonary Vascular Resistance 
in Normal Children. 426A 
Fibrinolytic Response of Cultured Vascular 
Endothelial Cells Induced by Addition of 
Thrombolytic Agents. 14A 
Flow-Mediated Vasodilatation Is Impaired in 
Congestive Heart Failure. 271A 
Impaired Endothelium-Dependent 
Vasodilation in Patients With Essential 
Hypertension: Evidence for a Generalized 
Endothelial Abnormality. 274A 
Myocardial Perfusion Dynamics and Heart 
Rate Variability in Syndrome X: Evidence for 
Autonomic and Endothelial Dysfunction. 161A 
Secretion of Atrial Natriuretic Peptide From 
Cultured Human Aortic Endothelial Cells • 17 A 
Segmental Constrictor and Dilator Responses 
to Intracoronary Acetylcholine in Patients With 
Coronary Artery Disease • 200A 
Sodium Nitroprusside and Isoproterenol 
Augment Acetylcholine-Induced Vasodilation. 
379A 
Variable Dose-Dependent Coronary 
Vasomotor Responses to Acetylcholine in 
Patients With Normal Coronary Arteries. 47SA 
Venous Endothelial Function in Experimental 
Chronic Heart Failure. 272A 
Endothelium-clerived relaxing factor 
17~Estradiol Attenuates Endothelial 
Dysfunction in Male Spontaneously 
Hypertensive Rats. 295A 
Acetylcholine Infusion Stimulates EDRF 
Release From Saphenous Vein Grafts. 273A 
Additive Effect of L-Arginine Infusion and 
Leukocyte Depletion on Recovery After 
Hypothermic Cardioplegic Ischemia in Neonatal 
Lamb Heart. 237 A 
Association of Decreased Endothelium-Dependent 
Relaxation With Preserved Coronary Flow 
Reserve Causes Exercise-Induced Ischemia in 
Patients With Chest Pain, Angiographically 
Normal Coronary Arteries. 200A 
Contribution of Nitric Oxide Release to Metabolic 
Vasodilation in the Human Heart. 274A 
EDRF-Mediated Control of Coronary Vascular Tone 
Is Associated With Local Platelet cGMP 
Accumulation. 273A 
Effect of Inhibition of Nitric Oxide Synthesis in the 
Human Coronary Circulation. 427A 
Endogenous Nitric Oxide Selectively Enhances Left 
Ventricular Relaxation. 228A 
Estradiol Potentiation of Endothelium-Dependent 
Vasodilation Is Dependent on Nitric Oxide 
Production. 37SA 
Expression of an Inducible NO Synthase in Heart 
Tissue From Patients With Inflammatory Heart 
Disease. 263A 
Inhibition of Coronary Nitric Oxide Release 
Decreases Left Ventricular Contractility in Dogs 
• 123A 
L-Arginine Deteriorates Contractile Function in 
Repetitively Occluded-Reperfused Myocardium 
• 263A 
Nitric Oxide Release From the Heart Contributes to 
the Cardioprotective Effects of Platelets Against 
Ischemia and Reperfusion-Induced Injury in the 
Isolated Rat Heart. 19SA 
Resting and Exercise-Induced Release of 
Endothelium-Derived Nitric Oxide Is Impaired in 
Patients With Heart Failure. 272A 
Restoration of Endothelial Function in Monkeys 
With Atherogenic LDL Levels Through 
Prevention of In Vivo LDL Oxidation and 
Membrane Lipid Bilayer Stabilization by 
Amlodipine • 162A 
Role of Endothelium-Derived Nitric Oxide in the 
Vasodilator Response to Bradykinin in 
Normotensive and Hypertensive Humans. 347A 
The Effect of Intravenously Administrated L•
Arginine on Myocardial Perfusion Abnormality 
in Patients With Microvascular Angina. 201A 
The Improved Myocardial Perfusion by L-Arginine 
in Patients With Vasospastic Angina. 201A 
Use of Exogenous and Endogenous Nitric Oxide 
Help Identify Degrees of Endothelial 
Dysfunction in Patients With Coronary Artery 
Disease. 200A 
Energy metabolism 
Do Changes in Calcium Transport During Changes in 
Contractility Affect Cardiac Energetics? • 94A 
Lower Susceptibility to Aging of Myocardial 
Mitochondria Compared With Skeletal Muscle 
Mitochondria. 45A 
Enzyme inhibitors 
Attenuation of Calcium Overload and Delay of Cell 
Death by Chlorpromazine and Trifluoperazine in 
Cardiomyocytes During Chemical Anoxia. 31A 
Augmented Arterial Pressure Responses to 
Cyclosporine in Spontaneously Hypertensive 
Rats: Influence of Renal Family 3A Cytochrome 
P-450 • 261A 
Enzymes 
Adenosine Deaminase and Carcinoembryonic 
Antigen in Pericardial Effusion Diagnosis: 
Especially in Suspected Tuberculous Pericarditis 
• 275A 
Diagnosis of Microinfarction in Acute Ischemic 
Syndromes Is of Prognostic Value. 316A 
Elevated Troponin-T Levels in Relation to the ECG 
as an Indicator of Myocardial Damage in 
Unstable Angina. 77A 
Troponin T in Patients With Acute Chest Pain. 412A 
Troponin T Release as a Specific Marker of Early 
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Reperfusion After Thrombolysis in Acute 
Myocardial Infarction. 7SA 
Epidemiologic methods 
Fees for Noninvasive Stress Tests Represent Only a 
Small Part of the Total Cost of Testing to 
Achieve a Favorable Outcome in Coronary 
Disease: Cost-Effectiveness of Nuclear Tests • 
160A 
Gender Determines Survival From Coronary Bypass 
Surgery. 347 A 
Important Correlates of Echocardiographic Left 
Ventricular Mass in the Elderly Include Gender, 
Weight, Systolic Blood Pressure, Pulse Pressure, 
Prevalent Disease, and ECG Abnormalities: The 
Cardiovascular Health Study. l00A 
Is the Decline in Coronary Heart Disease Mortality 
Due to Decreased Incidence? A Study of 
Atherosclerosis Among Patients With Valvular 
Heart Disease. 265A 
National Survey of Sudden Adult Death. 264A 
Natural History of Early Repolarization on EKG: A 
Prospective Study. 264A 
Regional and Ethnic Comparison of Total and 
Specific Cardiovascular Disease Mortality Rates 
in New York City, 1990. 50A 
The Profile of Basic Life Support Course Trainees: 
Should Course Design Be Restructured? • 151A 
Validity of Self-Report of Myocardial Infarction in 
the Elderly • 432A 
Exercise 
A Randomized Study of Cardiac Rehabilitation in 
Heart Transplant Recipients. 356A 
Aerobic and Myocardial Demands of Heavy Snow 
Shoveling: Comparability to Maximal Arm and 
Leg Exercise Testing. 327 A 
Age Related Changes in Hemodynamic Response to 
Exercise in Patients With Chronic Congestive 
Heart Failure. 122A 
Attenuated Response of Blood Flow Redistribution 
in Nonexercising Organs in Patients With Heart 
Failure • 400A 
Blunted Sinoatrial Node Response to Exercise in 
Patients After Cardiac Surgery With the Maze 
Procedure • 251A 
Cardiomyoplasty: Effect of Latissimus Dorsi Muscle 
Contraction on Exercise Capacity. 471A 
Cardiomyoplasty: Hemodynamic Effect of 
Latissimus Dorsi Muscle Contraction After Six 
Months. 430A 
Characteristics Predicting Improvement in 
Functional Capacity in a Cardiac Prevention and 
Rehabilitation Program. 50A 
Coronary Vasomotion and Serum Cholesterol in 
Angiographically Normal Vessels of Patients 
With and Without Coronary Artery Disease. 
209A 
Digitalization Increases Cardiac Potassium Exposure 
During Physical Activity. 25SA 
Exercise Training Improves Functional Capacity in 
Patients With Compensated Congestive Heart 
Failure. 399A 
Exercise-Induced Structural Remodeling of Left 
Ventricle in Super Athletes. 32SA 
Improved Physical Performance in Congestive Heart 
Failure by One-Leg Endurance Compared to 
One-Leg Strength Training. 472A 
Lack of Impaired Muscle Arteriolar Vasodilation 
During Leg Submaximal Exercise in Patients 
With Congestive Heart Failure. 471A 
Left Ventricular Function During Incremental and 
Steady State Exercise. 32SA 
Systemic Hypotension Is a Determinant of 
Functional Exercise Status in Chronic 
Congestive Heart Failure. 122A 
What Limits Exercise Tolerance in Mitral Stenosis? 
.2SSA 
Why Can't Patients With Heart Failure Exercise? 
xiii 
Exercise tests 
A Comparison of Myocardial "Risk Area" as 
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Detennined by Stress Imaging and by 
Intracoronary Tc-99m Sestamibi Injection. 
159A 
A Comparison of the Incremental Value of Exercise 
Testing in Men and Women for the Diagnosis of 
Coronary Artery Disease • 447 A 
Aerobic and Myocardial Demands of Heavy Snow 
Shoveling: Comparability to Maximal Arm and 
Leg Exercise Testing • 327 A 
Characterization of the Nine Minute Self-Powered 
Treadmill Walk: A New Submaximal Exercise 
Test in Patients With Heart Failure. 384A 
Clinical Correlates of Exercise-Induced Atrial 
Fibrillation. 328A 
Comparative Effects of Gallopamil, Metoprolol and 
Nifedipine in Stable Angina: A Multicenter 
Randomized Double Blind Placebo Controlled 
Study.54A 
Discrepancy Between Estimated METs and 
Measured METs on Exercise Treadmill Testing. 
327A 
Effect of Placebo and Naloxone on Exercise 
Performance. 258A 
Effort-Induced Silent Myocardial Ischemia Is a 
Better Predictor of Prognosis Than Silent 
Ischemia Detected During Daily Life. 133A 
Evidence for Different Pathophysiological 
Mechanisms Underlying Dobutamine- and 
Exercise-Induced Wall Motion Abnormalities. 
16A 
Exercise Echo and Perfusion Scintigraphy - Which 
is Best? • xii 
Exercise-Induced Prominent U-Wave as a Marker of 
Stenosis of the Left Circumflex or Right 
Coronary Artery • 38A 
Exercise-Induced ST-Segment Depression in 
Patients Without Angiographic Restenosis 
Following Balloon Angioplasty • 69A 
Hemodynamic and Ischemic Responses During 
Exercise Testing: Gender Differences. 447 A 
Improved Risk Stratification of Ambulatory 
Congestive Heart Failure Patients Using Age and 
Gender Adjusted Percent Predicted Peak 
Exercise Oxygen Uptake. 448A 
Is Rate of Angina and Silent Myocardial Ischemia 
During Exercise Testing Different Between 
Young and Elderly Populations? • 448A 
Neither Coronary nor Forearm Row Reserve Predict 
Exercise ST Depression or Symptoms in Patients 
With Chest Pain and Normal Coronary Arteries. 
201A 
Patients With Heart Failure Demonstrate Increased 
Oxygen Consumption and Symptoms Following 
Maximal and Submaximal Exercise. 471A 
Predictive Accuracy of Noninvasive Investigation for 
the Detection of Totally Silent Myocardial 
Ischemia. 246A 
Predictors of Outcome in Dilated Cardiomyopathy. 
399A 
Prognostic Significance of Maximal Symptom•
Limited Exercise Stress Testing After Acute 
Myocardial Infarction in 10,219 Patients Treated 
With Thrombolytic Agents. 197 A 
Prognostic Significance of Silent or Symptomatic 
Myocardial Ischemia Detected by Maximal 
Symptom-Limited Exercise Stress Testing After 
Myocardial Infarction in 6,296 Patients Treated 
With Thrombolytic Agents .197A 
Prognostic Value of Pre- and Posttreadmill Exercise 
Echocardiography in Women. 307A 
The AP or the TCPC Fontan: Which Is Better? • 
191A 
The Incremental Value of Thallium Exercise Testing 
for the Presence and Extent of Coronary Anery 
Disease. 39A 
The Incremental Value of Thallium Lung-Hean 
Ratio Over Other Thallium Variables for the 
Presence and Extent of Coronary Disease. 39A 
Treadmill Exercise Stress Tests Early After 
Uncomplicated Myocardial Infarctions. 40A 
Treadmill Exercise Test Parameters for Women 
Smokers Compared to Nonsmokers. 40A 
Why Do Women Have More Severe Angina Than 
Men When They Undergo Cardiac 
Catheterization? • 299A 
Extracellular matrix 
Altered Adhesion of Smooth Muscle Cells to 
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Increased Heart Rate Variability Is Associated With 
Improvement of Silent Ischemia in Hypertensive 
Patients With Coronary Disease. 331A 
Is Improvement in Exercise Chronotropic Response 
Late After Cardiac Transplantation Due to 
Supernormal Exercise Plasma Norepinephrine 
Levels? • 257 A 
Quantitative Relationship Between Efferent Vagal 
Stimulation and Heart Rate Variability. 253A 
Residual Myocardial Ischemia, 24-Hour Heart Rate 
Variability and Cardiac Events After First 
Myocardial Infarction. 65A 
Standalone C-Language-Based Program for Single 
and Mean Cosinor Analysis of Time Series. 
334A 
Heart septal defects 
Secundum Atrial Septal Defect: Clinical Profile and 
Surgical Experience in Septuagenarians and 
Older.465A 
The Fontan Procedure in Adults: Operative and Late 
Results With 121 Patients. 119A 
Transesophageal Echocardiographic Diagnosis of 
Sinus Venosus Atrial Septal Defects. 75A 
Two Year Follow-Up Results of Transcatheter 
Occlusion of Secundum Atrial Septal Defects 
With Buttoned Device. 358A 
Heart surgery 
A Comparison of Coronary Artery Bypass Surgery 
and Balloon Angioplasty in Patients With 
Coronary Artery Disease and Severe Left 
Ventricular Dysfunction. 352A 
A Graphical Interface Database for Step-by-Step 
Collection of Data During Cardiac Surgery • 
385A 
Anterior Leaflet Procedures During Mitral Repair Do 
Not Adversely Influence Long-Term Outcome. 
277A 
Aortic Stenosis With Severe Left Ventricular 
Dysfunction Determinants of Operative 
Morta1ity and Long-Term Survival. 457 A 
Are Coronary Angioplasty and Bypass Surgery 
Underused Among African Americans, Women 
and Poor and Uninsured Patients? .299A 
Arrhythmias in Infants and Children After Fontan 
Operation. 191A 
Arterial Switch Operation at a Consortium of 
University Hospitals. 287A 
Bidirectional Glenn Procedure in Patients Under 
Four Months of Age • 191A 
Clinical Features of Persistent Ductus Arteriosus in 
the 7th and 8th Decade and Results of 
Nonoperative Closure With Ivalon-R Plugs. 
46SA 
Complex Forms of Double Outlet RV: "Fontan" 
Versus "Biventricular Repair" • 8A 
Complex Pulmonary Atresia After Radical Repair. 
191A 
Do Women With Coronary Disease Truly Get 
Treated Differently Than Men? • 298A 
Early Changes in Ventricular Septal Defect Size in 
the Single Ventricle After Volume Unloading 
Surgery. 10SA 
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Effect of Gender on Early and Long-Term Outcome 
After Multiple Vessel Revascularization With 
Coronary Bypass Surgery or Balloon 
Angioplasty • 351A 
Estrogen Replacement Therapy After Coronary 
Artery Bypass Surgery: Effect on Survival. 7 A 
How Does PTCA Compare With Medical or Surgical 
Therapy? Results of the Completed Clinical 
Trials. xxviii 
Increased Systemic Lactate Production During 
Normothermic Bypass the Cause of Elevated 
Coronary Sinus Lactate During Continuous 
Cardioplegia. 303A 
Intracavitary Repair of Left Ventricular Aneurysm: 
Four Years of Follow-Up. 4S9A 
Life Expectancy in the Marfan Syndrome Revisited. 
402A 
Marked Diastolic Dysfunction Immediately After 
Aortic Valve Replacement for Aortic Stenosis. 
278A 
Multidose Cardioplegia Is Safe and Effective in 
Newborn Hearts. 237A 
One Stage Complete Repair of Pulmonary Atresia, 
Ventricular Septal Defect, Diminutive Central 
Pulmonary Arteries, and Multiple 
Aortopulmonary Collaterals • 8A 
Open Heart Surgery in Octogenarians: Can We? 
Should We? • 408A 
Overestimation of the Risk of Mortality Following 
Coronary Artery Bypass Surgery May Result in 
Inappropriate Denial of Revascularization in 
Patients Older Than 70 • 190A 
Perioperative Mechanical Support in Cardiac 
Surgery: Effect of Timing on Outcome. 459A 
Predictors of Early Mortality in Patients Treated 
Surgically for Infective Endocarditis. 252A 
Primary Bidirectional Glenn in Patients Between 
One and Four Months of Age. 8A 
Profound Platelet Inhibition Does Not Increase 
Emergency Bypass Surgery Complications: The 
EPIC Experience. 105A 
Protein-Losing Enteropathy Following the Fontan 
Operation. 306A 
Redo Heart Valve Surgery: A 30 Year Experience. 
408A 
Repeat Revascularization Following Coronary 
Artery Bypass Surgery and Coronary 
Angioplasty in Patients Over Age 65 in the 
United States. 433A 
Reversibility of Left Ventricular Remodeling After 
Aneurysmectomy for Anterior Postinfarction 
Aneurysm. 4S9A 
Risk Factors for Atrial Tachydysrhythmias After 
Fontan Operation. I04A 
Single-Stage Repair of Aortic Arch Obstruction and 
Associated Intracardiac Defects Using the 
Anterior Approach in Infants. 7A 
The Effect of Internal Mammary Artery Grafting on 
Basal Blood Flow in the Left Anterior 
Descending Coronary Artery. 189A 
The National Medicare Experience: Changing 
Patterns of Myocardial Revascularization 
Utilization and Outcome. 438A 
Warm Continuous Retrograde Cardioplegia: The 
Importance of High Flow Rates for Myocardial 
ProtectionlPatient Outcome. 303A 
Where Is Sinus Node in Hearts With Isometric 
Appendages? • 192A 
Heart valve prosthesis 
A Comparison of Failure Modes of Glutara1dehyde•
Treated Versus Antibiotic-Preserved Mitral 
Valve Allografts Implanted in Sheep. 248A 
A Study of Normal and Stenotic Mechanical Heart 
Valves Using Magnetic Resonance. 175A 
Accuracy of Doppler Ultrasound Assessment of 
Transvalvular Pressure Gradients Across Normal 
St. Jude Valve Prostheses In Vitro. 462A 
Artificial Heart Valves: What Is "Optimal" in 1994 
-xiv 
Is the Bernoulli Pressure-Velocity Relationship 
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Correct for St. Jude Valves? • 193A 
Joint Symposium InterAmerican Society of 
Cardiology/American College of Cardiology. 
xxi 
Mechanism of Hemolysis With Mitral Prosthetic 
Regurgitation: A Study Using Transesophageal 
Echo and Fluid Dynamic Simulation. 359A 
Predictors and Outcome of Small Abnormal 
Prosthetic Echoes in Transesophageal 
Echocardiography After Mitral Valve 
Replacement. 278A 
Reduction of Left Ventricular Afterload After 
Implantation of St. Jude Medical 19 mm Valve 
Prosthesis.409A 
Timing of Surgical Intervention for Mitral 
Insufficiency. xxviii 
Valve Replacement in Patients With Severe Left 
Ventricular Dysfunction. 278A 
Heart valves 
Delineation of Congenital Malformations of Mitral 
Valve Apparatus by Dynamic Three•
Dimensional Echocardiography and Unique 
Image Segmentation Using a Tomographic 
Transthoracic Approach. 169A 
Is Gender an Independent Risk Factor for 
Octogenarians Undergoing Coronary Artery 
Bypass Surgery? • 304A 
Redo Heart Valve Surgery: A 30 Year Experience. 
408A 
Hemodynamics 
Calculation of Regurgitant Volumes From the 
Proximal Orifice Flowfield Using a New 
Nondimensionalized Technique. 463A 
Computer Model for the Hemodynamic 
Coupling Between the Right Heart and the Left 
Heart·333A 
Dilated Cardiomyopathy: Correlation 
Between Myocardial Catecholamine 
Hemodynamics and Long Time Survival. 148A 
Effect of Steroid Withdrawal on Cardiac 
Allograft Function and Exercise Tolerance • 
483A 
Effects of Amlodipine on Venous Capacitance 
and Contractility in Acute Heart Failure. 383A 
Hemodynamic Effects of Adjustable ASD 
Closure in Fontan Patients • 105A 
Hemodynamic Responses During Dobutamine 
Stress Echocardiography Are Augmented in 
Cardiac Transplant Recipients. 92A 
High Dose Oral Amiodarone Loading Exerts 
Important Hemodynamic Actions in Patients 
With Congestive Heart Failure. 384A 
Improved Hemodynamics Achieved With 
Biventricular Pacing. 156A 
Measurement of Pulmonary Artery Diastolic 
Pressure From the Right Ventricle. 430A 
Persistence of Abnormal Ventriculoarterial 
Coupling and Decreased Conduit Vessel 
Compliance Despite Peripheral Vasodilation 
With Hydralazine and Nitroglycerin in 
Congestive Heart Failure. 382A 
Pulmonary Artery Pressure Estimated From a 
Right Ventricular Sensor. 430A 
The Effect of Changes in Heart Rate and 
Loading on Color M-Mode Doppler Filling 
Pattern in the Intact Ventricle. 27 A 
The Effects of Loading Conditions on 
Transmitral and Pulmonary Venous Flow in 
Severe Congestive Heart Failure. 281A 
Hemostasis 
A Randomized Study of the Femostop 
Compression Device to Prevent Vascular 
Complications After Coronary Angioplasty • 
106A 
Association Between Spontaneous Coronary 
Reperfusion and Altered Haemostatic Activity in 
Patients With Acute Myocardial Infarction. 77 A 
Moderate Alcohol Consumption Is Associated 
With a Beneficial Effect on Hemostasis: Analysis 
of the Framingham Offspring Study. 67 A 
Patient Mobilization at One Hour Following Cardiac 
Catheterization Using a Biodegradable CoHagen 
Hemostat. 167 A 
Relation Between Stability of Reperfusion and 
Activation of Haemostatic Mechanisms 
Following Streptokinase in Acute Myocardial 
Infarction. 245A 
The Hemostatic Puncture Closure Device Causes 
Similar Changes in Femoral Artery Flow as a 
Conventional Pressure Bandage: Results of a 
Randomized Study. 286A 
The Hemostatic Puncture Closure Device Shortens 
Time to Hemostasis and Ambulation After 
Arterial Catheterization: Results of a 
Randomized Study. 35SA 
Histamine 
Nonsedating Antihistamines Block Potassium 
Channels • 182A 
Hormones 
l7~-Estradiol Attenuates Endothelial Dysfunction in 
Male Spontaneously Hypertensive Rats. 295A 
Acute Vascular Responses to 17~-Estradiol in 
Postmenopausal Women With and Without 
Atherosclerosis • 380A 
Cardioprotective Effects of Estradiol-I 7 Beta in the 
Isolated Working Female Rat Heart. 231A 
Coronary Arterial Acetylcholine-Induced 
Vasoconstriction Is Reversed by Intracoronary 
Administration of Estradiol-17~ in Menopausal 
Women With Coronary Artery Disease. 7 A 
Differential Effects of Estrogen in Postmenopausal 
Women With Presence or Absence of Vascular 
Dysfunction. 377 A 
Effect of Estradiol-17beta on Forearm Blood Flow in 
Menopausal Women: A Double Blind 
Randomized Study. 273A 
Effects of Hormone Replacement Therapy on Blood 
Pressure in Hypertensive Women. 348A 
Erythropoietin in Heart Failure: A Novel Hormonal 
Mechanism?453A 
Estradiol Potentiation of Endothelium-Dependent 
Vasodilation Is Dependent on Nitric Oxide 
Production. 378A 
Estrogen Replacement in Post-Menopausal Women 
for Primary and Secondary Prevention of 
Coronary Artery Disease Sequelae. xii 
Hormone Replacement After Menopause: 
Importance of Heart Disease in Women's 
Decision Making. 51A 
Long-Term Estrogen Deprivation Alters 
Cardiovascular Structure and Function in Adult 
Female Rats. 469A 
Persistent Elevation of Neurohormones Despite 
Correction of Systolic Heart Failure by Cardiac 
Transplantation. 140A 
Proliferative Response of Human Vascular Smooth 
Muscle CeHs Incubated in Male Serum Is 
PartiaHy Inhibited by Estradiol. 16A 
Role of Calcium Channel and a-Adrenoceptor 
Antagonism in Estrogen-Induced Vasodilation in 
Coronary Conductance and Resistance Arteries. 
211A 
Symptomatic Response to l7beta-Estradiol in 
Women With Syndrome X • 6A 
The Direct Effects of Acute Administration of 3,5,3' 
Triiodo-L-thyronine on Isolated Myocyte 
Function. 464A 
HyperJipoproteinemia 
Effect of Vitamins A, C and E on Oxidative 
Modification of LDL From 
Hypercholesterolemic Subjects. 431A 
Hypertension 
A Windows Software Application to Assess Arterial 
Dynamic Behavior: A Useful Tool in Laboratory 
and Noninvasive Clinical Research. 4A 
Abnormal Transesophageal Doppler Coronary Flow 
Velocity Pattern in Hypertensive Patients With 
Angina Pectoris and Normal Coronary 
Angiogram. 47 A 
Antihypertensive Medication Use by Hypertensives 
SUBJECT INDEX 553A 
in the Women Take Heart Project. 332A 
Augmented Arterial Pressure Responses to 
Cyclosporine in Spontaneously Hypertensive 
Rats: Influence of Renal Family 3A Cytochrome 
P-450.261A 
Coronary Pressure-Flow Diagrams During Maximal 
Vasodilation as Assessed by Transesophageal 
Doppler of Left Coronary Artery: A New Tool 
for Evaluation of Absolute Coronary Flow 
Reserve. USA 
Current Treatment Strategies in Hypertension. xviii 
ECG Changes and Coronary Flow Reserve During 
Stress Testing in Hypertensive Patients. 47A 
Effect of Long-Term Calcium Channel Blocker 
Antihypertensive Therapy on Coronary 
Physiology. USA 
Effect of Persisting Left Ventricular Hypertrophy on 
Functional Capacity and Prognosis in 
Hypertensive Patients. 328A 
Exercise Ejection Fraction Responses During 
Upright and Supine Exercise in Hypertensives 
With Abnormal Filling Rates. 48A 
Hypertension. viii 
Hypertension Specifically Induces Insulin-Like 
Growth Factor Binding Protein-4 Expression in 
Rat Aorta. 348A 
Impaired Endothelium-Dependent Vasodilation in 
Patients With Essential Hypertension: Evidence 
for a Generalized Endothelial Abnormality. 
274A 
Increased Heart Rate Variability Is Associated With 
Improvement of Silent Ischemia in Hypertensive 
Patients With Coronary Disease. 331A 
Left Ventricular Hypertrophy in Elderly 
Hypertension: Relative Importance of Arterial 
WaH Stiffness and Dietary Salt Intake. 332A 
Overreliance on Diastolic Blood Pressure: 
Framingham Study. 114A 
Racial Differences in Myocardial Ischemia and 
Coronary Flow Reserve in Hypertension. 415A 
Radial Artery Mass Is Determined by the Level of 
Arterial Pressure and Correlated With Left 
Ventricular Mass. 114A 
Relationship Between Essential Hypertension and 
Coronary Heart Disease: Cell Lipid Mechanisms 
and Drug Correction. 331A 
Responses of Internal Mammary Artery Graft Flow 
to Nitroprusside: A Duplex Doppler Study in 
Hypertensive Hearts. 331A 
Role of Endothelium-Derived Nitric Oxide in the 
Vasodilator Response to Bradykinin in 
Normotensive and Hypertensive Humans. 347A 
The Determinants of Atrial Thickness and 
Thickening: A Transesophageal 
Echocardiography Study. 76A 
Update on the Management of Hypertension in 
Afro-Americans. xxvi 
Hypertension, pulmonary 
Acute Hemodynamic and Neurohumoral Effects of 
Intravenous Prostacyclin in Primary Pulmonary 
Hypertension.37SA 
Automated Determination of Pulmonary Artery 
Elastic Properties During Transesophageal 
Echocardiography • 310A 
Increased Frequency of the Angiotensin Converting 
Enzyme DID Genotype in Patients With Severe 
Pulmonary Hypertension. 177A 
Is There Neurohumoral Activation in Primary 
Pulmonary Hypertension and Isolated Right 
Ventricular Dysfunction? • 426A 
Hypertension, renal 
Contraction Amplitude and Amplitude-Frequency 
Relationship in Single Cardiomyocytes From 
Goldblatt Hypertensive Guinea Pigs. 464A 
Regression of Renal Fibrosis and Damage in 
Experimental Renovascular Hypertension Using 
an Angiotensin Type I Receptor Antagonist. 
332A 
Hypertrophy 
Age, bFGF and Coronary Adaptations to Left 
554A SUBJECf INDEX 
Ventricular Pressure Overload Hypertrophy. 
93A 
Atrial Natriuretic Peptide and Diastolic Function in 
Young Essential Hypertensives. 49A 
Compensatory Hypertrophy in Humans Following 
Extensive Myocardial Infarction Is Discordant 
With Changes in Left Ventricular Volume • 
413A 
Coronary Flow Reserve Measurement Allows 
Differentiation of Hypertrophic Cardiomyopathy 
From the Athlete's Heart. 160A 
Effect of Persisting Left Ventricular Hypertrophy on 
Functional Capacity and Prognosis in 
Hypertensive Patients. 328A 
Electrocardiographic Identification of Left 
Ventricular Hypertrophy: Relationship of Test 
Performance to QRS Duration and Validation of 
the Voltage-Duration Product. 370A 
Exercise and Dobutamine Stress Echocardiography 
in Patients With Left Ventricular Hypertrophy 
and Suspected Coronary Artery Disease. 143A 
Exercise-Induced Structural Remodeling of Left 
Ventricle in Super Athletes. 328A 
Gender Differences in QRS Duration and Voltage: 
Relationship to the Electrocardiographic 
Identification of Left Ventricular Hypertrophy. 
369A 
Hypertrophic Cardiomyopathy: New Advances. xxv 
In Older Patients With Normal Ejection Fraction, 
High Relative Wall Thickness Is Associated 
With Reduced Systolic Pump Performance and 
Depressed Myocardial Contractile Function • 
417A 
Is Left Ventricular Concentric Remodeling a 
Predictor of Left Ventricular Hypertrophy in 
Cardiac Transplant Recipients? .21A 
Left Ventricular Hypertrophy in Elderly 
Hypertension: Relative Importance of Arterial 
Wall Stiffness and Dietary Salt Intake. 332A 
Management and Prognosis of Hypertrophic 
Cardiomyopathies • xxvi 
Racial Differences in the Prevalence of Left 
Ventricular Hypertrophy Among Chronic 
Cocaine Abusers. 48A 
Ras and IGF-! Signaling Pathways in Cardiac 
Growth and Hypertrophy. 45A 
Regression of Left Ventricular Hypertrophy in 
Experimental Hypertension: Increased Diastolic 
Stiffness Is More Dependent on Myocardial 
Collagen Than Mass. 48A 
Relation of Left Ventricular Mass to Insulin 
Resistance and Blood Pressure in Nonobese 
Subjects. 48A 
Total QRS Voltage: Echocardiographic Evaluation 
of Its Accuracy in Diagnosing Left Ventricular 
Hypertrophy.37OA 
HypoxIa 
BMSI8132! Accumulation in Ischemic Myocardium 
Reflects the Severity of Ischemic Insult. 422A 
Docs Glucose andlor Insulin Influence Survival of 
Myocytes During Simulated Hypoxia? • 464A 
Enhanced Left Ventricular Function After Long•
Term Continuous Positive Airway Pressure 
'freatrnent of Sleep Apnea. 418A 
Fatty Acid Oxidation and Mechanical Function 
During and After Anoxia in Newborn Rabbit 
Myocardium.237A 
Kinetic Analysis of Technetium-99m Labeled 
Nitroimidazole (BMS-181321): A Marker for 
Hypoxic Myocardium. 343A 
Value of Transesophageal Echocardiography in the 
Evaluation of Persistent Hypoxemia in an ICU 
Setting.75A 
Image processIng. computer-asslsted 
3-D Intravascular Ultrasound Imaging With 
Automated Border Detection Using 2.9 F 
Catheters. 174A 
3-D Shape Based Tracking of Left Ventricular Wall 
Motion: Experimental Validation. 18lA 
A New Method for Determining Pulsatile Volume 
Flow Rate by Surface Integration of Velocity 
Vectors from Biplane Doppler Echocardiograms 
·239A 
Abrupt Vessel Closure After Coronary Angioplasty 
Is Associated With High Intraluminal Pixel 
Variance at the Postprocedure Angioplasty Site • 
435A 
Alignment Software to Facilitate the Accurate 
Registration of Myocardial Images Obtained 
With Different Imaging Techniques. 218A 
Automated Computer Algorithms Measuring Length 
and Area Parameters for Echo Images Are 
Unaffected by 25: 1 JPEG Compression. lOlA 
Automatic Detection of Arterial Lumen and 
Medioadventitial Boundaries in Intravascular 
Ultrasound Images Using Textural Operators and 
Mathematical Morphology. 3A 
Biologic Color EnCoding in Surface Modeling of 
Three-Dimensional Echocardiograms Enhances 
Appraisal of Cardiac Anatomy and Spatial 
Relations of Cardiac Structures by Simulating 
Natural Gross Anatomy. 310A 
Clinical Application of Echocardiographic 
Automatic Myocardial Contour Detection. 
218A 
Compression of Two-Dimensional 
Echocardiographic Images: How Far Can We 
Go? .I02A 
Echocardiographic Image Processing by Means of 
Methods of Mathematical Morphology. 51A 
Endocardial Phase Mapping Improves Detection of 
Regional Wall Motion Abnormalities. 3lOA 
Enhancing User Interaction by Implementing 
Graphical Objects, Video Images and Sound 
Memos in a Departmental Cardiovascular 
Network. 334A 
Feasibility of Applying Karhunen-Loeve Procedure 
to Transesophageal Echocardiographic Images. 
217A 
Highly-Compressed Digital Archival of 
Echocardiograms Can Replace Analog 
Videotape and Improve Objective Image Quality 
.409A 
Measurement of Absolute Coronary Flow by Three•
Dimensional Reconstruction of the Coronary 
Arterial Bed: Experimental Results. 209A 
Measurement of Left Ventricular Ejection Fraction 
by "Artificial Vision-Neural Network" • ISlA 
New Irreversible Compression Techniques for 
Archiving Angiocardiographic Static Images. 
I02A 
The Effect of Changes in Heart Rate and Loading on 
Color M-Mode Doppler Filling Pattern in the 
Intact Ventricle. 27 A 
Three-Dimensional Echocardiography: A Method for 
Right Ventricular Volume and Endocardial 
Surface Area Computation In Vivo by Polyhedral 
Surface Reconstruction. 333A 
Three-Dimensional Echocardiography: In Vitro 
Validation of Left Ventricular Volumes. 310A 
Variability in Quantitative Coronary Angiography: 
Higher Precision by Analysis in Consecutive 
Frames. 209A 
Immune system 
Increased Frequency of Organ-Specific Cardiac 
Antibodies in Asymptomatic Relatives of 
Patients With Familial and Nonfamilial Dilated 
Cardiomyopathy. 34IA 
Immunologic factors 
Functional Capacity of Murine Cardiac Allograft•
Infiltrating T -Cells Obtained by In Vitro 
Stimulation With IL-2 • 483A 
Prevention of Severe Cardiac Allograft Rejection 
With Pravastatin: A Randomized Thal • 483A 
The Natural History of Focal Moderate Rejection in 
Orthotopic Heart Transplant Recipients. 483A 
Immunologic factors 
Abnormalities in Lymphocyte Populations in Infants 
With Neural Crest Cardiovascular Defects • 
286A 
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Benefit of Steroid Weaning Late After Cardiac 
Transplant: Relationship to Transplant Coronary 
Artery Disease. 230A 
Cellular Immunity Is Activated in Young Normal 
Cholesterol Patients With Coronary Artery 
Disease • 337 A 
Chagas' Disea~e Cardiopathy: Antigenic 
Mimicry Between Trypanosoma Cruzi and Heart 
Myosin With Clinico-Biological Relevance • 
45A 
Early Infiltration of Arterial Intima by 
Activated GammalDelta-TCR Bearing Dendritic 
T Lymphocytes in Ligated Human Arteries. 
235A 
Identification of Cardiac Myosin-Specific T 
Cell Population in Rats With Myosin-Induced 
Autoimmune Myocarditis. 262A 
Levels of Soluble Interleukin-2 Receptor in 
Dilated Cardiomyopathy: Clinical and 
Histological Correlates. 214A 
Implants, artificial 
Changes in Mixed Venous Oxygen Saturation 
During Routine Daily Activities in Heart Failure 
Patients • 400A 
Effect of Capacitor Size on Defibrillation 
Threshold in Humans. 86A 
Implantable Cardioverter-Defibrillators: 
Should Patients Be Allowed To Drive? • 206A 
Improved Safety of Transcatheter Vascular 
Occlusion Utilizing a New Retrievable Coil 
Device. 359A 
Long-Term Clinical Results and Safety of 
Epidural Spinal Stimulation for Angina. 389A 
Prevention of Recurrent Pulmonary Embolism 
Following Thrombolysis by Percutaneous 
Insertion of Inferior Vena Caval Filter. 96A 
Transcatheter Occlusion of Patent Ductus 
Arteriosus With an Adjustable Buttoned Device: 
International Experience. 390A 
Two Year Follow-Up Results of Transcatheter 
Occlusion of Secundum Atrial Septal Defects 
With Buttoned Device. 358A 
Infarct size 
Acetylcholine Acts as a "Preconditioning•
Mimetic" in the Canine Model. 396A 
Alphal-Adrenergic Agonists Can Precondition 
Myocardium Through Direct Activation of 
Protein Kinase C • 396A 
Does Gender Influence Myocardial Injury and 
Dysfunction Following Experimental 
Myocardial Ischemia/Reperfusion? • 23IA 
Endothelins Protect the Ischemic Myocardium 
.30AA 
Exposure to Environmental Tobacco Smoke 
Increases Myocardial Infarct Size in Rats • 232A 
Inttarnyocardial Injection of Adenosine and 
Saline Stimulate a Cardioprotective Effect in 
Rats .232A 
Intravenous Nitrate in Acute Myocardial 
Infarction: Benefit in Non Q Wave but Not Q 
Wave Infarcts. 362A 
Limitation of Infarct Size in Rabbit Hearts by 
Adenosine Deaminase Inhibition Is Not 
Mediated via Adenosine Receptors • 232A 
Optimizing Recovery of Ischemic 
Myocardium by Combining Percutaneous 
Bypass With Coronary Venous Retroperfusion • 
30lA 
Protection of Myocardium by Transient 
Preischemic Alpha-Adrenoceptor Activation in 
the Rabbit. 397A 
Relationship Between Heat Shock Treatment, 
Catalase Inhibition, and Infarct Size in Rat Hearts 
.31A 
Sodium Kinetics in Interventions That Limit 
Infarct Size: Insights into Preconditioning. 
397A 
The Effect of Induced Tolerance to Bacterial 
Lipopolysaccharide on Myocardial Infarct Size 
in Rat~ • 199A 
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Insulin 
Effect of Insulin Infusion on Endothelium-Derived 
Vasoactive Mediators. 372A 
Inhibition by Gemfibrozil of Induction of 
Plasminogen Activator Inhibitor Type-l by 
Insulin and Its Precursors. 439A 
Insulin Increases Endothelin-l Release from Human 
Endothelial Cells • 42A 
Insulin Resistance in Chronic Heart Failure • 454A 
Insulin Resistance Syndrome in Patients With 
Angina. 163A 
Relation of Left Ventricular Mass to Insulin 
Resistance and Blood Pressure in Nonobese 
Subjects • 48A 
The Hyperinsulinemia-Fibrinolytic Relationship in 
Humans and Its Relationship to Premature 
Coronary Artery Disease. 337 A 
Intravascular ultrasound 
3-D Intravascular Ultrasound Imaging With 
Automated Border Detection Using 2.9 F 
Catheters. 174A 
Angiography Poorly Predicts Actual Lesion 
Eccentricity in Severe Coronary Stenoses: 
Confirmation by Intracoronary Ultrasound 
Imaging. 413A 
Assessment of Coronary Arterial Wall Elasticity 
Using Intravascular Ultrasound: Alteration 
Induced by Sublingual Nitadipina in Humans. 
242A 
Atherosclerotic Burden Detected by Intravascular 
Ultrasound in Familial Hyperlipidemia Relates 
Inversely to High Density Lipoproteins. 290A 
Brockenbrough Transseptal Puncture With Guidance 
of Intracardiac Echocardiography • 311A 
Calcium Estimation by Intravascular Ultrasound and 
Ultrafast Computed Tomography. 180A 
Can Intravascular Ultrasound Predict the Clinical 
Outcome Following Percutaneous Transluminal 
Angioplasty? • 242A 
Can Intravascular Ultrasound Yield Accurate 
Measures of Vascular Anatomy? Documentation 
of the Critical Importance of Uniform Rotational 
Velocity. 173A 
Changes in Wall Morphology and Stiffness of 
Saphenous Vein Graft One Year After 
Aortocoronary Bypass Surgery: Serial 
Intravascular Ultrasound Assessment In Vivo. 
241A 
Characterization of Vascular Mechanical Properties 
With Three-Dimensional Intravascular 
Ultrasound and Finite Element Analysis. 378A 
Chronic Compensatory Arterial Dilatation Following 
Coronary Angioplasty: An Intravascular 
Ultrasound Study. 139A 
Clinical Correlates of Atherosclerosis in 
Angiographically Normal Coronary Artery 
Reference Segments: An Intravascular 
Ultrasound Study. 373A 
Comparison of Coronary Luminal Area Obtained 
from Intracoronary Ultrasound and Both Edge 
Detection and Videodensitometric Quantitative 
Angiography Following PTCA and DCA. 70A 
Comparison of DCA and Rotoablation by 
Intravascular Ultrasound: Mechanism and Extent 
of Plaque Removal. 301A 
Detection of Coronary Atheroma by Quantitative 
Angiography: Insights Gained From 
Intracoronary Ultrasound Imaging. 174A 
Determinants of Lumen and Plaque Changes After 
Balloon Angioplasty: A Quantitative Ultrasound 
Study. 414A 
Differentiation of False Positive Scintigraphy by 
Intracoronary Ultrasound and Doppler. 257 A 
Does the Vasodilatory Response to Nitroglycerin 
Over Time Affect Quantitative Assessment of 
Coronary Artery Lesion Dimensions Using 
Intravascular Ultrasound? • 243A 
Dynamic Expansion of Coronary Arteries: 
Implications for Intravascular Ultrasound 
Measurements • 242A 
Extent of Plaque Fracture Explains Discrepancy 
Between Angiographic and Intravascular 
Ultrasound Measurements After PTCA • 271A 
Failure of Compensatory Enlargement During the 
Development of Coronary Artery Disease Is 
Often Responsible for Severe Coronary Stenoses 
• 414A 
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Nitric Oxide and Pulmonary Vascular 
Assessment Prior to Heart Transplantation. 
141A 
Pulmonary Hypertension - Advances in 
Treatment. ix 
Treatment of Pulmonary Hypertension With 
Prostacyclin Analogue Doprost • 375A 
Pulmonary edema 
Clinical Characteristics Associated With 
Acute Cardiogenic Pulmonary Edema. 466A 
Pulmonary embolism 
Circadian and Circannual Rhythm of 
Pulmonary Embolism in a Hospitalized 
Population. 381A 
New Infusion Removable Inferior Vena Caval 
Filter Catheter (Filcard RF 02) for Protected 
Thrombolytic Treatment in Deep Venous 
Thrombosis and Pulmonary Embolism: Results 
of an International Multicentric Study. 95A 
Prevention of Recurrent Pulmonary Embolism 
Following Thrombolysis by Percutaneous 
Insertion of Inferior Vena Caval Filter. 96A 
Treatment of Severe Pulmonary Embolism by 
Means of a High Speed Rotational Catheter 
(Angiocor Thrombolizer): First Experience of 
Mechanical Thrombolysis in Human Beings. 
474A 
Two-Dimensional Doppler Echocardiography 
as the Initial Diagnostic Tool for Acute 
Pulmonary Embolism. 95A 
When Should Thrombolytic Therapy Be Used 
for the Management of Pulmonary Embolism? • 
xxii 
Pulmonary function 
Normal Subjects ECG-and-Respiration 
Reference Databases on CD-ROM. 168A 
Positive Echo-Contrast Does Not Correlate 
With Physiologic Shunt Studies in Patients With 
Severe Liver Disease. 25A 
Pulmonary heart disease 
Comparison Between Automatic Border 
Detection and Planimetry of Right Ventricular 
Size and Function Following Surgical Treatment 
of Thromboembolic Pulmonary Hypertension. 
239A 
Differential Impact of Right Ventricular 
Pressure and Volume Overload on Left 
Ventricular Ejection Fraction. 419A 
RecClvery of Right Ventricular Function 
Following Lung Transplantation and Possible 
Relationship to Preop Diagnosis. 417A 
Right and Left Ventricular Diastolic Function 
at Rest and Exercise in Pulmonary Hypertension 
.418A 
Right and Left Ventricular Systolic Interaction 
at Rest and Exercise in Pulmonary Hypertension 
.418A 
Radioisotopes 
Assessment of Myocardial Viability by Tc-99m 
Tetrofosmin in a Canine Model of Coronary 
Occlusion and Reperfusion • 475A 
Kinetic Analysis of Technetium-99m Labeled 
Nitroimidazole (BMS-181321): A Marker for 
Hypoxic Myocardium. 343A 
Left Ventricular Ejection Fraction Response to 
Amrinone Bolus: A Challenge in Order To 
Identify Patients With Ischemic Cardiomyopathy 
and Reversible Chronic Left Ventricular 
Dysfunction. 343A 
Mechanisms and Implications of Redistribution 
During Dynamic Rest SPECT 1-123 IPPA 
Imaging. 423A 
Myocardial Tc-99m Q-12 (TechneCardTM) 
Clearance Is Not Affected by Ischemia and 
Reperfusion in an Isolated Perfused Rat Heart 
Model.422A 
Myocardial Teboroxime Clearance Derived From 
Canine Scans Differentiates Mild and Severe 
Flow Restrictions Following Dipyridamole. 
255A 
Residual Coronary Reserve Identifies Regional 
Viability in Man • 116A 
SPECT Tc-99m Tetrofosmin Imaging During 
Dipyridamole-Induced Coronary Hyperemia. 
255A 
Technetium-99m Tetrofosmin Perfusion Imaging: 
Analysis of Heart. Lung and Liver Kinetics After 
Dipyridamole and at Rest. 254A 
The 11-201-Tc-99m Difference Bullseye: An 
Objective Method to Identify Perfusion 
Abnormalities and Attenuation Artifacts in Dual 
11-201 Rest Tc-99m Stress Perfusions Scans. 
lS9A 
Radionuclide imaging 
"False Positive" Stress Myocardial Perfusion 
Tomographic Studies Are Significantly Reduced 
by Comparison to Physiologic Post-Stenotic 
Coronary Flow Reserve. Not Anatomic 
Quantitative Stenosis Severity. 2S6A 
125I-BMIPP as a Marker of Myocardial 
Hypoperfusion: Comparison to 201TI by 
Quantitative Dual Tracer Autoradiography. 
423A 
99mTc-Teboroxime Scintigraphy for the Early 
Diagnosis of Coronary Reperfusion During 
Thrombolytic Therapy for Acute Myocardial 
Infarction. 47SA 
A Comparison of Myocardial "Risk Area" as 
Determined by Stress Imaging and by 
Intracoronary Tc-99m Sestamibi Injection. 
lS9A 
Additional Prognostic Value of Thallium-201 
SPECT Perfusion Imaging According to the 
Results of the Exercise Electrocardiogram in 
Patients With Suspected Coronary Artery 
Disease. 62A 
Arbutamine Stress Using a Computerized Closed•
Loop Delivery System: A Multicenter Trial of 
Diagnostic Accuracy With Thallium-201 SPECT 
.126A 
Assessment of Myocardial Viability by Tc-99m 
Tetrofosmin in a Canine Model of Coronary 
Occlusion and Reperfusion • 47SA 
Clinical Significance of Left Ventricular Cavity 
Dilatation With Dipyridamole Tc-99m Sestamibi 
SPECT Imaging. lS9A 
Comparison of Sestamibi Perfusion Defects and 
LunglHeart Ratio During Exercise With Known 
Indices of Adverse Prognosis in Patients With 
Coronary Artery Disease. lS8A 
Comparison of Tc-99m QI2 and TI-201 Imaging for 
Detection of Angiographic Coronary Artery 
Disease. 2SSA 
Comparison of 11-201 and Tc-99m-Tetrofosmin 
Imaging in Patients With Coronary Artery 
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Disease Using Quantitative Circumferential 
Profile Analysis. 2S6A 
Computer-Based Teaching Program in Nuclear 
Cardiology. 168A 
Coronary Flow Response to Dipyridamole Using 
Transesophageal Echo Correlates Wi th 
Myocardial Blood Flow Measured by Positron 
Emission Tomography. 360A 
Do Persistent Regional Wall Motion Abnormalities 
After Exercise Represent Stunned Myocardium? 
.79A 
Dual Thallium-Fatty Acid SPECT and Prediction of 
Left Ventricular Improvement After 
Revascularization Following a Myocardial 
Infarction. 476A 
Effect of Nitroglycerin on Sestamibi Uptake in 
Coronary Artery Disease and Left Ventricular 
Dysfunction and Assessment of Myocardial 
Viability. 343A 
Exercise Tc-99m Sestamibi Myocardial Perfusion 
SPEC[: Comparative Prognostic Value in Males 
and Females. lS8A 
Exercise Thallium-201 Single Photon Emission 
Computed Tomography: An Effective Tool to 
Detect Late Coronary Artery Bypass Graft 
Stenosis. 254A 
Functional Outcome of Mild-to-Moderate and Severe 
Irreversible Thallium Defects After 
Revascularization as Assessed by Magnetic 
Resonance Imaging. 423A 
Hemodynamic Changes During Exercise After 
Exposure to Low Level Carbon Monoxide in 
Patients With Ischemic Heart Disease. 67 A 
Hyperacute Visualization of Myocardial Ischemic 
Injury: Comparison of Tc-99m-glucarate. 
Thallium-201. and Indium-lil-antimyosin • 
317A 
Long-Term Prognostic Significance of Normal or 
Abnormal Exercise TI-201 Myocardial 
Scintigraphy in Patients With or Without 
Significant Coronary Stenosis. lS8A 
Long-Term Prognosis in Relation to Adenosine 
TI-201 SPECT Scintigraphic Findings. 62A 
Marfan Syndrome - Clinical Molecular Interface. 
ix 
Mechanisms and Implications of Redistribution 
During Dynamic Rest SPECT 1-123 IPPA 
Imaging. 423A 
Mental Stress-Induced Silent Myocardial Ischemia 
Detected During Ambulatory Ventricular 
Function Monitoring. 247A 
Myocardial Blood Flow Response to Increasing 
Oxygen Consumption and to Pharmacologic 
Vasodilation Is Globally Impaired in Patients 
With Single Vessel Coronary Artery Disease. 
116A 
Myocardial Salvage From Recanalization in Patients 
Treated With Heparin and Aspirin Alone for 
Acute Myocardial Infarction. 362A 
Myocardial Tc-99m Q-12 (TechneCardTM) 
Clearance Is Not Affected by Ischemia and 
Reperfusion in an Isolated Perfused Rat Heart 
Model. 422A 
Myocardial Teboroxime Clearance Derived From 
Canine Scans Differentiates Mild and Severe 
Flow Restrictions Following Dipyridamole. 
2S5A 
New Directions in Myocardial Perfusion Imaging. 
xxii 
Nonivasive Assessment of Myocardial Viability. 
viii 
Noninvasive Imaging of Left Atrial Thrombi With 
Intravenous Administration of Radiolabeled 
Annexin V • 424A 
Nuclear Cardiology: Advances in Noninva~ive 
Assessment of Myocardial Perfusion and 
Viability. iv 
Optimal Use of SPECT Perfusion Imaging for 
Detection of Coronary Artery Disease • xvii 
Pediatric Silent Ischemia. 248A 
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Potential Diagnostic Role of Circumferential 
Thallium Washout Analysis in Patients With 
Hypertrophic Cardiomyopathy. 111A 
Prediction of Improvement of Left Ventricular 
Function After Coronary Revascularization From 
Alterations in Myocardial Metabolic Activity 
Detected With 1-123 Phenylpentadecanoic Acid 
Dynamic SPECf Imaging. 344A 
Predictive Accuracy of Noninvasive Investigation for 
the Detection of Totally Silent Myocardial 
Ischemia. 246A 
Preoperative Dipyridamole Thallium Imaging and 
Holter Monitoring as a Predictor of Preoperative 
Cardiac Events and Long-Term Outcome • 158A 
Prognosis in 484 Consecutive Patients Fol\owing 
Intravenous Dipyridamole Tc-99m Sestamibi 
SPECf Imaging. 63A 
Prognosis in Patients With Spontaneous Chest Pain 
but Without Significant Resting Ischemia on 
Tc99m Sestamibi Scintigraphy. 63A 
Prognosis of 1,044 Patients With Normal Exercise 
Tc-99m Sestamibi Myocardial Perfusion SPECf 
.63A 
Quantitative SPECf Tc99m-Sestamibi Provides an 
Accurate Assessment of Infarct Zone Collateral 
Flow: Experimental Validation. 422A 
Radionuclide Detection of Myocardial Viability -
Conventional Imaging vs. PET. xi 
Rapid Diagnosis of Coronary Disease Using 
Dipyridamole and Teboroxime Washout Imaging 
• 255A 
Rest Tl-201/Stress Tc-99m Sestamibi Separate 
Acquisition Dual Isotope Myocardial Perfusion 
SPECT: Diagnostic Efficacy in Detection of 
Coronary Artery Disease Among Octogenarians 
• lOlA 
Rest-Redistribution 20lThallium Tomography 
Identifies Viable Dysfunctional Myocardium in 
Patients With Coronary Artery Disease. 423A 
Safety of Early IV Dipyridamole Tc-99m Sestamibi 
SPECf Myocardial Perfusion Imaging After 
First Myocardial Infarction. 126A 
Serial Changes in PET Coronary Flow Reserve in 
Asymptomatic Patients Following Coronary 
Angioplasty: Implications for Late Restenosis • 
161A 
Simultaneous Biplane Tc-99m Sestamibi First Pass 
Angiocardiography Using a Scintillation Camera 
With Two Perpendicular Detectors. 424A 
Sinus Node Deceleration During Dobutamine Stress 
Perfusion Scintigraphy as a Marker of Inferior 
Ischemia. 159A 
SPECf Tc-99m Tetrofosmin Imaging During 
Dipyridamole-Induced Coronary Hyperemia. 
255A 
Symptom Limited Arm Exercise Increases Detection 
of Ischemia During Dipyridamole SPECT 
Thallium Stress Testing • 256A 
Tc-99m-Sestamibi SPECf Under Nitrate Infusion for 
Detecting Viable Hibernating Myocardium in 
Asynergic Territories. 343A 
Technetium-99m Sestamibi Distinguishes Stunned 
From Infarcted Myocardium and Predicts Six 
Week Left Ventricular Ejection Fraction After 
Acute Myocardial Infarction. 476A 
Technetium-99m Tetrofosmin Perfusion Imaging: 
Analysis of Heart, Lung and Liver Kinetics After 
Dipyridamole and at Rest. 254A 
Validation of a Noninvasive Method of Measuring 
Coronary Blood Flow Reserve: A Split Dose 
Thallium-201 Rest/Stress Imaging. 256A 
Viability of Sympathetic Nerves Versus Myocytes in 
Ischemic and Reperfused Myocardium. 424A 
WRC-470 (2-cyclohexylmethylhydrazino•
adenosine): A New Selective Adenosine a2a 
Receptor Agonist With Potential for 
Pharmacologic Stress Imaging. 127 A 
Receptors, ~·adrenergic 
Age-Related Decreases in ~1 Receptor mRNA 
Abundance in the Human Heart. 17 A 
Receptors, endogenous substances 
Antisense cDNA Transcription of Insulin-Like 
Growth Factor I Receptor Inhibits Vascular 
Smooth Muscle Cell Growth. 16A 
Do Persistent Regional Wall Motion Abnormalities 
After Exercise Represent Stunned Myocardium? 
.79A 
Proliferative Response of Human Vascular Smooth 
Muscle Cells Incubated in Male Serum Is 
Partially Inhibited by Estradiol. 16A 
The Role of Endothelin Receptors in the Regulation 
of Cardiovascular Function. 425A 
Reentry 
Characterization of Excitable Gap in a Functionally 
Determined Anisotropic Reentrant Circuit. 87 A 
Effects of Rapid Pacing on Components of a Stable 
Functionally Determined Reentrant Circuit. 
283A 
Evidence of Multiform Propagation in the Critical 
Zone of Slow Conduction in Reentrant 
Ventricular Tachycardia. 35A 
Mechanism of Proarrhythmic Action of Flecainide in 
the Postinfarction Canine Heart: High Resolution 
Determination of Conduction and Refractory 
Properties of Normal and Ischemic Tissue. 
183A 
Reflexes, cardiovascular 
Increased Splanchnic Vascular Capacity During 
Severe Hemorrhage. 378A 
The Role of Medical Therapy Is Uncertain in Patients 
With Recurrent Syncope and Positive Tilt Table 
Tests.330A 
The Skeletal Muscle Ergoreceptor Contribution to 
the Ventilatory Response to Exercise Is 
Enhanced in Patients With Chronic Heart Failure 
• 471A 
Rehabilitation 
A Randomized Study of Cardiac Rehabilitation in 
Heart Transplant Recipients. 356A 
Changes in Autonomic Regulation Induced by 
Physical Training in Patients With Congestive 
Heart Failure. 429A 
Characteristics Predicting Improvement in 
Functional Capacity in a Cardiac Prevention and 
Rehabilitation Program. 50A 
Discrepancy Between Estimated METs and 
Measured METs on Exercise Treadmill Testing. 
327A 
Effects of Cardiac Rehabilitation and Exercise 
Training on Exercise Capacity, Coronary Risk 
Factors, and Quality of Life in Women. 50A 
Long-Term (Five Year) Changes in HDL-Cholesterol 
in Cardiac Rehabilitation Patients: Do Gender 
Differences Exist? • 431A 
Marked Benefits of Cardiac Rehabilitation and 
Exercise Training in a Large Elderly Cohort • 
439A 
Poor Recovery in Young Women With Coronary 
Heart Disease. 400A 
Renal circulation 
Renal Artery Stenting for Control of Congestive 
Heart Failure. 96A 
Renal function 
Angiotensin Converting Enzyme Inhibition in 
Combination With Low Dose Salicylate in Heart 
Failure Patients: Effects on Renal Function. 
213A 
Clinical Importance of Preprocedural Renal 
Dysfunction and Its Relation to Procedure•
induCed Renal Failure to Patients Undergoing 
PTCA.69A 
Renin 
Impairment of Cardiac and Endothelial 
Function Is Independent From Blood Pressure 
Increase in Transgenic Rats Expressing the 
Renin-2 Gene. 347A 
Reperfusion 
A Preliminary Study of Lesion-Specific 
Strategy According to Angiographic Findings in 
Acute Myocardial Infarction. 171A 
SUBJECT INDEX 565A 
A Prospective Study of Transluminal Extraction 
Atherectomy in High Risk Patients With Acute 
Myocardial Infarction. 226A 
A Randomized Double Blind Placebo Controlled 
Trial of Adjunctive Therapy With RheothRx 
Injection (Poloxamer 188) in Patients Receiving 
Thrombolytic Therapy for Acute Myocardial 
Infarction. 344A 
An Open Infarct-Related Artery Influences 
Baroreflex Sensitivity: A Marker of Autonomic 
Balance. 148A 
Are Chronically Infarcted Nonfailing Rat Hearts 
More Susceptible to Subsequent Ischemia•
Reperfusion Injury? • 198A 
Are There Gender-Related Differences in Treatment 
Allocation for Acute Myocardial Infarction? • 
316A 
Aspirin Enhances the Benefits of Late Reperfusion 
on Infarct Shape: A Possible Mechanism of 
Aspirin's Beneficial Effects on Survival in Acute 
Myocardial Infarction. 30A 
Attenuation of Myocardial Stunning by the ACE 
Inhibitor Ramiprilat Through a Signal Cascade of 
Bradykinin and Prostaglandins but Not NO • 
199A 
Cardioprotective Effects of Estradiol-17 Beta in the 
Isolated Working Female Rat Heart. 231A 
Comparison Between Acute PTCA After Failed 
Thrombolysis and Immediate PTCA Without 
ThrOmbolysis in Acute Myocardial Infarction • 
405A 
Comparison of Perfluorochemical Emulsions in 
Experimental Myocardial Infarction and 
Reperfusion: Neither Fluosol nor Oxygen 
Reduce Infarct Size or Improve LV Function • 
198A 
Coronary Vasodilatory Reserve Is Impaired After 
Reperfusion in Acute Myocardial Infarction. 
455A 
Effect of Adenosine on Infarct Size Following 
Ischemia-Reperfusion When Lidocaine Is Given 
Only Before Reperfusion • 199A 
Expression of Polymorphonuclear Leukocyte 
Adhesion Molecules in Human Myocardial 
Ischemia-Reperfusion: A Study in Patients 
Treated With PTCA • 260A 
Inhibition of Na/H Exchange Is Not the Mechanism 
by Which Amiloride Improves Postischemic 
Function in Open Chest Dogs. 440A 
L-Arginine Deteriorates Contractile Function in 
Repetitively Occluded-Reperfused Myocardium 
• 263A 
Potential Role of Increased Myocardial Stiffness in 
the Attenuation of Ventricular Remodeling With 
Late Reperfusion Following Myocardial 
Infarction. 478A 
Predictors of In-Hospital and Six Month Outcome 
After Myocardial Infarction in the Reperfusion 
Era: A Report From the Primary Angioplasty in 
Myocardial Infarction (PAMI) Trial. 244A 
Preservation of Left Ventricular Shape and Volume 
(Remodeling) After Reperfusion Improve 
Hemodynamics Independently to Infarct Size in 
Rats With Chronic Myocardial Infarction. 478A 
Relation Between Stability of Reperfusion and 
Activation of Haemostatic Mechanisms 
Following Streptokinase in Acute Myocardial 
Infarction. 245A 
Reperfusion Rapidly Increases Electrical Stability 
and Prevents Fatal Arrhythmias in Rats With 
Acute Myocardial Infarction. 454A 
Substantial (Three-Fold) Benefit of Accelerated t-PA 
Over Standard Thrombolytic Therapy in Patients 
With Prior Bypass Surgery and Acute 
Myocardial Infarction: Results of the GUSTO 
Trial.345A 
The Influence of Both Time to Therapy and 
Collaterals on the Efficacy of Reperfusion 
Therapy in Acute Myocardial Infarction. 29A 
Troponin T Release as a Specific Marker of Early 
566A SUBJEcr INDEX 
Reperfusion After Thrombolysis in Acute 
Myocardial Infarction. 78A 
Use of Coronary Procedures in Patients With Acute 
Myocardial Infarction Hospitalized in Centers 
Willi and Without Coronary Angiography 
Facilities in Israel. 226A 
Restenosis 
Acute and Late Angiographic Results of the Stent 
Restenosis Study (STRESS) • 60A 
Analysis of Early and Late Clinical Events From the 
Stent Restenosis Study (SlRESS) • 60A 
Angiographic and Clinical Outcomes in Saphenous 
Vein Graft Versus Native Coronary Aortoostial 
Lesions • 302A 
Arterial Remodeling: Importance in Primary Versus 
Restenotic Lesions. 139A 
Balloon Overstretch Injury Correlates With 
Neointimal Formation and Not With Vascular 
Remodeling in the Pig Coronary Restenosis 
Model. 138A 
C-myc Antisense Oligomers Reduce Neointima 
Formation in Porcine Coronary Arteries. 395A 
Collagen Elaboration Following Balloon 
Angioplasty: Evidence for Rapid Expression and 
Deposition. 235A 
Comparative Effects of Long (> 12 min) Versus 
Standard « 3 min) Sequential Balloon Inflations 
in PTCA: Preliminary Results of a Prospective 
Randomized Study: Immediate Results and 
Restenosis Rate. 58A 
Comparison of an Experimental Restenosis Model 
With Human Arterial Vessels After Directional 
Peripheral Atherectomy • 300A 
Delayed Reexposure of Injured Arterial Subintima to 
Blood via Erodible Hydrogel Barriers Limits 
Neointimal Hyperplasia. 18A 
Detection of PDGF mRNA in Human Restenotic 
Plaque Tissue by In Situ Hybridization: 
Implication for Novel Therapeutic Approaches. 
124A 
Different Response to Balloon Angioplasty of 
Carotid and Coronary Arteries: Acute Platelet 
Deposition and Intimal Thickening. 234A 
Differential Expression and Function of Two 
Nonmuscle Myosin Isoforrns in Human Vascular 
Smooth Muscle Cells. 394A 
Do Vessel Size and Balloon/Artery Ratio Influence 
Restenosis After PTCA? • 70A 
Does Local Thrombus Formation Increase Long•
Term Luminal Renarrowing Following PTCA? A 
Quantitative Angiographic Analysis. 139A 
Does Stent Implantation in Ostial Saphenous Vein 
Graft Lesions Reduce Restenosis? • U8A 
Early Infiltration of Arterial Intima by Activated 
Gamma/Delta-TCR Bearing Dendritic T 
Lymphocytes in Ligated Human Arteries. 235A 
Effect of Anti-CDl8 Adhesion Glycoprotein 
Monoclonal Antibody on Restenosis Following 
Balloon Angioplasty in the Rabbit 
Atherosclerotic Model. 20A 
Effects of Endovascular Irradiation in a Swine Model 
of Restenosis After Angioplasty • 473A 
Feasibility of Local Drug Application With a New 
Catheter. 188A 
How Clinical Event Rates Relate to Angiographic 
Restudy Diameter Narrowing After Successful 
Angioplasty • 70A 
Immunohistologic Features in CAVEAT Biopsies 
From Directional Atherectomy Prone to 
Restenoses • 124A 
Impact of Stent Size and Indication for Stenting on 
Immediate Outcome and Restenosis • 102A 
In Situ Photo-Polymerized Thin Hydrogel Barriers 
Applied Following Arterial Injury Reduce 
Intimal Thickening • 473A 
In Vivo Endothelial Cell Seeding After Complete 
Vascular Denuding in a Porcine Model. 19A 
Increased Expression of Chemokine-Beta Proteins in 
Human Restenotic Coronary Artery Lesions 
Following Angioplasty • 123A 
Influence of Aldosterone on the Vascular Response 
to Injury. 234A 
Inhibition of Rabbit and Human Vascular Smooth 
Muscle Cell Proliferation: Efficiency of 
Protooncogene Messenger RNA Targeting by 
Antisense Oligonucleotide Compared to Heparin 
• 395A 
Inhibition of Smooth Muscle Cell Proliferation In 
Vivo Following Local Delivery of Antisense 
Oligonucleotides to C-myb During Angioplasty • 
396A 
Intravascular Ultrasound Evidence of 
Atherosclerosis at "Normal" Reference Sites 
Predicts Adverse Clinical Outcomes Following 
Percutaneous Coronary Interventions. 271A 
Late Luminal Loss Is Linearly Related in Tangential 
Wall Tension Following Coronary Intervention: 
Why Loss and Gain Are Proportional. 137 A 
Local Drug Delivery and Photodynamic Therapy in 
an Experimental Restenosis Model. 473A 
Long-Term Effects of Angiopeptin Treatment in 
Coronary Angioplasty: Reduction of Clinical 
Events but Not of Angiographic Restenosis • 
59A 
Lovastatin Restenosis Trial: Results in Patients With 
Cholesterol Over 200 mgldl • 470A 
Low Dose Subablative Ultraviolet (UV-C) Laser 
Irradiation From a Q-Switched Frequency•
Quadrupled Nd: YLF Diode Laser Inhibits 
Neointimal Hyperplasia in Balloon-Injured Rat 
Carotid Arteries • 472A 
Low Power Red Laser Light Inhibits Smooth Muscle 
Cell Proliferation Following Balloon 
Angioplasty • 472A 
M-CSF (Macrophage Coronary Stimulating Factor) 
Decreases Neointimal Formation After Vascular 
Injury.20A 
Medtronic Wiktor Stent Implantation and Follow•
Up: Results From the Core Laboratory. 117A 
Microspheres for Drug Delivery to the Arterial Wall: 
A Study of Kinetics, Toxicity and Effects of 
Corticosteroid Loaded Microspheres • 19A 
Nitric Oxide Donors Reduce Restenosis After 
Coronary Angioplasty: The ACCORD Study. 
59A 
Palmaz-Schatz Coronary Stent Restenosis: Pattern 
and Management .117A 
Palmaz-Schatz Stent as Treatment for Refractory 
Restenosis: Retrospective Comparison With 
Repeat Balloon Angioplasty • 473A 
Predictors of Restenosis After Gianturco-Rubin 
Coronary Stent Deployment: Analysis of 135 
Consecutive Patients From a Single Center. 71A 
Pretreatment With Antagonists to Thromboxane A2, 
Serotonin and ADP Reduces Neointimal 
Proliferation in Canine Coronary Arteries After 
Endothelial Injury. 234A 
Quantitative Angiographic Analysis of Vein Graft 
Lesions Treated With Excimer Laser 
Angioplasty: Immediate and Follow-Up Results 
.449A 
Rational Use of Coronary Stenting To Prevent 
Restenosis: A Randomized Study in Lesions 
With Early Minimal Luminal Diameter loss 
After PTCA • 118A 
Recombinant Human ApoJipoprotein AI-Milano 
Reduces Injury-Induced Neointimal Thickening 
in Hypercholesterolemic Rabbits. 233A 
Residual Stenosis and MLD Following Coronary 
Stenting Do Not Predict Restenosis in the 
Strecker Stent • 134A 
Restenosis Following Directional Coronary 
Atherectomy Is Associated With Inflammation 
and Increased Fibronectin • 124A 
Restenosis in Coronary Artery Disease: Trials and 
Prospects • xvii 
Restenosis With Chronic Total Occlusion: The 
MARCATOR Randomized Trial Experience • 
470A 
Results of Coronary Stenting for Restenosis • 118A 
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Six Month Follow-Up After Acute Phase Platelet 
ITh/IIIa Integrin Blockade in the EPIC Trial: 
Reduction in Need for Revascularization 
Procedures. 60A 
Smooth Muscle Cell Proliferation in Coronary 
Restenosis Is Limited to a Few Generations: Cell 
Kinetic Model Implications. 20A 
Smooth Muscle Proliferation During Neointimal 
Development After PTCA in Swine: 
Identification of Site and Sequence Using 
Proliferating Cell Nuclear Antigen Staining. 
235A 
Stimulation of Vascular Smooth Muscle Cell 
Migration by Thrombin and Its Requirement for 
Protein Synthesis. 233A 
The Impact of Arterial Remodeling on the Chronic 
Lumen Size After Angioplasty in the 
Atherosclerotic Rabbit. 138A 
The Impact of Fish Oil on Restenosis Following 
Coronary Angioplasty: The Fish Oil Restenosis 
Trial (FORT) • 59A 
The Need for Late Target Lesion Revascularization 
After Rotational Coronary Atherectomy Is Lower 
in Women and in Patients With a Larger Acute 
Angiographic Result. 137 A 
The Porous Balloon Catheter Deposits Gold 
Microparticle Suspension Primarily at the Site of 
Medial Fracture in Balloon-Dilated Pig Coronary 
Arteries. 188A 
The Potential Influence of Intramural Expression of 
Plasminogen Activator Inhibitor Type-Ion 
Restenosis • 233A 
The Usefulness of Dobutamine Stress 
Echocardiography for Detecting Restenosis After 
PTCA • 142A 
The Value of Exercise Testing in the Detection of 
"Silent" Restenosis After Successful Coronary 
Angioplasty • 40A 
Thin Hydrogel Barriers for Prevention of Thrombosis 
and Intimal Thickening After Balloon Injury • 
5A 
Transfer of Microparticles to Balloon-Injured Swine 
Coronary Arteries Using the Microporous 
Infusion Catheter. 5A 
Vessel Remodeling After Angioplasty: Comparative 
Anatomic Studies. 138A 
Rheumatic heart disease 
Predictors of Valve Performance Following Mitral 
Valve Repair in Young Patients With Rheumatic 
Mitral Disease. 408A 
Risk factors 
Apolipoprotein(a)-Lowering Effect of Hormone 
Replacement Therapy in Postmenopausal 
Women May Be One Mechanism of 
Cardioprotective Effect of Estrogen. 431A 
Chest Pain With Normal Coronary Arteries: Do 
Atherogenic Risk Factors Cause Syndrome X? • 
67A 
Effects of Cardiac Rehabilitation and Exercise 
Training on Exercise Capacity, Coronary Risk 
Factors, and Quality of Life in Women. 50A 
Endothelium-Dependent Dilation in the Arteries of 
Asymptomatic Subjects Relates to Coronary 
Risk Factors and Their Interaction. 426A 
Lack of Patient Awareness and Physician Treatmeni 
of Hypercholesterolemia in Patients Undergoing 
Coronary Angioplasty • 50A 
Poor Recovery in Young Women With Coronary 
Heart Disease. 400A 
Predictors of Future Coronary Events in 
Asymptomatic Siblings of People With 
Premature Coronary Artery Disease • 264A 
Relationship of Short Stature to Traditional Coronary 
Risk Factors in the Incidence and Survival 
Among Patients With Angiographically Defined 
Coronary Artery Disease. 49A 
The Quantity of Coronary Artery Calcium Predicts 
Maximum Stenosis Better Than Risk Factors. 
401A 
The Relationship Between Coronary Risk Factors 
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and the Angiographic Characteristics of 
Coronary Artery Lesions • 484A 
Which Postoperative Risk Factors Can Predict 
Mortality and Event Rates IS Years After 
Venous Coronary Artery Bypass Grafting? • 
347A 
Shock 
Cardiogenic Shock: Therapeutic Options. xii 
Cardiogenic Shock: Changing Therapies and 
Prognosis • 226A 
Characterization and 'Outcome of Cardiogenic Shock 
Due to Acute Myocardial Infarction by EKG 
Abnormalities: Results of the International 
Registry. 312A 
Evaluation of Systemic Arterial Mechanical 
Properties During Septic Shock in the Absence of 
Volume Resuscitation. 165A 
Impact of Age on Survival After Reperfusion 
Therapy of Cardiogenic Shock. 3I2A 
Myocardial Protective Effects of Percutaneous 
Cardiopulmonary Support in Experimental 
Shock.441A 
Optimal Management of Cardiogenic Shock in AMI: 
Role of Acute Angioplasty • xviii 
Signal averaging 
Abnormal Signal-Averaged Electrocardiogram in 
Patients With Idiopathic Ventricular Fibrillation 
• 460A 
Abnormal Signal-Averaged Electrocardiogram in 
Patients With Nonischemic Dilated 
Cardiomyopathy: Correlation With Ventricular 
Tachyarrhythmias? • 254A 
Adjustment of the Signal-Averaged 
Electrocardiogram for Differences in Baseline 
QRS Duration. 460A 
Efficient Computation of Multivariate Receiver 
Operator and Predictive Characteristics. 52A 
Immediate and Short-Term Reproducibility of the P 
Wave Signal-Averaged Electrocardiogram. 
252A 
Incidence and Prognostic Value of Late Potentials 
After Acute Myocardial Infarction in the 
Thrombolytic Era: Results of a Stepwise 
Regression Analysis. 461A 
Influence of Filtering Techniques on the Time•
Domain Analysis and Clinical Use of Signal•
Averaged Electrocardiogram. 461A 
Late Potentials Are of No Prognostic Value 
and Signal-Averaged ECG Is of Little Use in 
Patients With Coronary Artery Disease in the 
Absence of a Myocardial Infarction. 254A 
Myocardial Viability May Account for Late 
Potentials Detection Early After Acute 
Myocardial Infarction. 196A 
Natural History of Ventricular Late Potentials 
Detected From Immediately After Acute 
Myocardial Infarction and the Subsequent Six 
Months and the Influence of Fibrinolytic Therapy 
.461A 
Prediction of Ventricular Arrhythmias by 
Ventricular Late Potentials in the Short- and 
Long-Term FOllow-Up After Coronary Artery 
Bypass Grafting. 46IA 
Utility of the Signal-Averaged 
Electrocardiogram to Identify Circumflex 
Coronary Infarctions. 196A 
Signal transduction 
Ras and IGF-I Signaling Pathways in Cardiac 
Growth and Hypertrophy. 45A 
Sinoatrial node 
Outpatient Electrophysiological Assessment 
of Sinoatrial and Atrioventricular Nodal 
Function Is Reproducible. 325A 
Radiofrequency Catheter Modification of the 
Sinus Node for Management of Sinus 
Tachyarrhythmias • 83A 
Smoking 
Exposure to Environmental Tobacco Smoke 
Increases Myocardial Infarct Size in Rats. 232A 
Increased Platelet Activation in Cigarette 
Smokers in the Framingham Offspring Study 
Demonstrated by Elevated P-Selectin Activity. 
67A 
Progression of Coronary Artery Disease Following 
Cessation of Cigarette Smoking. 49A 
Smoking Cessation and the Risk of Acute 
Myocardial Infarction and After Venous 
Coronary Artery Bypass Grafting: IS Year 
Follow-Up. 460A 
Treadmill Exercise Test Parameters for Women 
Smokers Compared to Nonsmokers. 40A 
Vasoconstriction of Coronary Stenoses From 
Exposure to Environmental Tobacco Smoke. 
l07A 
Sodium 
Activation of the Cardiac Renin-Angiotensin System 
in Response to Sodium Restriction. 11SA 
Sodium Kinetics in Interventions That Limit Infarct 
Size: Insights Into Preconditioning. 397 A 
The Modulating Action of an Atrial Natriuretic 
Peptide Receptor Inhibitor Upon the Natriuretic 
Effects of Exogenous and Endogenous ANP • 
94A 
Spectrum analysis 
An Interactive User Friendly Computer Program for 
Heart Rate Variability Analysis. 3A 
Comparison of Cohen-Class Time-Frequency 
Distributions of Intracardiac Heart Sounds in 
Man. 267A 
Enhanced Sympathetic Activity Identified by Heart 
Rate Variability Analysis in Hypertrophic 
Cardiomyopathy. 47 A 
Heart Rate Variability as an Assessment of Brain 
Death·66A 
STsegments 
Differentiation of "Benign Mirror Image" From 
High Risk Reciprocal ST Depression Using 
Continuous 12-Lead ST-Segment Recovery 
Analysis. 195A 
Electrocardiographic Evidence of Myocardial 
Preconditioning in Patients Undergoing PTCA • 
68A 
Exercise-Induced ST Elevation After Q Wave 
Infarction: Difference in Implications Between 
Recent and Old Infarction. 8lA 
Exercise-Induced ST Segment Elevation on Infarct•
Related Leads Is Not Related to Myocardial 
Viability: Study on I-Vessel Disease Patients. 
39A 
Gender Differences in Speed and Stability of 
Coronary Reperfusion Following Thrombolytic 
Therapy for Acute Myocardial Infarction. 3l6A 
Improved Ischemia Detection With a 
Microprocessor-Driven 12-Lead Portable Real•
Time ECG Monitor: A Comparison With Holter 
Monitoring. 253A 
Rebound Ischemia During Nitrate-Free Periods With 
Intermittent Cutaneous Nitroglycerin. 54A 
The ST Interval in Children With Long QT 
Syndrome .179A 
Stent 
A Biocompatible Phosphotidylcholine Coating 
Applied to Metallic Stents • 5A 
A Costing Study of Coronary Stenting in Failed 
Angioplasty • 73A 
Acute and Late Angiographic Results of the Stent 
Restenosis Study (STRESS) • 60A 
Amphiphilic Polyurethane Coating of Intracoronary 
Stents Decreases Mortality Due to Subacute 
Thrombosis in a Porcine Coronary Model. l86A 
Analysis of Early and Late Clinical Events From the 
Stent Restenosis Study (STRESS) • 60A 
Autologous Vein Graft Coating Applied to Vascular 
Stents: The Ideal Coated Stent? • 13SA 
Bailout Coronary Stenting for Failed Balloon 
Angioplasty Using Six French Guiding Catheters 
.72A 
Caveats About the CAVEAT Atherectomy Trial. iii 
Complications Related to Intracoronary Stents 
Placed for Moderate and Severe Dissections: 
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Cook FlexStent Registry Report. l02A 
Coronary Stenting With Multiple Stents: 
567A 
Complications and Angiographic FOllow-Up. 
135A 
Coronary Stenting Without Coumadin • 336A 
Coronary Stenting Without Coumadin Phase II • 
335A 
Development of the Heat Activated Recoverable 
Temporary Stent With a Slotted-Tube Design for 
Coronary Application. l03A 
Dilatation Prior to Stent Implantation Predisposes to 
Thrombotic Complications. 72A 
Do Indications Influence Long-Term Clinical 
Outcome After Palmaz-Schatz Coronary 
Stenting? • 134A 
Does Stent Implantation in Ostial Saphenous Vein 
Graft Lesions Reduce Restenosis? • 118A 
Emergency Temporary Stenting Should Be Preferred 
to Permanent Stenting for Abrupt Closure During 
Coronary Angioplasty • l03A 
Emergent Stent Placement: Worse Outcome in the 
Patients With a Recent Myocardial Infarction. 
71Ab 
Hemodialysis Access Angioplasty: Stent 
Deployment for Suboptional Balloon 
Angioplasty Results. 470A 
Impact of Stent Size and Indication for Stenting on 
Immediate Outcome and Restenosis • l02A 
Intracoronary Stents - Who, When, and Where. xii 
Intracoronary Ultrasound Guidance of Stent 
Deployment Leads to an Increase of Luminal 
Gain Not Discernible by Angiography. 7lA 
Intravascular Stents in Coarctation of the Aorta: 
Early Results and Intermediate Follow-Up. 
358A 
Intravascular Ultrasound Assessment of "Biliary" 
Stent Implantation in Saphenous Vein Graft 
Lesions. l36A 
Intravascular Ultrasound Guided Coronary Stenting 
of Angiographic Small Vessels «3.0 mm) • 
l36A 
Local Arterial Wall Drug Delivery From a Polymer 
Coated Removable Metallic Stent: Kinetics, 
Distribution and Bioactivity of Forskolin • 4A 
Management of Abrupt Closure andlor Severe 
Dissection After PTCA • xxvi 
Mechanical Compression (FemostopN)Alone Versus 
Combined Collagen Application (VasoseaIN)and 
FemostopNfor Arterial Puncture Site Closure 
After Coronary Stent Implantation: A 
Randomized Trial. 355A 
Medtronic Wiktor Stent Implantation and Follow•
Up: Results From the Core Laboratory .117A 
Multiple Gianturco-Roubin Stents for Long 
Dissections Causing Acute and Threatened 
Coronary Artery Closure. 73A 
Noninvasive Assessment of Intracoronary Stent 
Patency Using Ultrafast Computed Tomography: 
Early Results. 181A 
Palmaz-Schatz Coronary Stent Restenosis: Pattern 
and Management. 117 A 
Palmaz-Schatz Stent as Treatment for Refractory 
Restenosis: Retrospective Comparison With 
Repeat Balloon Angioplasty • 473A 
Perfusion Balloon Versus Stent for Acute or 
Threatened Closure: Equal Efficacy but 
Significantly Higher Costs After Stenting • lOlA 
Predicting the Risk of Ischemic Complications After 
Bailout Stenting for Failed Angioplasty • 72A 
Predictors of Restenosis After Gianturco-Rubin 
Coronary Stent Deployment: Analysis of 135 
Consecutive Patients From a Single Center. 71A 
Preliminary Patency Experience With Renal Artery 
Stents for Atherosclerotic Renal Artery Stenoses 
• 474A 
Prevention of Stent Subacute Thrombosis by 
Segmented Polyurethaneurea-Polyethylene 
Oxide-Heparin Coating in the Rabbit Carotid. 
187A 
Qualitative Comparison of Intravascular Ultrasound 
568A SUBJECT INDEX 
and Angioscopy With Angiographic Assessment 
of Pa1maz-Schatz Coronary Stents • 72A 
Quantitative Angiographic Analysis of a New 
Ultrasound-Guided Stent Implantation 
Technique. 135A 
Rational Use of Coronary Stenting to Prevent 
Restenosis: A Randomized Study in Lesions 
With Early Minimal Luminal Diameter Loss 
After !'TCA • U8A 
Reduction in Emergency Bypass Surgery Following 
!'TCA Despite an Increase in High Risk Patient 
Characteristics. 353A 
Relation of Clinical Presentation and Lesion 
Morphology to the Procedural Results of PaImaz•
Schatz Stent Placement: A New Approaches to 
Coronary Intervention (NACI) Registry Report • 
135A 
Renal Artery Stent Placement. 474A 
Renal Artery Stenting for Control of Congesti ve 
Heart Failure • 96A 
Residual Stenosis and MLD Following Coronary 
Stenting Do Not Predict Restenosis in the 
Strecker Stent • 134A 
Results of Coronary Stenting for Restenosis • U8A 
Results of Intravascular Ultrasound Guided Coronary 
Stenting Without Subsequent Anticoagulation. 
33SA 
Results With Elective Stenting of the Protected Left 
Main Coronary Artery • 71A 
Stent Placement for the Treatment of Aortoostial 
Saphenous Vein Graft Lesions. 118A 
Stent Redilation in Canine Models of Pulmonary 
Artery Stenosis and Coarctation of the Aorta • 
392A 
Stent Sizing Should Make Allowance for Both 
Inhomogenous Inflation and Recoil • 73A 
Stents for "BailOut" • xxi 
Survival and Event-Free Survival After Stent 
Implantation in Saphenous Vein Grafts and 
Coronary Arteries. 336A 
Sustained Local Drug Delivery by a Novel 
Intravascular Eluting Stent to Prevent Restenosis 
in the Porcine Coronary Artery. 18A 
Three Year Clinical Follow-Up After Palmaz-Schatz 
Coronary Stent Implantation. 134A 
Thrombin Activity and Platelet Activation Following 
Cessation of Heparin in Patients After 
Intracoronary Stenting • 336A 
Timing of Stent OcclusionlThrombosis After Stent 
Placement. 70A 
Treatment of Failed !'TCA With Perfusion Balloon 
Versus Intracoronary Stent: A Short-Term 
Follow-Up. 136A 
Two-Center Experience With the Palmaz-Schatz 
Biliary Stent for Treating Vein Graft and Native 
Coronary Stenoses • 336A 
Vascular Complications Following Directional 
Coronary Atherectomy or Palmaz-Schatz 
Stenting • 136A 
Vascular Complications of Palmaz-Schatz Coronary 
Stenting: Predictors, Management and Outcome 
• 134A 
When Should Atherectomy, Lasers, and Stents Be 
Used, and What Evidence Is There That Outcome 
Is Different Compared to Conventional 
Angioplasty? • xi 
Stress 
Arbutamine Stress Using a Computerized Closed•
Loop Delivery System: A Multicenter Trial of 
Diagnostic Accuracy With Thallium-201 SPECT 
.126A 
Changes in Hemostatic Function at Times of Cyclic 
Variation in Occupational Stress. 37SA 
Comparison of Exercise and Catecholamine Stress 
Agents in Producing Myocardial Ischemia. ISA 
Do Conventional Measures of Coronary Artery 
Disease Severity Predict Mental Stress-Induced 
Myocardial Ischemia? .247A 
Effect of Aggressive Arousal on Precordial T Wave 
Alternans Magnitude in the Normal and Ischemic 
Canine Heart With and Without Betal -
Adrenergic Blockade With Metoprolol • 329A 
Mental Stress-Induced Regional LV Dysfunction in 
Coronary Artery Disease: Relation to Ischemia 
During Sedentary Activity. 247 A 
Safety and Efficacy of High Dose (55 Jlg) 
Dobutamine/Atropine Stress Echo. 238A 
Systolic Anterior Motion of the Mitral Valve During 
Dobutamine Stress Echocardiography in Normal 
Subjects Versus Patients. 144A 
Value of Exercise-Induced QTc Dispersion in the 
Interpretation of Stress Electrocardiogram • 
178A 
Wall Stress and Geometric Adaptation of the Left 
Ventricle Following Orthotopic Heart 
Transplantation. 356A 
Stress echocardiography 
Adequacy of Low Stress Arbutamine Delivered by a 
Computerized Closed Loop System To Provoke 
Ischemia During Echocardiography • 411A 
Arbutamine Echocardiography: Sensitivity and 
Specificity With a New Stress Agent Delivered 
by a Computerized Closed-Loop System. 120A 
Can Quantitative Wall Motion Analysis (Centerline 
Method) Improve the Sensitivity and Specificity 
of Exercise Echocardiography for the Detection 
of Coronary Artery Disease? • 240A 
Chest Pain Despite Angiographically Normal 
Coronary Arteries: Perfusion Defects on 
Technetium Sestamibi SPECT Are Not 
Associated With Abnormal Stress 
Echocardiograms • 120A 
Chest Pain in Association With Dynamic Left 
Ventricular Outflow Obstruction During 
Dobutamine Stress Testing. 142A 
Comparison of Dobutamine and Dipyridamole Stress 
Echocardiography in Patients With Single- and 
Multivessel Disease Undergoing !'TCA • 144A 
Concordance of Myocardial Contrast 
Echocardiography and Dobutamine Stress 
Echocardiography in Evaluation of Myocardial 
Viability. 451A 
Dobutamine Echocardiography in Single Vessel 
Coronary Artery Disease: Relationship With 
Fractional Flow Reserve and Quantitative 
Coronary Angiography • ISA 
Dobutamine Echocardiography Predicts Recovery of 
Hypoperfused Dysfunctional Myocardium in 
Patients With Coronary Artery Disease. 55A 
Dobutamine Echocardiography To Distinguish 
Ischemic From Nonischemic Dilated 
Cardiomyopathy. 149A 
Dobutamine Stress Echocardiography in Patients 
With Severe Aortic Stenosis and Low 
Transvalvular Gradients. 142A 
Dobutamine Stress Echocardiography in the 
Presence of Left Bundle Branch Block: Clinical 
Utility. 143A 
Evidence for Different Pathophysiological 
Mechanisms Underlying Dobutamine- and 
Exercise-Induced Wall Motion Abnormalities. 
16A 
Exercise and Dobutamine Stress Echocardiography 
in Patients With Left Ventricular Hypertrophy 
and Suspected Coronary Artery Disease. 143A 
Exercise Echo and Perfusion Scintigraphy - Which 
Is Best? • xii 
Gender Specific Outcomes After Dobutamine Stress 
Echocardiography: Increased Incidence of Death 
and Myocardial Infarction in Women With an 
Ischemic Response • 55A 
Hemodynamic Responses During Dobutamine Stress 
Echocardiography Are Augmented in Cardiac 
Transplant Recipients. 92A 
How to Perform and Interpret Stress 
Echocardiography • xxi 
Importance of Dobutamine Stress Echocardiography 
in Noninvasive Evaluation of Cardiac Allograft 
Vasculopathy. 141A 
Increasing Myocardial Oxygen Demand Adding 
JACC February 1994:523A-574A 
Atropine to Dipyridamole Improves Diagnostic 
Accuracy of Dipyridamole Echo-Stress Test. 
16A 
Is Diagnostic Accuracy of Exercise 
Echocardiography Affected by Antianginal 
Agents? • 308A 
Lack of Ejection Fraction Increase With Exercise 
Predicts the Progression to Left Ventricular 
Systolic Dysfunction in Hypertrophic 
Cardiomyopathy. 110A 
Left Ventricular Outflow Obstruction and 
Hypotensive Response During Dobutamine 
Stress Echocardiography: Is There a 
Relationship? • 143A 
Multistage Dobutamine Echocardiography Identifies 
High Risk Patients After Acute Myocardial 
Infarction Treated With Thrombolysis. 143A 
Myocardial Viability May Account for Late 
Potentials Detection Early After Acute 
Myocardial Infarction. 196A 
Optimal Dobutamine Dose for the Assessment 
of Myocardial Hibernation With Dobutamine 
Echocardiography: Implications for Digital 
Quad-Screen Image Display. 121A 
Optimal Duration of the Stages in Dobutamine 
Stress Echocardiography • 121A 
Quantitative Coronary Arteriography Versus 
Stress Echocardiography: Which Is the "Best" 
Angiographic Cut-off? • 38A 
Reduction of Exercise-Induced Segmental 
Wall Motion Abnormalities by Long-Term 
Pharmacologic Treatment of Patients With 
Chronic Stable Angina. 114A 
Simultaneous Biplane Transesophageal 
Echocardiography and Concomitant 
Transesophageal Atrial Pacing of the Right 
Ventricle Substantiates Right Ventricular Wall 
Motion Abnormalities. 311A 
Simultaneous Transthoracic and 
Transesophageal Dobutamine Stress 
Echocardiography • 360A 
Superiority of Dobutamine Stress 
Echocardiography Over Electrocardiographic 
Treadmill Test in Diagnosis of Coronary Artery 
Disease in Hypertensive Patients. 47 A 
The Addition of Adenosine to Dobutamine 
Increases the Sensitivity of Detecting Wall 
Motion Abnormalities in the Ischemic Canine 
Model. 142A 
The Atropine Factor in Pharmacological Stress 
Echocardiography • 54A 
The Incremental Diagnostic Value of Addition 
of Dobutamine to the Negative Dipyridamole 
Echocardiography Test. 55A 
The Unk Between Coronary Lesion 
Morphology and Dipyridamole Stress 
Echocardiography Results. 121A 
The Usefulness of Dobutamine Stress 
Echocardiography for Detecting Restenosis After 
!'TCA • 142A 
The Value of Dipyridamole Echocardiography 
in Risk Stratification Before Vascular Surgery • 
308A 
Stroke 
Aortic Arch Atheromas as a Risk Factor for 
Cryptogenic Stroke. 145A 
Asymptomatic Stroke in Patients With 
Chronic Nonrheumatic Atrial Fibrillation. 441A 
Atherosclerotic Disease of the Aortic Arch and 
the Risk of Ischemic Stroke: Preliminary Results 
of a Case Control Study, French Stu~y of Aortic 
Plaques in Stroke (FAPS) • 144A 
Cost-Effectiveness of Transesophageal 
Echocardiography-Guided Cardioversion With 
Anticoagulation Compared to Conventional 
Therapy in Patients With Atrial Fibrillation. 
128A 
Functional Status Following Stroke After 
Thrombolytic Therapy: Results From the 
GUSTO Trial. 28A 
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Higher Arterial Blood Pressure Is Associated With 
Lower Mortality but Higher Risk of Stroke: 
Results From the GUSTO Trial 0 28A 
Is Spontaneous Echocardiographic Contrast in the 
Aorta a Marker for Embolic Events? 0 128A 
Left Atrial Spontaneous Echocardiography Contrast 
Is a Risk Factor for Future Thromboembolic 
Events in Nonvalvular Atrial Fibrillation: Results 
of a Prospective Study 0 441A 
More Aggressive Thrombolytic Treatment Increases 
Stroke Risk: Results From the GUSTO Trial 0 
28A 
Morphological Characteristics of Atrial Septal 
Aneurysms: A.French Multicenter Study Using 
Transesophageal Echocardiography in 259 
Patients 0 74A 
Quantification of Left Atrial Spontaneous Echo 
Contrast Using a New Approach of Integrated 
Backscatter 0 76A 
Redundant Loops of Chordae Tendineae: A New 
Potential Cardiac Source of Embolism Detected 
by Transesophageal Echocardiography 0 7SA 
Role of Transesophageal Echo in Suspected 
Cardiogenic Stroke 0 xvii 
Valve Strands Are Strongly Associated With 
Systemic Embolization: A Transesophageal 
Study ol29A 
Stroke volume 
Homeometric Autoregulation in the Newborn Heart 0 
287A 
Superoxide dismutase 
Low Level of Myocardial Superoxide Dismutase in 
Patients With Atrioventricular Canal 0 306A 
Supraventricular tachycardia 
A New Proposal for Classification of Uncommon 
Atrioventricular Nodal Reentrant Tachycardia 0 
249A 
A Randomized Placebo-Controlled Trial of 
Propafenone in the Prophylaxis of Paroxysmal 
Supraventricular Tachyarrhythmias 0 2S1A 
AdenosineNeraparnil Sensitive Atrial Tachycardia: 
Endocardial Mapping and Radiofrequency 
Catheter Ablation 0 lSSA 
Closed-Loop Temperature-Controlled 
Radiofrequency Catheter Ablation Reduces 
Impedance Rise in Children and Adolescents 0 
304A 
Differential Mechanistic Responses of Atrial 
Tachycardia to Adenosine 0 443A 
Do Infants Have Medically Refractory 
Supraventricular Tachycardia? 0 2S0A 
Effects of Enhanced Vagal Tone on Fast and Slow 
Pathway Conduction During AV Nodal 
Reentrant Tachycardia 0 369A 
Fast Pathway Properties Before and After Slow 
Pathway Ablation in Patients With AV Node 
Reentrant Tachycardia 0 lS4A 
Functionally Distinct Dual Inputs Into the Human 
AV Node o2SlA 
Intermittent Atrial Fibrillation: Factors Which 
Predict Maintenance of Sinus Rhythm 0 2S1A 
New Technologies and Techniques in Catheter 
Ablation 0 xx 
Penetration of Atrioventricular Nodal Reentrant 
Circuit During Atrial Extrastimulation Without 
Resetting Tachycardia Cycle Length: Further 
Insights into the Anatomic Boundary of ReentrY 
o 367A 
Radiofrequency Ablation Therapy in Atypical or 
Multiple Atrioventricular Node ReentrY 
Tachycardias 0 lS4A 
Site of Origin of Ectopic Atrial Tachycardia Predicts 
Its Response to Adenosine 0 2S0A 
Specific Signals From the Fast Pathway in AV Nodal 
Reentrant Tachycardias Confirmed by 
Radiofrequency Catheter Ablation 0 lS4A 
Supraventricular Dysrhythmias: Diagnosis and 
Therapy 0 168A 
Temperature Guided Radiofrequency Catheter 
Ablation: Comparison of Rapidly and Slowly 
Ascending Temperature Curves in Controlling 
the Growth of Lesions 0 83A 
The "Encircling" Mapping Technique: A Simplified 
Approach to Radiofrequency Current Ablation of 
Ectopic Atrial Tachycardia 0 82A 
The Response to Atrial Pacing as an Aid to the 
Diagnosis of Atypical Atrioventricular Nodal 
Reentrant Tachycardia 0 444A 
Unusual Features of Intermediate Septal Bypass 
Tracts: Multiple Ventricular Insertions 0 368A 
Use of P Wave Morphology To Predict Site of Origin 
of Retrograde Atrial Activation: Validation With 
Atrial Pacing at the AV Annulus o2S3A 
Syncope 
Diagnostic Yield of Echocardiography in Patients 
With Syncope: Is Current Use Justified? 0 307A 
Echocardiography Has a Low Diagnostic Yield in the 
Evaluation of Syncope of Unclear Etiology 0 
43SA 
Endothelin-l as a Predictor of Response to Head-Up 
Tilt Study in Children With Syncope 0 306A 
Evaluation of Syncope 0 ix 
Heart Rate Variability for the Assessment of 
Autonomic Function in Patients With Vasovagal 
Syncope 0 66A 
Increase in Plasma Beta Endorphins Precedes 
Vasodepressor Syncope 0 338A 
Increased Splanchnic Vascular Capacity During 
Severe Hemorrhage 0 378A 
Is Venous Function Abnormal in Patients With 
Neurocardiogenic Syncope? Assessment Using 
Radionuclide Plethysmography 0 330A 
Prevention of Vasovagal Reaction During Removal 
of Femoral Arterial Sheath 0 377 A 
Syncope and Its Significance in Acute Myocardial 
Infarction 0 312A 
The Role of Medical Therapy Is Uncertain in Patients 
With Recurrent Syncope and Positive Tilt Table 
Tests o 330A 
Tilt Table Evaluation for Control Pediatric Patients: 
Comparison to Symptomatic Patients 0 287 A 
Utility of Electrophysiologic Evaluation for Syncope 
in Women 0 202A 
Systole 
Right and Left Ventricular Systolic Interaction at 
Rest and Exercise in Pulmonary Hypertension 0 
418A 
Tetralogy of Fallot 
Cine Magnetic Resonance Imaging Assessment of 
Right Ventricular Function for Long-Term 
Follow-Up of Primary Repair of Tetralogy of 
Fallot in Infancy 0 24A 
Late Results After Repair of Tetralogy of Fallot -
Fate of the Dilated Right Ventricle 0 xiii 
Pericardia! Tube Unifocalization in Patients With 
Pulmonary Atresia. Ventricular Septal Defect 
and Multiple Aortopulmonary Collaterals 0 190A 
Pulmonary Valve Dilation in Tetralogy of Fallot 
With Diminutive Pulmonary Arteries 0 357 A 
Serial Follow-Up of Ventricular Function and Death 
in Adult Patients With Repaired Tetralogy of 
Fallot 0 3119A 
Transesophageal Echo for Predicting Results for 
Repair of Tetralogy of Fallot: Using New High 
Resolution Biplane 5-7.5 MHz Probes With CW 
Doppler Capability 0 22A 
Thromboembolism 
Elevated Plasma Levels of Hemostatic Markers 
Indicate a Prethrombotic State in Patients With 
Nonvalvular Atrial Fibrillation 0 442A 
Plasma Fibrin D-Dimer Levels in Patients With 
Atrial Fibrillation and Left Ventricular 
Aneurysms: Effects of Introducing Warfarin 
Therapy on Thrombogenesis 0 227 A 
Red Cells and Plasma Proteins Are Required for 
Echocardiographic Contrast Formation in 
Human Blood 0 U8A 
The First 72 Hours of Acute Atrial Fibrillation Are 
Associated With Significant Thromboembolic 
Risk 0 4S7A 
SUBJECT INDEX 569A 
Treatment of Severe Deep Venous Thrombosis by 
Means of a High Speed Rotational Catheter 
(Angiocor Thrombolizer): Experience of 
Mechanical Thrombolysis in Peripheral Veins in 
Human Beings 0 9SA 
Warfarin MOnitoring Evaluation of the 
Reproducibility of Fingerstick INR 
Determinations and Comparison With Value 
Obtained With Recombinant Thromboplastins 0 
47SA 
Thrombolysis 
99mTc-Teboroxime Scintigraphy for the Early 
DiagnOSis of Coronary Reperfusion During 
Thrombolytic Therapy for Acute Myocardial 
Infarction 0 47 SA 
A New Variant of Tissue Plasminogen Activator 
With Enhanced Efficacy and Lower Incidence of 
Bleeding When Compared to Recombinant 
Human Tissue Plasminogen Activator (Activase) 
o 314A 
Abnormal Q Waves Are Common Early in Acute 
Myocardial Infarction and Do Not Predict 
Decreased Myocardial Salvage With 
Thrombolytic Therapy 0 19SA 
Advantages of Patient-Specific Predictions Over 
Subgroup Analysis in Defining Differential 
Treatment Effects of t-PA and Streptokinase 
From the GUSTO Trial. 27A 
Bolus Versus Prolonged Intracoronary Urokinase 
Infusion: A Therapeutic Quagmire? 0 18SA 
Clinical Experience With Intracoronary t-PA: 
Results of a Multicenter RegistrY 0 40SA 
Coronary Reperfusion in Patients With an Acute 
Myocardial Infarction Following Intravenous 
Administration of Recombinant Staphylokinase 0 
31SA 
Delaying Thrombolytic Therapy Until Arrival at a 
Tertiary Center Increases Mortality 0 29A 
Dipyridamole Thallium-201 Scintigraphy in 
Uncomplicated Acute Myocardial Infarction 
Treated by Thrombolysis: Diagnostic and 
Prognostic Value 0 476A 
Does Late Thrombolysis Improve Prognosis in 
Patients With ST Depression? 0 147A 
Dose Ranging Trial of Intraanerial r-Prourokinase 
(A-74187) for Thrombolysis of Total Peripheral 
Arterial Occlusions 0 9SA 
Early Angiographic Predictors of Excess Mortality 
Risk Following Lytic Therapy for Myocardial 
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Perfusion. 74A 
The Value of Dipyridamole Echocardiography in 
Risk Stratification Before Vascular Surgery • 
308A 
Vasoconstriction 
Vasoconstriction of Coronary Stenoses From 
Exposure to Environmental Tobacco Smoke. 
l07A 
Vasodilation 
Acute Vascular Responses to 17~-Estradiol in 
Postmenopausal Women With and Without 
Atherosclerosis. 380A 
Coronary Flow-Mediated Dilation Is Preserved in 
Hypertensive Patients. I07A 
Differential Effects of Estrogen in Postmenopausal 
Women With Presence or Absence of Vascular 
Dysfunction. 377 A 
Does High Intensity. Low Frequency Catheter 
Delivered Ultrasound Induce Vasodilation In 
Vivo? • 188A 
Effect of Thermal Vasodilation on Coronary Blood 
Flow and Myocardial Metabolism. 2S8A 
Vasodilator agents 
Acute Vasodilatory Responsiveness in Severe 
Pulmonary Hypertension and Treatment With 
Continuous Prostacyclin (PGI2l Infusion. 375A 
Aminophylline Attenuates Dipyridamole but Not 
Adenosine-Induced Coronary Hyperemia: 
Challenging Clinically Accepted Drug-Receptor 
Mechanisms .107A 
Differential Effect of Acetylcholine on Atrial and 
Ventricular Resistance Vessels Isolated From 
Human Hearts. 427A 
Nifedipine Reduces and/or Delays Need for Valve 
Replacement in Asymptomatic Patients With 
Severe Aortic Regurgitation. 311A 
Pulmonary Hypertension - Advances in Treatment 
.ix 
Sodium Nitroprusside and Isoproterenol Augment 
Acetylcholine-Induced Vasodilation. 379A 
The Role of Inotropic Therapy and New Vasodilators 
in Congestive Heart Failures. viii 
Treatment of Pulmonary Hypertension With 
Prostacyc1in Analogue lIoprost • 37SA 
Vasodilator Therapy in Chronic Aortic Regurgitation 
Enalapril Versus Hydralazine. 367 A 
WRC-470 (2-
cyclohexylmethylhydrazinoadenosine): A New 
Selective Adenosine Ala Receptor Agonist With 
Potential for Pharmacologic Stress Imaging. 
127A 
Ventilation 
The Skeletal Muscle Ergoreceptor Contribution to 
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the Ventilatory Response to Exercise Is 
Enhanced in Patients With Chronic Heart Failure 
o 471A 
Ventricular action potential 
Automatic Accurate Analysis of Monophasic Action 
Potential Recordings 0 4A 
Computer Simulation Using Nonlinear Dynamics 
Accurately Predicts Action Potential Alternans 
Following Sudden Rate Changes and Ischemia 0 
334A 
Effect of Sustained Load On Electrophysiologic 
Parameters During Steady-State Pacing and 
Premature Extrastimulation in the Isolated Intact 
Rabbit Heart 0 327 A 
Ventricular arrhythmia 
A Second Subcutaneous Patch Will Increase 
Implantation Rates for Nonthoracotomy 
Defibrillators 0 12A 
Arrhythmogenic Effects of Myocardial Stretch in 
Chronically Dilated and Failing Ventricles. 
207A 
Benign Long-Term Prognosis of Frequent and 
Complex Ventricular Arrhythmias in Apparently 
Healthy Subjects but Evidence Over Time of 
Silent Underlying Cardiac Diseases 0 323A 
Circadian Pattern of Ventricular Tachyarrhythmias in 
Patients With Implantable Cardioverter•
Defibrillators 0 204A 
Classification of Shocks by History Versus 
Classification by Stored Electrograms in Patients 
With Implantable Defibrillators 0 20SA 
Color Visualization of Propagating Contraction 
From the Focus of Ventricular Premature 
Contraction by High Speed Digital Subtraction 
Echography 0 410A 
Early Hospital Discharge After Initiation of 
Amiodarone Therapy: Mortality and Cost o 280A 
Effect of Propranolol on Mortality in Elderly Patients 
With Heart Disease and Complex Ventricular 
Arrhythmias 0 433A 
Heart Rate Variability and Its Relation to Ventricular 
Arrhythmias in Congestive Heart Failure 0 392A 
How To Program and Troubleshoot the Third 
Generation Cardioverter-Defibrillator • xxix 
Incidence of Clinical Nonbundle Branch Reentrant 
Ventricular Tachycardia After Right Bundle 
Ablation for Bundle Branch Reentrant 
Ventricular Tachycardia 0 203A 
Induction of Ventricular Fibrillation but Not of 
Sustained Monomorphic Ventricular 
Tachycardia Predicts Sudden Death in Patients 
on Amiodarone Because of Ventricular 
Tachyarrhythmias After Myocardial Infarction 0 
280A 
Influence of Exercise and Sport Activity on 
Functional Symptoms and Ventricular 
Arrhythmias in Arrhythmogenic Right 
Ventricular Disease 0 34A 
Initial Experience With a Transvenous Implantable 
Cardioverter-Defibrillator System Using a 
Biphasic Shock 0 112A 
Long-Tenil Efficacy and Safety of 
Electrophysiologic Guided Sotalol Therapy for 
Life-Threatening Ventricular Arrhythmias 0 
322A 
Long-Term Outcome of Patients With 
Arrhythmogenic Right Ventricular Dysplasia 0 
34A 
Long-Term Prognosis of Arrhythmogenic Right 
Ventricular Disease: Follow-Up of 74 Patients 0 
203A 
Morning Peak in Ventricular Arrhythmias Detected 
by Time of Implantable Cardioverter•
Defibrillator Therapy 0 204A 
Predictive Value of Combined Holter Monitoring 
and Electrophysiologic Testing in the ESVEM 
Study o 279A 
Safety and Efficacy of Implantation of Cardioverter•
Defibrillators With Nonthoracotomy Lead 
Systems by Electrophysiologists 0 20SA 
Should Children With Ventricular Ectopic Rhythm 
and a Normal Heart Have an Endomyocardial 
Biopsy? 0 323A 
The SQ Array: A New Nonthoracotomy Implantable 
Cardioverter-Defibrillator Lead That Reduces 
the Defibrillation Threshold 0 111A 
Three-Dimensional Mapping of Cesium Chloride•
Induced Ventricular Arrhythmias 0 467 A 
Torsade de Pointes With Sotalol: Relationship of 
Gender to Risk 0 279A 
Ventricular Arrhythmias and Mortality After 
Myocardial Infarction: A Follow-Up Study of 
14,534 Patients in the CAST Holter Registry 0 
296A 
Ventricular Pacing-Induced Ventricular Tachycardia 
in Patients With Implantable Cardioverter•
Defibrillators 0 323A 
When Is Amiodarone Justified in the Treatment of 
Cardiac Arrhythmias: What Dose to Use and 
How Should the Patient Be Monitored? 0 xxv 
Ventricular fibrillation 
A Prospective Randomized Comparison in Humans 
of 60 JlF Versus 120 JlF 65% Tilt Biphasic Pulse 
Defibrillation Using a Unipolar Pectoral 
Transvenous Defibrillation System 0 13A 
Abnormal Signal-Averaged 
Electrocardiogram in Patients With Idiopathic 
Ventricular Fibrillation 0 460A 
Acute Amiodarone Terminates Ventricular 
Fibrillation by Improving Intracellular Calcium 
Homeostasis in Isolated Perfused Rat Hearts 0 
282A 
Baroreceptor Reflex Sensitivity but Not Heart 
Rate Variability Is Reduced in Patients With 
Clinical Life-Threatening Ventricular 
Arrhythmias 0 148A 
Bretylium Causes a Use-Dependent Increase 
in Refractoriness During Ventricular Fibrillation 
o 184A 
Comparison of Three Commercially Available 
Waveforms Using the ENDOTAK 
Nonthoracotomy Lead System in Pigs 
o13A 
Complications Following Implantation of 
Nonthoracotomy Lead System Cardioverter•
Defibrillators. l11A 
Effects of Biphasic Shocks on Electrogram 
Amplitudes Using a New Integrated Bipolar 
Transvenous Dual Chamber Defibrillator 
Electrode System. 420A 
Electrocardiographic Evidence of Nonuniform 
Ventricular Recovery in Patients With Idiopathic 
Ventricular Fibrillation 0 370A 
Emergency Revascularization for Refractory 
Ventricular FibriUation • 440A 
How Useful Is Electrophysiologic Testing in 
Patients Resuscitated From Ventricular 
Fibrillation? 0 202A 
Influence of a Right Ventricular Foamed 
Electrode on Defibrillation Efficacy 0 8SA 
Initial Experience With 71 Patients 
Undergoing Nonthoracotomy Defibrillator 
System Implantation Using the New 
Subcutaneous Array • 204A 
Is Antitachycardia Pacing Really an 
Advantage in Patients With Cardioverter•
Defibrillators? • 20SA 
Mechanism of Termination of Circus Reentry 
in Ventricular Fibrillation. 207 A 
Propranolol Decreases Number of Ventricular 
Fibrillation Activation Fronts Detected by 506 
Epicardial Electrodes. 327 A 
Regional Capture of Fibrillating Right 
Ventricular Myocardium: Evidence of an 
Excitable Gap in VF Using High Resolution 
Cardiac Mapping 0 283A 
Relationship of Upper Limit of Vulnerability 
to Defibrillation Threshold for Monophasic and 
Biphasic Waveform Human Nonthoracotomy 
Defibrillation. 293A 
SUBJECT INDEX 573A 
Short-Term Predictability of Epicardial Potential 
Fields in VF 0 lS2A 
The Effect of Polarity on Defibrillation Threshold 
Using a Nonthoracotomy Lead System. 12A 
The Effects of Lidocaine on the Vulnerable Period 
During Ventricular Fibrillation 0 292A 
Upper Limit of Vulnerability Tested On or Before the 
Peak ofT Wave Predicts Defibrillation Threshold 
in Dogs 0 293A 
Ventricular Fibrillation and Polymorphic Ventricular 
Tachycardia With Critical Coronary Stenosis: Is 
Bypass Surgery Enough? 0 421A 
Ventricular function 
Accuracy of Biplane Long Axis Cine Magnetic 
Resonance Imaging Volumes in Patients With 
Regional and Global Left Ventricular 
Dysfunction 0 90A 
Accuracy of Three-Dimensional Echocardiographic 
Reconstruction by Electromagnetic Positional 
Location: A Further Step Toward Practical 
Implementation of the Technique 0 9A 
Altered Effects of Load on Rate of Pressure Fall in 
the Stunned Left Ventricle: Impaired Relaxation 
or Decreased Contractility 0 229A 
Assessment of Right Ventricular Volume and 
Function With Intracardiac Ultrasonography: In 
Vivo Validation. 411A 
Beat-ta-Beat Hemodynamics During Atrial 
Fibrillation: Observations in Normal and 
Impaired Left Ventricular Function 0 416A 
Calculation of Left Ventricular Volume From Its 
Three-Dimensional Reconstruction Is 
Independent of Its Geometry 0 309A 
Calibration of Conductance Catheter Ventricular 
Volume for Parallel Conductance by Dual•
Frequency Technique. 16SA 
Clinical and Echocardiographic Findings in Patients 
With Dynamic Left Ventricular Mid-Cavity 
Obstruction 0 193A 
Combined Use of Thrombolysis and Dipyridamole: 
Its Effect on Regional Left Ventricular 
Remodeling and Function in Patients With Acute 
Myocardial Infarction and Single Vessel Disease 
o 31SA 
Comparison of Left Ventricular Performance 
Immediately After Aortic Valve Replacement 
Using Crystalloid or Blood Cardioplegia. 304A 
Contrast Enhanced Color Doppler Technique for 
Measuring Left Ventricular Ejection Fraction. 
468A 
Coronary Microembolization Model of Reversible 
Regional Myocardial Dysfunction 0 16SA 
Defining the Normal Heart in Elite Basketball 
Players 0 401A 
Depressed MidwaU Left Ventricular Performance 
Predicts Cardiac Death in Arterial Hypertension 
.11SA 
Diastolic Creep Causes Depressed Right Ventricular 
Free Wall Systolic Shortening Following 
Pressure Overload 0 229A 
Discordance of Right and Left Ventricular 
Remodeling in Active Myocarditis 0 36SA 
Does a Short-Lasting Mild Episode of Myocardial 
Ischemia Result in Stunning in Patients With 
Coronary Artery Disease? • 79A 
Does Gender Influence Myocardial Injury and 
Dysfunction Following Experimental 
Myocardial Ischemia/Reperfusion? 0 231A 
Effects of Collagen Disruption on Left Ventricular 
Properties in Rat Hearts. 229A 
Exercise Capacity and Cardiac Performance After 
Heart Transplant: Importance of Chronotropic 
Incompetence. 417 A 
Exercise Ejection Fraction Responses During 
Upright and Supine Exercise in Hypertensives 
With Abnormal Filling Rates. 48A 
Force-Frequency Relations During Heart Failure in 
the Pig o97A 
Improvement of Global and Regional Left 
Ventricular Function by Percutaneous 
574A SUBJECT INDEX 
Transluminal Coronary Angioplasty After 
Myocardial Infarction • 68A 
In Older Patients With Normal Ejection Fraction, 
High Relative Wall Thickness Is Associated 
With Reduced Systolic Pump Performance and 
Depressed Myocardial Contractile Function. 
417A 
Increased Left Ventricular Mass, Rather Than 
Atrophy, Is a Precursor of Cardiomyopathy in 
AIDS Patients Despite Significant Loss of Body 
Mass • 365A 
Indications for Aortic Valve Replacement in 
Children With Severe Aortic Regurgitation. 7 A 
Ischemic Myocardium Recoil Impairs Early 
Diastolic Filling. 317A 
Late Cardiotoxicity Following Childhood 
Malignancy: The Effects of Gender and 
Doxorubicin Dose • 120A 
Late Results After Repair of Tetralogy of Fallot -
Fate of the Dilated Right Ventricle. xiii 
Left and Right Ventricular Performance Early and 
Late After Mitral Valve Repair Versus Mitral 
Valve Replacement for Mitral Regurgitation. 
366A 
Left Ventricular Dynamic Geometry, Function, 
Myocardial Oxygen Consumption, and 
Efficiency During Atrial and Ventricular Pacing 
in Conscious Dogs • 94A 
Left Ventricular Ejection Fraction: Three•
Dimensional Echocardiography Versus Two•
Dimensional Echocardiographic Visual 
Estimation With Comparison to Multigated 
Acquisition Radionuclide Angiography. lOA 
Left Ventricular Function After Successful Coronary 
Thrombolysis: Impact of Reocclusion • 129A 
Left Ventricular Function During Incremental and 
Steady State Exercise. 328A 
Left Ventricular Function in Significant Mitral 
Stenosis: Echocardiographic and Hemodynamic 
Data.32A 
Left Ventricular Volumes Predict Development of 
Heart Failure and Potential Clinical Utility of 
ACE Inhibitors in Patients With Asymptomatic 
Systolic Dysfunction. 382A 
Magnetic Resonance Imaging of Left Ventricular 
Mass, Geometry and Function in Elite Cyclists 
and Weightlifters • 89A 
Magnetic Resonance Imaging of Ventricular 
Geometry and Performance in Patients With 
Functional Single Ventricle Throughout Staged 
Fontan Reconstruction. 23A 
Measurement of Left Ventricular Ejection Fraction 
by "Artificial Vision-Neural Network" • 182A 
Mechanism of Atrial Fibrillation: Consequences for 
Left Ventricular and Atrio-Nodal Function. iii 
Mental Stress-Induced Silent Myocardial Ischemia 
Detected During Ambulatory Ventricular 
Function Monitoring. 247 A 
Monitoring of Ventricular Function After Heart 
Transplantation With an Implantable Wall 
Motion Sensor. 355A 
Noninvasive Estimation of Pulmonary Wedge 
Pressure With Doppler Transmitral Inflow in 
Patients With Heart Disease. 240A 
Regional Curvature of the Left Ventricle, an Index of 
Regional Wall Tension, Predicts Progressive 
Ventricular Dilatation Better Than an Index of 
Global Wall Tension: One Year Follow-Up of a 
Randomized Study of Enalapril After First 
Anterior Myocardial Infarction. 130A 
Relationship Between Right and Left Ventricular 
Hemodynamics During Sustained Ventricular 
Tachycardia in Humans. 421A 
Right Ventricular Function in Obstructive Sleep 
Apnea. 418A 
Serial Evaluation of PCr/ATP Ratio and Left 
Ventricular Mass and Volumes in Chronic Mitral 
Regurgitation in the Intact Dog • 446A 
Simultaneous Biplane Tc-99m Sestamibi First Pass 
Angiocardiography Using a Scintillation Camera 
With Two Perpendicular Detectors. 424A 
Transverse Versus Apical Assessment of Systolic 
and Diastolic Function in Children Using 
Automatic Border Detection • 23A 
Valve Replacement in Patients With Severe Left 
Ventricular Dysfunction • 278A 
What Determines the Extent of Mitral Valve Motion? 
A Combined Hemodynamic-Echocardiographic 
Experimental Study. 446A 
Ventricular tachycardia 
A Prospective Randomized Comparison of 
Amiodarone and Sotalol for the Treatment of 
Ventricular Tachycardia. 398A 
Adenosine Sensitivity of Verapamil-Responsive 
Ventricular Tachycardia: Role of 
Catecholamines • 397 A 
An Animal Model for Studying Class TIl-Induced 
Proarrhymias in the Halothane-Anesthetized Dog 
• 326A 
Autonomic Triggers of Ventricular Tachycardia in 
Patients With Repetitive Monomorphic 
Ventricular Tachycardia. 372A 
Benign Long-Term PrognosiS of Frequent and 
Complex Ventricular Arrhythmias in Apparently 
Healthy Subjects but Evidence Over Time of 
Silent Underlying Cardiac Diseases. 323A 
Bretylium Tosylate Is Ineffective for Ventricular 
Tachycardia. 35A 
Changing in Autonomic Influence on the Heart 
lnunediately Before the Onset of Spontaneous 
Idiopathic Ventricular Tachycardia. 322A 
Clinical Outcomes in Elderly Patients Treated for 
Inducible Monomorphic Sustained Ventricular 
Tachycardia. 100A 
Comparison of Monophasic and Biphasic Shocks in 
Cardioversion of Ventricular Tachycardia in the 
Canine Infarct Model. 208A 
Efficacy of Amiodarone in Patients With Ventricular 
Tachycardia and Chronic Chagasic 
Cardiomyopathy. 322A 
Endocardial Resection for Ventricular Tachycardia 
in 353 Patients. 480A 
Endpoints of Drug Therapy: Is Tachycardia Slowing 
Enough?280A 
Evidence of Multiform Propagation in the Critical 
Zone of Slow Conduction in Reentrant 
Ventricular Tachycardia. 35A 
F1unarizine as a Pharmacologic Probe To Identify 
Triggered Activity in Patients With Cardiac 
Arrhythmias. 228A 
Impaired Very Low Frequency Oscillations of Heart 
Rate in Patients With Life-Threatening 
Arrhythmias • 38A 
Incidence and Prognostic Significance of Primary 
Ventricular Tachycardia in 11,483 Patients 
Treated With Reperfusion Therapy After 
Myocardial Infarction in the GISSI 2 Trial. 
314A 
Interstitial Fibrosis as a Substrate of Spontaneous 
Nonsustained Ventricular Tachycardia in 
Idiopathic Dilated Cardiomyopathy. 340A 
Left Ventricular Catheter Endocardial Mapping 
During Sinus Rhythm Chronic Myocardial 
Infarction: Correlation of Electograms Within 
Electrical Impedance • 202A 
Left Ventricular Fibromuscular Band Is the Substrate 
for Idiopathic Left Ventricular Tachycardia. 
398A 
Long-Term Results of Catheter Ablation of 
Ventricular Tachycardia in Patients With 
Coronary Artery Disease. 480A 
Mechanism of Surface ECG Polymorphism of 
Monomorphic Ventricular Tachycardia: Insights 
From Simultaneous Endocardial and Epicardial 
Activation Sequence Mapping in a Canine Infarct 
Model.326A 
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Occurrence of Spontaneous Shocks in Patients With 
Implantable Cardioverter-Defibrillator Without 
any Shocks Before Generator Replacement for 
Battery Depletion. 205A 
On-Line Computerized Body Surface Pace Mapping: 
A Novel Method of Localizing the Origin of 
Ventricular Tachycardias. 51A 
Percutaneous Computerized Electrical Activation 
Mapping of the Heart via Multipolar Electrode 
Catheters in the Coronary Arteries and Veins in 
Dogs • 481A 
Percutaneous Microwave Ablation of the Ventricular 
Myocardium Using a 4-mm Split-Tip Antenna 
Electrode: A Novel Method for Potential 
Ablation of Ventricular Tachycardia. 34A 
Presystolic Spikes Are Not a Specific Marker for 
{diopathic Ventricular Tachycardia With a QRS 
Pattern of Right Bundle Branch Block and 
Superior Axis • 480A 
Proarrhythmia of a Class Ie Antiarrhythmic Drug 
Suppressed by Combination With a Potassium 
Channel Blocking Drug in the Dog Late After 
Infarction. 324A 
Radiofrequency Ablation in Chronic Infarction: An 
In Vitro Investigation of Endocardial Lesion 
Formation and Tissue Electrical Characteristics. 
202A 
Radiofrequency Catheter Ablation for Ventricular 
Tachycardia Not Associated With Coronary 
Heart Disease • 35A 
Relationship Between Right and Left Ventricular 
Hemodynamics During Sustained Ventricular 
Tachycardia in Humans. 421A 
The Diastolic Slope as a Parameter to Demonstrate 
Delayed Afterdepolarizations and Triggered 
Arrhythmias In Vivo: Validation With Lidocaine 
• 426A 
The Pattern of Block of Stimulated Premature 
Impulses Determines the QRS Morphology of the 
Initial Beats of Inducible Monomorphic 
Ventricular Tachycardia. 481A 
The Very Low Frequency Component of Heart Rate 
Variability Is Increased in Patients With Chronic 
Heart Failure Prior to Episodes of Nonsustained 
Ventricular Tachycardia. 66A 
To What Depth Is Cryothermal Mapping Effective? • 
203A 
Viruses 
Anti viral Effects of Human Recombinant Interferons 
a-2a, ~, and 'Y in Persistently Coxsackievirus B3 
Infected Human Myocardial Fibroblasts: A 
Comparative Study In Vitro. 261A 
Arterial Endothelium Abrasion Permits Adenovirus•
Medicated Gene Transfer to Medial Smooth 
Muscle Cells. 372A 
Cardiovascular Gene Therapy Using Adenoviral 
Vectors: Distant Transduction Following Local 
Delivery Using a Porous Balloon Catheter. 
177A 
Enterovirus in Dilated Cardiomyopathic Hearts: 
Molecular Evidence Using PCR and Nucleotide 
Sequencing of the Amplified Product. 262A 
Quantitation of Enteroviral RNA in Endomyocardial 
Biopsy by Competitive Polymerase Chain 
Reaction. 365A 
WoIff-Parkinson-White syndrome 
Fasciculoventricular Accessory Pathways Coexisting 
With Atrioventricular Accessory Pathways. 
155A 
Lessons Learned From Surgery for Failed 
Radiofrequency Catheter Ablation of Accessory 
Pathways. 224A 
Right-Sided Accessory Pathway Ablation Using an 
Anatomically Conforming Long Vascular Sheath 
Design.277A 
Unusual Features of Intermediate Septal Bypass 
Tracts: Multiple Ventricular Insertions. 
368A 
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